contrast	FILTERED OUT	SIMPLE	Medium	0.7	0.9258	0.64806
temporomandibular joint	BEYOND_CUTOFF	Normal_NP	Good	1	0.6205	0.6205
population-based cohort	BEYOND_CUTOFF	Normal_NP	Good	1	0.6205	0.6205
topotecan	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
timisoara	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
redefinition	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
protein-1	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.6192	0.6192
presynaptic	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
prednisone	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
precancerous	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
phlebology	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
minnesota	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
grade dcis	BEYOND_CUTOFF	Normal_NP	Good	1	0.6192	0.6192
focal lesion	BEYOND_CUTOFF	Normal_NP	Good	1	0.6192	0.6192
factor-23	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.6192	0.6192
end-point	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.6192	0.6192
edinburgh	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
dysphonia	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
dermabrasion	BEYOND_CUTOFF	SIMPLE	Good	1	0.6192	0.6192
co-occurrence	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.6192	0.6192
abrasivity	BEYOND_CUTOFF	SIMPLE	Good	1	0.6172	0.6172
pseudomonas aeruginosa	BEYOND_CUTOFF	Normal_NP	Good	1	0.6159	0.6159
multidisciplinary team	BEYOND_CUTOFF	Normal_NP	Good	1	0.6159	0.6159
interprofessional team	BEYOND_CUTOFF	Normal_NP	Good	1	0.6159	0.6159
parasomnia	BEYOND_CUTOFF	SIMPLE	Good	1	0.6153	0.6153
immunoglobulin	BEYOND_CUTOFF	SIMPLE	Good	1	0.6146	0.6146
epileptogenesis	BEYOND_CUTOFF	SIMPLE	Good	1	0.6146	0.6146
pre	BEYOND_CUTOFF	SIMPLE	Good	1	0.6133	0.6133
transmembrane protein	BEYOND_CUTOFF	Normal_NP	Good	1	0.6126	0.6126
cerebrovascular accidents	BEYOND_CUTOFF	Normal_NP	Good	1	0.6126	0.6126
bronchoalveolar lavage	BEYOND_CUTOFF	Normal_NP	Good	1	0.6126	0.6126
immunogens	BEYOND_CUTOFF	SIMPLE	Good	1	0.612	0.612
downregulation	BEYOND_CUTOFF	SIMPLE	Good	1	0.612	0.612
neurological deficit	BEYOND_CUTOFF	Normal_NP	Good	1	0.6094	0.6094
lymphocytic leukemia	BEYOND_CUTOFF	Normal_NP	Good	1	0.6094	0.6094
subclasses	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
salzburg	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
rifampin	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
re-evaluation	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.6088	0.6088
neoplastic	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
hiv drug	BEYOND_CUTOFF	Normal_NP	Good	1	0.6088	0.6088
epistaxis	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
endocrine	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
defibrillators	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
databank	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
co-existence	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.6088	0.6088
carboxylation	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
carboxyl	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
canadians	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
biosecurity	BEYOND_CUTOFF	SIMPLE	Good	1	0.6088	0.6088
anti-viral	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.6088	0.6088
lipid peroxidation	BEYOND_CUTOFF	Normal_NP	Good	1	0.6075	0.6075
neurodegenerative disease	BEYOND_CUTOFF	Normal_NP	Good	1	0.6068	0.6068
rett syndrome	BEYOND_CUTOFF	Normal_NP	Good	1	0.6062	0.6062
paravalvular	BEYOND_CUTOFF	SIMPLE	Good	1	0.6062	0.6062
nccn oncology	BEYOND_CUTOFF	Normal_NP	Good	1	0.6062	0.6062
esc guidelines	BEYOND_CUTOFF	Normal_NP	Good	1	0.6062	0.6062
bioprosthesis	BEYOND_CUTOFF	SIMPLE	Good	1	0.6062	0.6062
vitamin k antagonists	BEYOND_CUTOFF	Normal_NP	Good	1	0.6055	0.6055
schlottke	BEYOND_CUTOFF	SIMPLE	Good	1	0.6049	0.6049
neurological disorders	BEYOND_CUTOFF	Normal_NP	Good	1	0.6042	0.6042
hemodynamic parameters	BEYOND_CUTOFF	Normal_NP	Good	1	0.6042	0.6042
confocal microscopy	BEYOND_CUTOFF	Normal_NP	Good	1	0.6042	0.6042
cpe	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.6036	0.6036
tmd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.6029	0.6029
cholangiocarcinoma	BEYOND_CUTOFF	SIMPLE	Good	1	0.6023	0.6023
fr	BEYOND_CUTOFF	SIMPLE	Good	1	0.6016	0.6016
exercise physiology	BEYOND_CUTOFF	Normal_NP	Good	1	0.601	0.601
patient-year	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.6004	0.6004
tesla	BEYOND_CUTOFF	SIMPLE	Good	1	0.5991	0.5991
bsc	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5984	0.5984
ventricular outflow	BEYOND_CUTOFF	Normal_NP	Good	1	0.5971	0.5971
tibialis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5965	0.5965
thrombus	BEYOND_CUTOFF	SIMPLE	Good	1	0.5965	0.5965
reevaluation	BEYOND_CUTOFF	SIMPLE	Good	1	0.5965	0.5965
proband	BEYOND_CUTOFF	SIMPLE	Good	1	0.5965	0.5965
nk cells	BEYOND_CUTOFF	Normal_NP	Good	1	0.5965	0.5965
myocarditis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5965	0.5965
hpv dna	BEYOND_CUTOFF	Normal_NP	Good	1	0.5965	0.5965
crossover	BEYOND_CUTOFF	SIMPLE	Good	1	0.5965	0.5965
co-operation	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.5965	0.5965
chicago	BEYOND_CUTOFF	SIMPLE	Good	1	0.5965	0.5965
psychopharmacology	BEYOND_CUTOFF	SIMPLE	Good	1	0.5959	0.5959
pigmentary disorders	BEYOND_CUTOFF	Normal_NP	Good	1	0.5959	0.5959
perioperative care	BEYOND_CUTOFF	Normal_NP	Good	1	0.5959	0.5959
non-melanoma skin	BEYOND_CUTOFF	Normal_NP	Good	1	0.5959	0.5959
multidisciplinary	BEYOND_CUTOFF	SIMPLE	Good	1	0.5959	0.5959
coxiella burnetii	BEYOND_CUTOFF	Normal_NP	Good	1	0.5959	0.5959
cognitive deficit	BEYOND_CUTOFF	Normal_NP	Good	1	0.5959	0.5959
hlh	BEYOND_CUTOFF	SIMPLE	Good	1	0.5952	0.5952
receptor expression	BEYOND_CUTOFF	Normal_NP	Good	1	0.5939	0.5939
glomerular filtrate	BEYOND_CUTOFF	Normal_NP	Good	1	0.5939	0.5939
electrophysiology	BEYOND_CUTOFF	SIMPLE	Good	1	0.5939	0.5939
cochrane library	BEYOND_CUTOFF	Normal_NP	Good	1	0.5939	0.5939
bacterial infection	BEYOND_CUTOFF	Normal_NP	Good	1	0.5939	0.5939
trastuzumab	BEYOND_CUTOFF	SIMPLE	Good	1	0.5933	0.5933
london valves	BEYOND_CUTOFF	Normal_NP	Good	1	0.592	0.592
first-generation	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.592	0.592
backprojection	BEYOND_CUTOFF	SIMPLE	Good	1	0.592	0.592
vertebral	BEYOND_CUTOFF	SIMPLE	Good	1	0.5914	0.5914
strontium ranelate	BEYOND_CUTOFF	Normal_NP	Good	1	0.5907	0.5907
proteomic studies	BEYOND_CUTOFF	Normal_NP	Good	1	0.5907	0.5907
osteoprotegerin	BEYOND_CUTOFF	SIMPLE	Good	1	0.5907	0.5907
corynebacterium	BEYOND_CUTOFF	SIMPLE	Good	1	0.5907	0.5907
comorbid disorders	BEYOND_CUTOFF	Normal_NP	Good	1	0.5907	0.5907
cochrane review	BEYOND_CUTOFF	Normal_NP	Good	1	0.5907	0.5907
antipsychotic drugs	BEYOND_CUTOFF	Normal_NP	Good	1	0.5901	0.5901
wh	BEYOND_CUTOFF	SIMPLE	Good	1	0.5895	0.5895
ui	BEYOND_CUTOFF	SIMPLE	Good	1	0.5895	0.5895
rw	BEYOND_CUTOFF	SIMPLE	Good	1	0.5895	0.5895
rn	BEYOND_CUTOFF	SIMPLE	Good	1	0.5895	0.5895
pz	BEYOND_CUTOFF	SIMPLE	Good	1	0.5895	0.5895
jl	BEYOND_CUTOFF	SIMPLE	Good	1	0.5895	0.5895
jd	BEYOND_CUTOFF	SIMPLE	Good	1	0.5895	0.5895
gi	BEYOND_CUTOFF	SIMPLE	Good	1	0.5895	0.5895
taylorism	BEYOND_CUTOFF	SIMPLE	Good	1	0.5882	0.5882
sweden	BEYOND_CUTOFF	SIMPLE	Good	1	0.5882	0.5882
septum	BEYOND_CUTOFF	SIMPLE	Good	1	0.5882	0.5882
scielo	BEYOND_CUTOFF	SIMPLE	Good	1	0.5882	0.5882
perioral	BEYOND_CUTOFF	SIMPLE	Good	1	0.5882	0.5882
intron	BEYOND_CUTOFF	SIMPLE	Good	1	0.5882	0.5882
funders	BEYOND_CUTOFF	SIMPLE	Good	1	0.5882	0.5882
dermal	BEYOND_CUTOFF	SIMPLE	Good	1	0.5882	0.5882
ctla-4	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.5882	0.5882
centro	BEYOND_CUTOFF	SIMPLE	Good	1	0.5882	0.5882
alanine	BEYOND_CUTOFF	SIMPLE	Good	1	0.5882	0.5882
ros	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5875	0.5875
statin therapy	BEYOND_CUTOFF	Normal_NP	Good	1	0.5869	0.5869
papillomaviruses	BEYOND_CUTOFF	SIMPLE	Good	1	0.5869	0.5869
one-way sensitivity	BEYOND_CUTOFF	Normal_NP	Good	1	0.5869	0.5869
histone acetylation	BEYOND_CUTOFF	Normal_NP	Good	1	0.5869	0.5869
encephalopathy	BEYOND_CUTOFF	SIMPLE	Good	1	0.5869	0.5869
cytomegalovirus	BEYOND_CUTOFF	SIMPLE	Good	1	0.5869	0.5869
blood withdrawal	BEYOND_CUTOFF	Normal_NP	Good	1	0.5869	0.5869
antifibrinolytic	BEYOND_CUTOFF	SIMPLE	Good	1	0.5869	0.5869
airway inflammation	BEYOND_CUTOFF	Normal_NP	Good	1	0.5869	0.5869
5-fluorouracil	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.5869	0.5869
staphylococcus	BEYOND_CUTOFF	SIMPLE	Good	1	0.5863	0.5863
human epidermal growth	BEYOND_CUTOFF	Normal_NP	Good	1	0.5856	0.5856
botulinum toxin injections	BEYOND_CUTOFF	Normal_NP	Good	1	0.5856	0.5856
catalase	BEYOND_CUTOFF	SIMPLE	Good	1	0.585	0.585
non-small cell lung cancer	BEYOND_CUTOFF	Normal_NP	Good	1	0.5837	0.5837
respiratory infection	BEYOND_CUTOFF	Normal_NP	Good	1	0.5831	0.5831
non-small cell lung	BEYOND_CUTOFF	Normal_NP	Good	1	0.5825	0.5825
luxation	BEYOND_CUTOFF	SIMPLE	Good	1	0.5818	0.5818
revista	BEYOND_CUTOFF	SIMPLE	Good	1	0.5812	0.5812
faecium	BEYOND_CUTOFF	SIMPLE	Good	1	0.5812	0.5812
faecalis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5812	0.5812
chronification	BEYOND_CUTOFF	SIMPLE	Good	1	0.5812	0.5812
texas	BEYOND_CUTOFF	SIMPLE	Good	1	0.5806	0.5806
tissue calcification	BEYOND_CUTOFF	Normal_NP	Good	1	0.5799	0.5799
retinoic acid	BEYOND_CUTOFF	Normal_NP	Good	1	0.5799	0.5799
polysaccharides	BEYOND_CUTOFF	SIMPLE	Good	1	0.5799	0.5799
hyper-responsive	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.5799	0.5799
high-risk hpv	BEYOND_CUTOFF	Normal_NP	Good	1	0.5799	0.5799
cytotoxic activity	BEYOND_CUTOFF	Normal_NP	Good	1	0.5799	0.5799
s o paulo	BEYOND_CUTOFF	Normal_NP	Good	1	0.5787	0.5787
carcinogenesis	BEYOND_CUTOFF	SIMPLE	Good	1	0.578	0.578
gliosis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5774	0.5774
exfoliation	BEYOND_CUTOFF	SIMPLE	Good	1	0.5774	0.5774
single-nucleotide polymorphism	BEYOND_CUTOFF	Normal_NP	Good	1	0.5768	0.5768
pulmonary fibrosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9605	0.5763
platinum-sensitive population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9597	0.57582
fws	BEYOND_CUTOFF	SIMPLE	Good	1	0.5755	0.5755
masseter muscle	BEYOND_CUTOFF	Normal_NP	Good	1	0.5749	0.5749
active antiretroviral therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9581	0.5748599999999999
polypharmacy	BEYOND_CUTOFF	SIMPLE	Good	1	0.5742	0.5742
complementarity	BEYOND_CUTOFF	SIMPLE	Good	1	0.5742	0.5742
cardiomyocytes	BEYOND_CUTOFF	SIMPLE	Good	1	0.5742	0.5742
cancer health disparities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9556	0.57336
pcr london	BEYOND_CUTOFF	Normal_NP	Good	1	0.573	0.573
nrem sleep	BEYOND_CUTOFF	Normal_NP	Good	1	0.573	0.573
mycoplasma	BEYOND_CUTOFF	SIMPLE	Good	1	0.573	0.573
minneapolis	BEYOND_CUTOFF	SIMPLE	Good	1	0.573	0.573
micronesia	BEYOND_CUTOFF	SIMPLE	Good	1	0.573	0.573
id genbank	BEYOND_CUTOFF	Normal_NP	Good	1	0.573	0.573
hyperactivation	BEYOND_CUTOFF	SIMPLE	Good	1	0.573	0.573
heart valve	BEYOND_CUTOFF	Normal_NP	Good	1	0.573	0.573
haemophilus	BEYOND_CUTOFF	SIMPLE	Good	1	0.573	0.573
cf foundation	BEYOND_CUTOFF	Normal_NP	Good	1	0.573	0.573
ought	BEYOND_CUTOFF	SIMPLE	Good	1	0.5724	0.5724
mthfr	BEYOND_CUTOFF	SIMPLE	Good	1	0.5724	0.5724
hscrp	BEYOND_CUTOFF	SIMPLE	Good	1	0.5724	0.5724
fgf23	BEYOND_CUTOFF	SIMPLE	Good	1	0.5724	0.5724
enablers	BEYOND_CUTOFF	SIMPLE	Good	1	0.5724	0.5724
boluses	BEYOND_CUTOFF	SIMPLE	Good	1	0.5724	0.5724
avium	BEYOND_CUTOFF	SIMPLE	Good	1	0.5724	0.5724
ascites	BEYOND_CUTOFF	SIMPLE	Good	1	0.5724	0.5724
arousal	BEYOND_CUTOFF	SIMPLE	Good	1	0.5724	0.5724
calcium-sensing receptor	BEYOND_CUTOFF	Normal_NP	Good	1	0.5717	0.5717
ev	BEYOND_CUTOFF	SIMPLE	Good	1	0.5711	0.5711
complementary food	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9508	0.57048
osteogenesis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5698	0.5698
nephropathy	BEYOND_CUTOFF	SIMPLE	Good	1	0.5698	0.5698
hypercapnia	BEYOND_CUTOFF	SIMPLE	Good	1	0.5698	0.5698
chest x-ray	BEYOND_CUTOFF	Normal_NP	Good	1	0.5698	0.5698
end-tidal carbon dioxide	BEYOND_CUTOFF	Normal_NP	Good	1	0.5686	0.5686
chemical loss	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9475	0.5685
dental hygiene research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9459	0.5675399999999999
op	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5667	0.5667
oi	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5667	0.5667
specialty pharmacy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9427	0.56562
kv	BEYOND_CUTOFF	SIMPLE	Good	1	0.5655	0.5655
iu	BEYOND_CUTOFF	SIMPLE	Good	1	0.5655	0.5655
chronic care hospital	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9419	0.56514
attention deficit hyperactivity disorder	BEYOND_CUTOFF	Normal_NP	Good	1	0.5648	0.5648
post-menopausal women	BEYOND_CUTOFF	Normal_NP	Good	1	0.5642	0.5642
toothbrushing	BEYOND_CUTOFF	SIMPLE	Good	1	0.563	0.563
single-arm	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.563	0.563
self-evaluation	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.563	0.563
reconsideration	BEYOND_CUTOFF	SIMPLE	Good	1	0.563	0.563
periosteum	BEYOND_CUTOFF	SIMPLE	Good	1	0.563	0.563
osteopenia	BEYOND_CUTOFF	SIMPLE	Good	1	0.563	0.563
dna methylation	BEYOND_CUTOFF	Normal_NP	Good	1	0.563	0.563
diclofenac	BEYOND_CUTOFF	SIMPLE	Good	1	0.563	0.563
anti-tumoral	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.563	0.563
anti-tumor	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.563	0.563
primary hyperparathyroidism	BEYOND_CUTOFF	Normal_NP	Good	1	0.5623	0.5623
heart failure patients	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.937	0.5622
quality observation sites	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9354	0.56124
mp	BEYOND_CUTOFF	SIMPLE	Good	1	0.5611	0.5611
rhinosinusitis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5605	0.5605
ns	BEYOND_CUTOFF	SIMPLE	Good	1	0.5599	0.5599
native hawaiian health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.933	0.5598
hodgkin lymphoma	BEYOND_CUTOFF	Normal_NP	Good	1	0.5586	0.5586
mental health network	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9306	0.55836
transcriptional activity	BEYOND_CUTOFF	Normal_NP	Good	1	0.558	0.558
intrauterine growth	BEYOND_CUTOFF	Normal_NP	Good	1	0.558	0.558
cancer diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9298	0.5578799999999999
hp serology	BEYOND_CUTOFF	Normal_NP	Good	1	0.5574	0.5574
muscle contraction	BEYOND_CUTOFF	Normal_NP	Good	1	0.5568	0.5568
ldl cholesterol	BEYOND_CUTOFF	Normal_NP	Good	1	0.5568	0.5568
hyaluronic acid	BEYOND_CUTOFF	Normal_NP	Good	1	0.5568	0.5568
ihc	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5555	0.5555
dic	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5555	0.5555
appe	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5555	0.5555
ami	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5555	0.5555
tlr9	BEYOND_CUTOFF	SIMPLE	Good	1	0.5549	0.5549
tlr2	BEYOND_CUTOFF	SIMPLE	Good	1	0.5549	0.5549
lysis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5549	0.5549
cd40	BEYOND_CUTOFF	SIMPLE	Good	1	0.5549	0.5549
cd22	BEYOND_CUTOFF	SIMPLE	Good	1	0.5549	0.5549
cd19	BEYOND_CUTOFF	SIMPLE	Good	1	0.5549	0.5549
pc	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5543	0.5543
southern california	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9234	0.55404
hypertension status	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9226	0.5535599999999999
non-steroidal anti-inflammatory drugs	BEYOND_CUTOFF	Normal_NP	Good	1	0.553	0.553
varicella	BEYOND_CUTOFF	SIMPLE	Good	1	0.5524	0.5524
teratogenicity	BEYOND_CUTOFF	SIMPLE	Good	1	0.5524	0.5524
teratogen	BEYOND_CUTOFF	SIMPLE	Good	1	0.5524	0.5524
substantiality	BEYOND_CUTOFF	SIMPLE	Good	1	0.5524	0.5524
portuguese	BEYOND_CUTOFF	SIMPLE	Good	1	0.5524	0.5524
peroxidase	BEYOND_CUTOFF	SIMPLE	Good	1	0.5524	0.5524
nonspecific	BEYOND_CUTOFF	SIMPLE	Good	1	0.5524	0.5524
hp infection	BEYOND_CUTOFF	Normal_NP	Good	1	0.5524	0.5524
high-quality	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.5524	0.5524
g protein	BEYOND_CUTOFF	Normal_NP	Good	1	0.5524	0.5524
congruence	BEYOND_CUTOFF	SIMPLE	Good	1	0.5524	0.5524
biogenesis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5524	0.5524
parathyroid hormone	BEYOND_CUTOFF	Normal_NP	Good	1	0.5518	0.5518
histological evaluation	BEYOND_CUTOFF	Normal_NP	Good	1	0.5518	0.5518
oral glucose-lowering drug	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9194	0.55164
cultural sensitivity training	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9194	0.55164
psychiatric services	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9186	0.55116
hypoplastic	BEYOND_CUTOFF	SIMPLE	Good	1	0.5506	0.5506
neurologic disorders	BEYOND_CUTOFF	Normal_NP	Good	1	0.5487	0.5487
knee arthroplasty	BEYOND_CUTOFF	Normal_NP	Good	1	0.5487	0.5487
kidney transplantation	BEYOND_CUTOFF	Normal_NP	Good	1	0.5487	0.5487
restraint	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7838	0.54866
connectors	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7838	0.54866
model observer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9139	0.54834
thrombin	BEYOND_CUTOFF	SIMPLE	Good	1	0.5475	0.5475
multimodal	BEYOND_CUTOFF	SIMPLE	Good	1	0.5475	0.5475
coxiella	BEYOND_CUTOFF	SIMPLE	Good	1	0.5475	0.5475
expression analysis tools	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9123	0.54738
vendors	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7816	0.5471199999999999
exploration tools	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9107	0.5464199999999999
episode psychosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9107	0.5464199999999999
single-arm study	BEYOND_CUTOFF	Normal_NP	Good	1	0.5463	0.5463
macrophage polarization	BEYOND_CUTOFF	Normal_NP	Good	1	0.5463	0.5463
histomorphometry	BEYOND_CUTOFF	SIMPLE	Good	1	0.5463	0.5463
end-tidal carbon	BEYOND_CUTOFF	Normal_NP	Good	1	0.5463	0.5463
gastroesophageal reflux disease	BEYOND_CUTOFF	Normal_NP	Good	1	0.545	0.545
ras	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5444	0.5444
dental hygienist	BEYOND_CUTOFF	Normal_NP	Good	1	0.5438	0.5438
treatment regime	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9059	0.54354
chronic constipation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9059	0.54354
reactive oxygen species	BEYOND_CUTOFF	Normal_NP	Good	1	0.5426	0.5426
non-pharmacological intervention	BEYOND_CUTOFF	Normal_NP	Good	1	0.542	0.542
surgical resection	BEYOND_CUTOFF	Normal_NP	Good	1	0.5414	0.5414
alopecia	BEYOND_CUTOFF	SIMPLE	Good	1	0.5407	0.5407
glucose-lowering drug	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9004	0.5402399999999999
emergency action plan	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.9004	0.5402399999999999
oc	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5395	0.5395
health network	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8988	0.53928
progressive responsibility program	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.898	0.5388
substance use disorders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8973	0.53838
misunderstanding	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7684	0.5378799999999999
mit	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5377	0.5377
metformin	BEYOND_CUTOFF	SIMPLE	Good	1	0.5365	0.5365
hemostasis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5365	0.5365
gallbladder	BEYOND_CUTOFF	SIMPLE	Good	1	0.5365	0.5365
reconstruction filter	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8941	0.5364599999999999
occupational disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8941	0.5364599999999999
negative likelihood	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8941	0.5364599999999999
radiation oncology	BEYOND_CUTOFF	Normal_NP	Good	1	0.5359	0.5359
filamentous fungi	BEYOND_CUTOFF	Normal_NP	Good	1	0.5359	0.5359
fibroblast growth	BEYOND_CUTOFF	Normal_NP	Good	1	0.5359	0.5359
ulcerative colitis	BEYOND_CUTOFF	Normal_NP	Good	1	0.5353	0.5353
renal dysfunction	BEYOND_CUTOFF	Normal_NP	Good	1	0.5353	0.5353
glomerulonephritis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5353	0.5353
cytotoxic drugs	BEYOND_CUTOFF	Normal_NP	Good	1	0.5353	0.5353
occipital	BEYOND_CUTOFF	SIMPLE	Good	1	0.5347	0.5347
myeloid	BEYOND_CUTOFF	SIMPLE	Good	1	0.5347	0.5347
kappa b	BEYOND_CUTOFF	Normal_NP	Good	1	0.5347	0.5347
illinois	BEYOND_CUTOFF	SIMPLE	Good	1	0.5347	0.5347
hbv dna	BEYOND_CUTOFF	Normal_NP	Good	1	0.5347	0.5347
deliverability	BEYOND_CUTOFF	SIMPLE	Good	1	0.5347	0.5347
condensate	BEYOND_CUTOFF	SIMPLE	Good	1	0.5347	0.5347
coaptation	BEYOND_CUTOFF	SIMPLE	Good	1	0.5347	0.5347
scientific environment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8902	0.5341199999999999
continuous surveillance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8902	0.5341199999999999
pm10	BEYOND_CUTOFF	SIMPLE	Good	1	0.534	0.534
picu	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.534	0.534
surgical site	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8894	0.53364
asthma management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8886	0.53316
quality plans	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8871	0.53226
bt	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5322	0.5322
non-small cell	BEYOND_CUTOFF	Normal_NP	Good	1	0.5316	0.5316
wbc	BEYOND_CUTOFF	SIMPLE	Good	1	0.531	0.531
pfa	BEYOND_CUTOFF	SIMPLE	Good	1	0.531	0.531
npv	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.531	0.531
nih	BEYOND_CUTOFF	SIMPLE	Good	1	0.531	0.531
kda	BEYOND_CUTOFF	SIMPLE	Good	1	0.531	0.531
hpi	BEYOND_CUTOFF	SIMPLE	Good	1	0.531	0.531
b12	BEYOND_CUTOFF	SIMPLE	Good	1	0.531	0.531
9th	BEYOND_CUTOFF	SIMPLE	Good	1	0.531	0.531
1st	BEYOND_CUTOFF	SIMPLE	Good	1	0.531	0.531
native hawaiian medical students	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8847	0.53082
myelosuppression	BEYOND_CUTOFF	SIMPLE	Good	1	0.5304	0.5304
armamentarium	BEYOND_CUTOFF	SIMPLE	Good	1	0.5304	0.5304
percutaneous coronary intervention	BEYOND_CUTOFF	Normal_NP	Good	1	0.5286	0.5286
vibration disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8808	0.52848
flood risk management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8808	0.52848
knowledge service platform	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.88	0.528
conventional sleep parameter	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.88	0.528
passion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7539	0.5277299999999999
stay hospital	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8792	0.52752
viral infection	BEYOND_CUTOFF	Normal_NP	Good	1	0.5274	0.5274
otitis media	BEYOND_CUTOFF	Normal_NP	Good	1	0.5274	0.5274
interstitium	BEYOND_CUTOFF	SIMPLE	Good	1	0.5274	0.5274
arthroplasty	BEYOND_CUTOFF	SIMPLE	Good	1	0.5274	0.5274
physical activity monitors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8785	0.5270999999999999
orthopedic trauma surgeons	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8785	0.5270999999999999
hospital community hospitals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8785	0.5270999999999999
conventional disease-modifying antirheumatic drugs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8754	0.5252399999999999
predecessors	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7503	0.52521
prosthetic	BEYOND_CUTOFF	SIMPLE	Good	1	0.525	0.525
palladin	BEYOND_CUTOFF	SIMPLE	Good	1	0.525	0.525
oral sgas	BEYOND_CUTOFF	Normal_NP	Good	1	0.525	0.525
nobel prize	BEYOND_CUTOFF	Normal_NP	Good	1	0.525	0.525
honolulu	BEYOND_CUTOFF	SIMPLE	Good	1	0.525	0.525
semantic integration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8746	0.52476
secondary eruption	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8746	0.52476
relative survival	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8746	0.52476
pharmacy practice experience	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8738	0.52428
xerosis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5238	0.5238
russia	BEYOND_CUTOFF	SIMPLE	Good	1	0.5238	0.5238
reoperation	BEYOND_CUTOFF	SIMPLE	Good	1	0.5238	0.5238
pre-operatively	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.5238	0.5238
pre-operative	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.5238	0.5238
orthotics	BEYOND_CUTOFF	SIMPLE	Good	1	0.5238	0.5238
laryngeal	BEYOND_CUTOFF	SIMPLE	Good	1	0.5238	0.5238
focussing	BEYOND_CUTOFF	SIMPLE	Good	1	0.5238	0.5238
epoxide	BEYOND_CUTOFF	SIMPLE	Good	1	0.5238	0.5238
capita	BEYOND_CUTOFF	SIMPLE	Good	1	0.5238	0.5238
pacific islander physical activity questionnaire	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8715	0.5229
thromboembolic disease	BEYOND_CUTOFF	Normal_NP	Good	1	0.5226	0.5226
haematological malignancies	BEYOND_CUTOFF	Normal_NP	Good	1	0.5226	0.5226
clinical interview	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8699	0.52194
ppm f	BEYOND_CUTOFF	Normal_NP	Good	1	0.5214	0.5214
missionary	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7446	0.52122
contradiction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7446	0.52122
contractor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7446	0.52122
trauma fellowship match	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8684	0.52104
particle size distribution	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8684	0.52104
identification strategy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8684	0.52104
cervical cancer prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8684	0.52104
rheumatology	BEYOND_CUTOFF	SIMPLE	Good	1	0.5208	0.5208
doxorubicin	BEYOND_CUTOFF	SIMPLE	Good	1	0.5208	0.5208
mental health professional	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8676	0.52056
apoptotic cell death	BEYOND_CUTOFF	Normal_NP	Good	1	0.5202	0.5202
reactive oxygen	BEYOND_CUTOFF	Normal_NP	Good	1	0.519	0.519
seizure recurrence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8645	0.5187
secondary theme	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8645	0.5187
ec	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5184	0.5184
dyeing	BEYOND_CUTOFF	SIMPLE	Good	1	0.5178	0.5178
bmd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5178	0.5178
youth alcohol consumption	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.863	0.5177999999999999
focal infection theory	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.863	0.5177999999999999
federal joint committee	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.863	0.5177999999999999
experimental dentifrices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.863	0.5177999999999999
weapons	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7389	0.51723
hbv	BEYOND_CUTOFF	SIMPLE	Good	1	0.5172	0.5172
national diabetes quality improvement alliance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8606	0.51636
doc	BEYOND_CUTOFF	SIMPLE	Good	1	0.516	0.516
auc	BEYOND_CUTOFF	SIMPLE	Good	1	0.516	0.516
nutritional recommendations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8591	0.5154599999999999
family medicine resident	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8591	0.5154599999999999
family medicine residency	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8591	0.5154599999999999
radiographic outcomes	BEYOND_CUTOFF	Normal_NP	Good	1	0.5154	0.5154
cerebrospinal fluid	BEYOND_CUTOFF	Normal_NP	Good	1	0.5154	0.5154
antiretroviral drug	BEYOND_CUTOFF	Normal_NP	Good	1	0.5154	0.5154
multiplex ligation-dependent probe amplification	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8583	0.51498
emergency department substance use disorders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8583	0.51498
utilises	BEYOND_CUTOFF	SIMPLE	Good	1	0.5148	0.5148
utilisation	BEYOND_CUTOFF	SIMPLE	Good	1	0.5148	0.5148
voice therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8576	0.51456
plasma leakage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8576	0.51456
health examinations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8576	0.51456
flux delivery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8576	0.51456
critical patient	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8576	0.51456
basal ganglia	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8576	0.51456
absolute risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8576	0.51456
ckd patients	BEYOND_CUTOFF	Normal_NP	Good	1	0.5142	0.5142
scorecard	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7339	0.51373
pseudonyms	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7339	0.51373
islander physical activity questionnaire	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.856	0.5136
ige	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.513	0.513
psychosomatic diseases	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8545	0.5127
integration scenarios	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8545	0.5127
integration approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8545	0.5127
health impact assessment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8545	0.5127
developmental disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8545	0.5127
dental public health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8545	0.5127
psychosocial	BEYOND_CUTOFF	SIMPLE	Good	1	0.5118	0.5118
cell adhesion	BEYOND_CUTOFF	Normal_NP	Good	1	0.5118	0.5118
breakpoints	BEYOND_CUTOFF	SIMPLE	Good	1	0.5118	0.5118
arthrodesis	BEYOND_CUTOFF	SIMPLE	Good	1	0.5118	0.5118
primary studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.853	0.5117999999999999
clinical scores	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.853	0.5117999999999999
psychiatric emergency department substance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8514	0.51084
introductory pharmacy practice experience	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8507	0.51042
systematic significance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8499	0.50994
mass media campaigns	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8499	0.50994
healthcare research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8499	0.50994
ethnic health inequities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8499	0.50994
dental hygiene education	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8499	0.50994
comprehensive models	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8499	0.50994
ranelate	BEYOND_CUTOFF	SIMPLE	Good	1	0.5094	0.5094
hyphae	BEYOND_CUTOFF	SIMPLE	Good	1	0.5094	0.5094
hif-1	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.5094	0.5094
hbeag	BEYOND_CUTOFF	SIMPLE	Good	1	0.5094	0.5094
primary theme	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8484	0.50904
face rejuvenation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8484	0.50904
neurodegeneration	BEYOND_CUTOFF	SIMPLE	Good	1	0.5088	0.5088
k antagonists	BEYOND_CUTOFF	Normal_NP	Good	1	0.5088	0.5088
disease-modifying antirheumatic drugs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8476	0.50856
onabotulinumtoxina	BEYOND_CUTOFF	SIMPLE	Good	1	0.5083	0.5083
ic50	BEYOND_CUTOFF	SIMPLE	Good	1	0.5077	0.5077
pathophysiologically diverse disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8461	0.50766
national family health survey india	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8461	0.50766
commercial plasma-derived vwf-fviii	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8461	0.50766
treatment considerations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8445	0.5067
software connectors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8445	0.5067
significant impact	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8445	0.5067
concentration peaks	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8445	0.5067
open-label extension	BEYOND_CUTOFF	Normal_NP	Good	1	0.5065	0.5065
native hawaiian cardiac care queen	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8438	0.50628
pacific islander outpatient population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8422	0.50532
multiplex ligation-dependent probe	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8422	0.50532
inappropriate antidiuretic hormone	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8422	0.50532
global aesthetic improvement scales	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8422	0.50532
end-tidal carbon dioxide concentration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8422	0.50532
cost-effective treatment strategy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8422	0.50532
care administration physician roles	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8422	0.50532
infliximab	BEYOND_CUTOFF	SIMPLE	Good	1	0.5053	0.5053
fluid infusion	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8407	0.50442
refrigerator	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7204	0.50428
ministry	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7204	0.50428
idealist	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7204	0.50428
homework	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7204	0.50428
handbook	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7204	0.50428
contemplation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7204	0.50428
chronicle	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7204	0.50428
agglomeration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7204	0.50428
hematology	BEYOND_CUTOFF	SIMPLE	Good	1	0.5041	0.5041
hematological	BEYOND_CUTOFF	SIMPLE	Good	1	0.5041	0.5041
hematologic	BEYOND_CUTOFF	SIMPLE	Good	1	0.5041	0.5041
botulinum	BEYOND_CUTOFF	SIMPLE	Good	1	0.5041	0.5041
treatment parameters	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
syntactic complexity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
sanitation reform	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
rural primary care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
respiratory chain	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
prophylaxis treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
personnel recruitment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
outpatient services	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
inversion formula	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
inhibitor development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
dental practitioner	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.84	0.504
surgical ventricular reconstruction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8392	0.50352
sequential cross-sectional studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8392	0.50352
prophylactic replacement therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8392	0.50352
population-based cancer registries	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8392	0.50352
neural connectivity recent studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8392	0.50352
national knowledge infrastructure	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8392	0.50352
national diabetes quality improvement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8392	0.50352
inter-organizational partnership	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8392	0.50352
exclusive participation criteria	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8392	0.50352
culturally sensitive survey tool	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8392	0.50352
myeloid leukemia	BEYOND_CUTOFF	Normal_NP	Good	1	0.5035	0.5035
in-hospital mortality	BEYOND_CUTOFF	Normal_NP	Good	1	0.5035	0.5035
first-line treatment	BEYOND_CUTOFF	Normal_NP	Good	1	0.5035	0.5035
von willebrand disease	BEYOND_CUTOFF	Normal_NP	Good	1	0.5029	0.5029
occupational therapeutic service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8377	0.50262
national guideline clearinghouse	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8377	0.50262
government-funded dental hospitals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8377	0.50262
department substance use disorders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8377	0.50262
congenital malformation syndrome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8377	0.50262
bd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.5023	0.5023
bonta	BEYOND_CUTOFF	SIMPLE	Good	1	0.5018	0.5018
asians	BEYOND_CUTOFF	SIMPLE	Good	1	0.5018	0.5018
colorectal cancer	BEYOND_CUTOFF	Normal_NP	Good	1	0.5012	0.5012
rejuvenation combination treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8346	0.50076
organizational change strategies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8346	0.50076
family medicine residency clinic	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8346	0.50076
comprehensive medical documentation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8346	0.50076
complementary orthopaedic skills	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8346	0.50076
electromyography	BEYOND_CUTOFF	SIMPLE	Good	1	0.5006	0.5006
temporal resolution	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8339	0.50034
national networks	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8339	0.50034
infection theory	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8339	0.50034
fellowship match	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8339	0.50034
fastidious organisms	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8339	0.50034
evaluation scheme	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8339	0.50034
economic development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8339	0.50034
calcium concentration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8339	0.50034
acidic dentifrices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8339	0.50034
xr	BEYOND_CUTOFF	SIMPLE	Good	1	0.5	0.5
o3	BEYOND_CUTOFF	SIMPLE	Good	1	0.5	0.5
nt	BEYOND_CUTOFF	SIMPLE	Good	1	0.5	0.5
ib	BEYOND_CUTOFF	SIMPLE	Good	1	0.5	0.5
fz	BEYOND_CUTOFF	SIMPLE	Good	1	0.5	0.5
eg	BEYOND_CUTOFF	SIMPLE	Good	1	0.5	0.5
cz	BEYOND_CUTOFF	SIMPLE	Good	1	0.5	0.5
specialty pharmacy practitioners	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
prophylactic medicine concept	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
pacific islander physical activity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
orthopaedic trauma fellowship	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
occupational disease diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
new non-pharmacological treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
native hawaiian health disparities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
national family health survey	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
introductory pharmacy practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
inflammatory response benefit	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
fundamental mathematical link	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
diabetes intervention program	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
developmental language disorders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
certain durable medical equipment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
cardiovascular function damage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
cancer prevention radio drama	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
acidic experimental dentifrices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8324	0.49944
hospital admission	BEYOND_CUTOFF	Normal_NP	Good	1	0.4994	0.4994
cyclophosphamide	BEYOND_CUTOFF	SIMPLE	Good	1	0.4994	0.4994
flood risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8316	0.49895999999999996
cancer site	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8316	0.49895999999999996
acidic gases	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8316	0.49895999999999996
oxygen species	BEYOND_CUTOFF	Normal_NP	Good	1	0.4988	0.4988
systematic literature search	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
systematic literature review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
rigorous laboratory investigation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
psychiatric emergency department	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
psychiatric emergence attendances	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
primary prevention recommendations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
primary care workforce crisis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
preventive treatment programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
knowledge utilization theory	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
foundation practice guidelines	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
environmental computer simulation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
embryonic stem cell research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
cost-effective treatment option	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
comprehensive content review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
clinical guideline recommendations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
classical antibiotic therapies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
cardiovascular system diseases	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
administration physician roles	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
academic research consortium	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
academic orthopaedic surgery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8308	0.49848
taxane	BEYOND_CUTOFF	SIMPLE	Good	1	0.4982	0.4982
lateralization	BEYOND_CUTOFF	SIMPLE	Good	1	0.4982	0.4982
willebrand disease	BEYOND_CUTOFF	Normal_NP	Good	1	0.4976	0.4976
surgical services	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
stress recognition	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
research involvement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
practice experience	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
observation sites	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
language disorders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
diabetes services	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
cultural immersion	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
contrast sensitivity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
chemical weapons	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
cancer research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
cancer institutions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
analgesic dosage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8286	0.49716
valve implantation	BEYOND_CUTOFF	Normal_NP	Good	1	0.4971	0.4971
vaccine vaccination history	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
routine bedside medical care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
respiratory chain inhibitor	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
native hawaiian cardiac care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
mitochondrial inner membrane	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
inter-organizational commitment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
haemophilia treatment centres	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
favourable treatment outcome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
experimental glaucoma model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
curriculum development team	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
culturally sensitive survey	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
culturally sensitive effort	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
arthritis response criteria	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
aggressive preventive treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8278	0.49667999999999995
real-time	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.4965	0.4965
mismatch	BEYOND_CUTOFF	SIMPLE	Good	1	0.4965	0.4965
misalignment	BEYOND_CUTOFF	SIMPLE	Good	1	0.4965	0.4965
michigan	BEYOND_CUTOFF	SIMPLE	Good	1	0.4965	0.4965
cytometric	BEYOND_CUTOFF	SIMPLE	Good	1	0.4965	0.4965
bayesian	BEYOND_CUTOFF	SIMPLE	Good	1	0.4965	0.4965
various treatment approaches	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
transition movement disorders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
specialty pharmacy practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
retrospective data collection	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
quality patient safety indicators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
quality improvement efforts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
practical training program	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
pharmaceutical care outcomes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
orthopedic trauma research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
nocturnal epileptic seizures	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
native hawaiian health care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
manufacturer-sponsored trials	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
investigator global assessment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
infectious disease prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
in-patient hospital admissions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
emergency department visits	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
disease prevention programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
conventional culture media	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
chronic migraine introduction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
aesthetic improvement scales	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8263	0.49578
multidimensionality	BEYOND_CUTOFF	SIMPLE	Good	1	0.4953	0.4953
multidimensional	BEYOND_CUTOFF	SIMPLE	Good	1	0.4953	0.4953
trauma surgeons	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8248	0.49488
trauma practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8248	0.49488
surgical capacity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8248	0.49488
school inspections	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8248	0.49488
observer study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8248	0.49488
dietary diversity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8248	0.49488
booster injections	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8248	0.49488
alcohol supply	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8248	0.49488
neurophysiology	BEYOND_CUTOFF	SIMPLE	Good	1	0.4947	0.4947
neurophysiological	BEYOND_CUTOFF	SIMPLE	Good	1	0.4947	0.4947
neurophysiologic	BEYOND_CUTOFF	SIMPLE	Good	1	0.4947	0.4947
homozygous mutation	BEYOND_CUTOFF	Normal_NP	Good	1	0.4947	0.4947
surgical infections	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.824	0.49439999999999995
cancer guidelines	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.824	0.49439999999999995
attention deficit hyperactivity	BEYOND_CUTOFF	Normal_NP	Good	1	0.4941	0.4941
treasure	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7057	0.49399
renaissance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7057	0.49399
remembrances	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7057	0.49399
postponement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7057	0.49399
palliation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7057	0.49399
oppression	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7057	0.49399
entanglement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7057	0.49399
concurrence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7057	0.49399
antecedents	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7057	0.49399
cancer health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8233	0.49398
gaba	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4936	0.4936
uterine smooth muscle cells	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
surgical removal approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
scientific advisory panel	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
respiratory system diseases	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
representative cross-section	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
physical activity programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
pharmacological interventions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
pacific islander ancestry	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
molecular diagnostic tools	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
medication abuse criteria	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
inter-organizational team	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
inflammation recent studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
haemophilia patient population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
external environmental cues	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
episodic migraine prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
emergency service context	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
embryonic neural stem cell	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
diabetes coalition diabetes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
current practice guidelines	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
constitutive skin pigmentation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
bilateral symmetrical lesions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
alternative model assumptions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8218	0.49307999999999996
cardiomyopathy	BEYOND_CUTOFF	SIMPLE	Good	1	0.493	0.493
project cities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.821	0.4925999999999999
pediatric critical care	BEYOND_CUTOFF	Normal_NP	Good	1	0.4924	0.4924
participatory research	BEYOND_CUTOFF	Normal_NP	Good	1	0.4924	0.4924
unambiguous patient identification	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8203	0.49218
pfa-100	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.4918	0.4918
autonomic	BEYOND_CUTOFF	SIMPLE	Good	1	0.4918	0.4918
unusual genomic rearrangements	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
transcendental representations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
therapeutic possible options	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
theoretical study analyses	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
rhythmic movement disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
review infectious diseases	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
quality improvement alliance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
prostate cancer committee	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
prospective data collection	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
professional voice teaching	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
primary prevention studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
plasma-derived vwf-fviii	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
physical activity experts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
pacific islander outpatient	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
optimal maternal therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
intensive community education	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
hawaii homeless outreach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
growth factor antagonists	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
extraordinary accomplishment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
epileptic motor behaviors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
dental hygiene discipline	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
decision-making strategies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
comprehensive health care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
collaborative health care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
clinical follow-up studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
clinical cancer registries	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
autistic spectrum disorders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
address diabetes prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
acute respiratory infection	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
academic medicine sector	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8195	0.49169999999999997
protein kinase	BEYOND_CUTOFF	Normal_NP	Good	1	0.4912	0.4912
apoptotic cell	BEYOND_CUTOFF	Normal_NP	Good	1	0.4912	0.4912
aberration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.7015	0.49105
record review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.818	0.49079999999999996
impact assessment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.818	0.49079999999999996
ground air quality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.818	0.49079999999999996
federal joint	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.818	0.49079999999999996
ethnic health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.818	0.49079999999999996
dental hospital	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.818	0.49079999999999996
asthma disparities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.818	0.49079999999999996
access target	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.818	0.49079999999999996
antipsychotic long-acting injection	BEYOND_CUTOFF	Normal_NP	Good	1	0.4906	0.4906
vessel growth inhibitor	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
ventricular reconstruction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
valve academic research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
tumor genetics platforms	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
symptomatic severe aortic	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
spinal muscular atrophy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
species vaccine development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
rigorous surgical residency	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
renal transplant prevalence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
provincial health officer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
professional case management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
primary haemophilia care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
potential teaching tool	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
physical therapy association	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
peripheral nerve impulse	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
pacific trust territories	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
oppression questionnaire	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
molecular biology assays	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
minimum acceptable diet	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
methodological perspectives	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
medicine residency clinic	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
mathematical experimentation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
interdisciplinary treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
influence media coverage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
inconclusive laboratory	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
implementation strategy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
health equity framework	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
haemophilia care providers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
global aesthetic improvement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
executive behavior scale	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
evidence-based approaches	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
derivative daughter cells	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
dental anesthesia story	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
critical patient safety	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
coordination skill gait	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
conical crown morphology	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
congenital heart defect	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
congenital defect heart	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
clinical trial programme	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
chronic movement disorders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
bilateral basal ganglia	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
allergic asthma exacerbation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
agricultural land irrigation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8173	0.49038
synapse	BEYOND_CUTOFF	SIMPLE	Good	1	0.4901	0.4901
trauma research involvement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
sleep behaviour disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
serum calcium concentration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
rural training pipeline	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
research dental hygiene	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
relevant clinical issues	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
reconstruction formula	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
quality patient safety	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
psychological diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
principal match service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
primary prevention trials	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
preventive oral health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
prevention radio drama	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
prescription drug abuse	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
plain film radiography	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
participation criteria	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
pacific islander population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
new treatment paradigms	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
neural stem cell regulation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
national family health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
morphological criteria	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
minimum dietary diversity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
lexical access defaults	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
innovative partnerships	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
hygienic-dietary habits	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
homogeneous methodology	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
hereditary breast cancer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
heart failure readmission	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
health treatment centre	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
guideline clearinghouse	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
gene expression domain	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
gene analysis research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
dental hygiene scholars	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
dental hygiene profession	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
dental hygiene practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
cooperative health care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
collaborative approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
collaboration contract	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
antenatal clinic visits	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
alcoholic liver disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
accreditation criteria	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8158	0.48947999999999997
scholarity	BEYOND_CUTOFF	SIMPLE	Good	1	0.4889	0.4889
ovarian	BEYOND_CUTOFF	SIMPLE	Good	1	0.4889	0.4889
myeloma	BEYOND_CUTOFF	SIMPLE	Good	1	0.4889	0.4889
vocal effort	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8143	0.48858
review questions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8143	0.48858
quality scores	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8143	0.48858
health organization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8143	0.48858
dental treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8143	0.48858
self-assembly	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.4883	0.4883
radiation oncologists	BEYOND_CUTOFF	Normal_NP	Good	1	0.4877	0.4877
basal cell carcinoma	BEYOND_CUTOFF	Normal_NP	Good	1	0.4877	0.4877
three-dimensional laser	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
substance abuse treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
spontaneous pain sensation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
septic shock children	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
sensitive survey tool	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
school food administrators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
salivary gland disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
rural neighbor islands	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
risk management actors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
renal vascular disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
quality control checks	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
psychological account	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
prospective follow-up	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
participant satisfaction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
orthopedic trauma care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
optimal health outcomes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
molecular tumor genetics	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
meeting time standards	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
maternal-fetal morbidity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
mainstream health care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
life-threatening situation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
journalistic strategy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
intravenous administration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
intervention approaches	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
institutional projects	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
inflammatory progression	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
idiosyncratic character	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
hyponatremia	BEYOND_CUTOFF	SIMPLE	Good	1	0.4872	0.4872
healthy adult subjects	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
healthcare practitioners	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
health care administration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
federal supreme court	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
exponential distribution	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
embryonic neural stem	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
discussion mantle cell	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
developmental history	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
dental philanthropist	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
critical illness score	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
collaborative projects	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
clinical illness score	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
chronic disease management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
chromosome type aberrations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
biological phenomenon	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
authorization program	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
atmospheric chemistry	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.812	0.4872
s o	BEYOND_CUTOFF	Normal_NP	Good	1	0.4866	0.4866
haq	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4866	0.4866
negative symptoms	BEYOND_CUTOFF	Normal_NP	Good	1	0.486	0.486
helicobacter pylori	BEYOND_CUTOFF	Normal_NP	Good	1	0.4854	0.4854
youth service providers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
urinary calcium loss	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
unintentional injuries	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
typical rbd behaviors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
trauma patient population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
therapeutic guidelines	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
theoretical perspectives	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
technical leadership	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
supervisor interview	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
spontaneous recovery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
southern californian	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
satisfactory proportion	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
rehabilitation centre	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
psychological theory	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
psychological explanations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
prospective diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
prophylactic medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
primary renal diseases	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
preventive therapists	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
preventive dentistry	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
prevention recommendations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
political leadership	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
orthopaedic research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
occupational medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
negative calcium balance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
national diabetes quality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
morbidity peak month	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
mental health reform	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
malformation syndrome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
mainland counterparts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
linguistic behaviour	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
life quality parameters	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
initial dialysis modality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
inflammatory pathways	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
incidental phenomena	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
identification models	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
identification errors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
heart failure disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
health disparity gap	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
fundamental challenge	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
extensive laboratory	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
excess absolute risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
environmental safety	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
educational opportunities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
diverse clinic population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
distribution channel	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
discrimination index	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
developmental vulnerability	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
developmental outcomes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
critical patient care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
conventional surgery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
comprehensive health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
comparative approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
collaborative health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
collaborative effort	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
cholesterol synthesis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
care workforce crisis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
cancer patient population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
cancer patient navigator	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
attenuation coefficients	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
artery plaque rupture	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
anesthesia administration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
anatomical predictors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8083	0.48497999999999997
haematoma	BEYOND_CUTOFF	SIMPLE	Good	1	0.4848	0.4848
situ hybridization	BEYOND_CUTOFF	Normal_NP	Good	1	0.4843	0.4843
mitochondrial	BEYOND_CUTOFF	SIMPLE	Good	1	0.4843	0.4843
modis	BEYOND_CUTOFF	SIMPLE	Good	1	0.4837	0.4837
imrt	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4837	0.4837
cosmetic indication	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.806	0.48360000000000003
talk	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6904	0.48328
cure	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6904	0.48328
agitation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6904	0.48328
risk calculators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8053	0.48318
muscle pain	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8053	0.48318
model estimation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8053	0.48318
food desert	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8053	0.48318
dental public	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8053	0.48318
dental patient	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8053	0.48318
pasi	BEYOND_CUTOFF	SIMPLE	Good	1	0.4825	0.4825
neuroimaging studies	BEYOND_CUTOFF	Normal_NP	Good	1	0.4819	0.4819
treaties	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6877	0.48138999999999993
sterilization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6877	0.48138999999999993
modernization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6877	0.48138999999999993
detention	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6877	0.48138999999999993
deputy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6877	0.48138999999999993
defendant	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6877	0.48138999999999993
cancellation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6877	0.48138999999999993
appeal	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6877	0.48138999999999993
answer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6877	0.48138999999999993
ventricular development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
vaccination history	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
unambiguous identification	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
therapeutic molecules	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
theological doctrine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
tentative hypothesis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
symptomatic headache	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
symptomatic etiology	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
sustainable development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
sup-optimal practices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
substance abuse care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
subsequent research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
strategic oversight	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
scientific chronicle	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
scientific challenge	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
routine medical care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
rigorous laboratory	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
review group report	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
review board approval	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
retrospective status	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
research consortium	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
questionnaire yields	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
prophylactic replacement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
post-traumatic loss	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
physiological regulator	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
pharmacy practitioners	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
pharmacist collaboration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
pathological alternations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
orientation program	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
ongoing epidemiological	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
occupational morbidity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
nutritional counseling	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
northern california	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
nitrous oxide dream	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
new mexico lifestyle	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
new england treasure	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
methodological issues	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
mental health staff	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
maternal inadequacy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
low-molecular substances	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
life quality assessment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
lethal underdevelopment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
laboratory diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
key performance indicators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
interactive programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
intensive interventions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
individual disposition	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
improvement programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
immunization services	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
humanitarian efforts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
historical significance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
heart failure complications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
haemophilia therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
gastric cancer risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
frontal lobe seizures	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
environmental inequities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
efficiency opportunities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
economic constraint	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
ecological contamination	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
discharge counselors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
diagnostic image quality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
development pipeline	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
custom motion simulator	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
current risk calculators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
cross-cultural education	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
counsel cancer patients	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
conventional trauma	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
conventional culture	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
conceptual perspectives	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
commercial opportunities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
collective approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
collaborative models	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
cohort study surveys	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
clinical geneticists	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
biological diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
biological concentration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
axiomatic antithesis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
authorization decision	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
anesthetic delivery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
adaptation strategies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
academic trauma career	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
academic health sciences	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8016	0.48095999999999994
renal calcium	BEYOND_CUTOFF	Normal_NP	Good	1	0.4808	0.4808
identification bracelet	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8008	0.48047999999999996
valve depth deployment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
utilization theory	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
treatment contamination	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
transformation rules	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
training care teams	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
track child health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
tomography projection	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
therapeutic service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
therapeutic importance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
theoretical reports	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
theoretical domains	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
technical approaches	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
talk story discussion	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
supply agency prices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
subsistence dependence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
student pharmacists	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
spinal cord stimulation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
significant associations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
secondary diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
scientific account	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
school milk policy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
risk factor profiles	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
renal calcium stones	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
quantitative assays	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
pulmonary air leak	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
psychological tasks	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
psychological findings	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
prophylactic treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
primitive behaviors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
practical expertise	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
potential challenges	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
pharmacist faculty	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
pharmaceutical care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
personal transformation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
participant burden	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
paradoxical occurrence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
orthopedic surgeons	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
oral health services	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
nutritional disorders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
negative repercussions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
nasal sinus disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
narrative synthesis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
migraine introduction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
lifestyle behavior	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
left heart syndrome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
laboratory surveillance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
jaw movement capacity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
invasive interventions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
intervention models	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
interpretation bias	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
individual therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
incremental improvements	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
improvement efforts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
hospital administrators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
historical antecedents	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
heterogeneous tools	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
heart failure education	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
healthcare resources	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
health care experts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
health care deficiencies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
financial attributes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
experimental beginnings	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
executive director	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
executive behavior	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
exclusive participation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
epileptic manifestations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
environmental deviations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
electrical potential	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
digital photographs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
diabetes intervention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
developmental stage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
dental comic strips	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
cooperative health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
conventional sleep	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
controversial situations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
controversial issue	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
continuous development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
collaborative team	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
classification tree	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
chronic care model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
cardiac care queen	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
ambiguous criteria	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
acute otitis media	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
acceptable coverage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.8001	0.48006
mrsa	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4796	0.4796
casr	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4796	0.4796
incidence study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7993	0.47958
cultural sensitivity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7993	0.47958
cancer registries	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7993	0.47958
yangtze	BEYOND_CUTOFF	SIMPLE	Good	1	0.4791	0.4791
uveitis	BEYOND_CUTOFF	SIMPLE	Good	1	0.4791	0.4791
skeletal	BEYOND_CUTOFF	SIMPLE	Good	1	0.4791	0.4791
overuse	BEYOND_CUTOFF	SIMPLE	Good	1	0.4791	0.4791
irradiation	BEYOND_CUTOFF	SIMPLE	Good	1	0.4791	0.4791
cinahl	BEYOND_CUTOFF	SIMPLE	Good	1	0.4791	0.4791
affective	BEYOND_CUTOFF	SIMPLE	Good	1	0.4791	0.4791
abstinent	BEYOND_CUTOFF	SIMPLE	Good	1	0.4791	0.4791
lamellae	BEYOND_CUTOFF	SIMPLE	Good	1	0.4785	0.4785
lamella	BEYOND_CUTOFF	SIMPLE	Good	1	0.4785	0.4785
care hospital	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7956	0.47735999999999995
prefrontal cortex	BEYOND_CUTOFF	Normal_NP	Good	1	0.4773	0.4773
autoimmune disorder	BEYOND_CUTOFF	Normal_NP	Good	1	0.4773	0.4773
anti-inflammatory	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.4773	0.4773
quality improvement initiative	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7949	0.47694000000000003
talk story	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7941	0.47646
quality stations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7941	0.47646
primary stability	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7941	0.47646
peak month	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7941	0.47646
legal basis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7941	0.47646
final year	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7941	0.47646
treatment therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
treatment practices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
treatment concept	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
transplant prevalence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
total study population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
therapeutic choices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
therapeutic centre	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
therapeutic avenue	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
theological motivation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
task force report	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
syndrome research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
surgical expertise	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
surgery interventions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
study data exploration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
strategic development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
static joint instability	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
spontaneous reaction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
spatial characterization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
school difficulties	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
school curriculum	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
satisfactory answer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
review contractor	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
respiratory complications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
research endeavors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
pulmonary medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
psychotic depression	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
provincial review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
provincial health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
prognosis prediction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
professional voice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
problematic adherence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
primary complaint	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
preventive services	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
preventive detention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
prescription drug	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
preliminary incubation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
preceptor resources	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
practical development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
potential synergies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
potential success	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
potential prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
postgraduate education	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
political discussion	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
plasma viral load	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
orthopedic trauma	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
original investigation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
numerous challenges	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
nuclear factor-kb	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
normative account	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
negative bone balance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
navigator program	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
national knowledge	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
national guideline	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
multiple challenges	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
molecular therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
molecular pathways	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
mathematical link	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
massive complaints	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
mainstream health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
life-span development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
kinetic characterization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
islander ancestry	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
innovative experience	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
industrial hygiene	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
induction therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
individual effort	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
homeless outreach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
health care status	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
haemophilia population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
geriatric medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
genetics platforms	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
fellowship candidates	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
face clinical trial	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
expression domain	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
experimental evidence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
exchange programme	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
excessive accumulation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
eventual acquisition	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
erroneous assumption	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
employee handbook	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
elementary school	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
electronic search	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
educational models	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
economic perspectives	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
differential work	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
dietary recommendations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
diagnostic analyses	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
diabetes knowledge	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
development delay	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
derivative daughter	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
dental trade cards	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
dental missionary	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
dental care habits	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
cultural perspectives	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
coordination skill	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
continuous improvement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
constitutive skin	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
considerable evidence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
congenital disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
clinical rationale	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
classical medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
cancer care management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
calcium distribution	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
biological linkage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
basal ganglia lesions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
bacterial particles	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
available therapies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
autistic manifestations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
anatomical abnormalities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
analytical review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
alternative model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
agricultural land	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7927	0.47561999999999993
leakage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6794	0.47557999999999995
neuroplasticity	BEYOND_CUTOFF	SIMPLE	Good	1	0.4751	0.4751
eosinophils	BEYOND_CUTOFF	SIMPLE	Good	1	0.4751	0.4751
bartonella	BEYOND_CUTOFF	SIMPLE	Good	1	0.4751	0.4751
precancerous lesions	BEYOND_CUTOFF	Normal_NP	Good	1	0.4745	0.4745
hormonal therapy	BEYOND_CUTOFF	Normal_NP	Good	1	0.4745	0.4745
cardiac troponin	BEYOND_CUTOFF	Normal_NP	Good	1	0.4745	0.4745
rois	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4739	0.4739
pkc	BEYOND_CUTOFF	SIMPLE	Good	1	0.4739	0.4739
nh3	BEYOND_CUTOFF	SIMPLE	Good	1	0.4739	0.4739
hcl	BEYOND_CUTOFF	SIMPLE	Good	1	0.4739	0.4739
afp	BEYOND_CUTOFF	SIMPLE	Good	1	0.4739	0.4739
antipsychotic lais	BEYOND_CUTOFF	Normal_NP	Good	1	0.4733	0.4733
workshop presentations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
vessel irregularity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
vascular protection	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
valvular surgery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
treatment providers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
transitory nature	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
trajectory model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
training pipeline	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
theoretical tool	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
theoretical finding	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
temporal consistency	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
television journalism	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
supervision plan	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
substance use illnesses	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
subjective evaluation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
strategic policies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
strategic agendas	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
spectrum parameters	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
somatic stem cells	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
software development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
sleep laboratory	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
service platform	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
sensitive effort	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
scientific questions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
scientific decision	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
research programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
removal approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
reassurance close	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
quality research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
psychotic dimension	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
psychological stance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
prototype strain	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
protective capacity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
primary investigators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
prevention studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
pregnancy termination	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
pragmatic review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
practice success	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
policy interventions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
physical malformations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
personal impressions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
pediatrics model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
pathogen identification	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
orthopaedic skills	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
nucleus fragmentation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
nocturnal seizures	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
natural antibodies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
muscular atrophy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
migraine prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
medicine concept	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
maternal environment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
management actors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
long term survival	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
liability reform	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
key opinion leaders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
integral parameter	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
innovative model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
injection intervals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
influenza epidemic	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
influence survival	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
infectious shock	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
improvement tendencies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
improvement scales	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
improvement alliance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
household wealth	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
healthcare organizations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
growth inhibitor	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
graduate programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
follow-up service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
focus group sessions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
film radiography	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
favourable treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
family satisfaction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
extensive efforts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
experimental trials	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
evidence submission	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
ethical guidelines	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
esthetic medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
essential review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
error-prone task	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
equity framework	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
epileptic seizures	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
epileptic origin	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
empirical theory	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
emergence attendances	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
electrical barrier	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
elective surgery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
educational sessions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
educational leaders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
diverse landscape	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
discussion mantle	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
digital radiology	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
diabetes prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
development team	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
dental literature	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
defendant hospital	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
cumulative treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
cumulative index	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
critical success	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
continuous infusion	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
conceptual models	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
comparative risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
cocktail therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
coalition diabetes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
clinical diagnoses	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
clinical consequences	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
classical hormone	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
calcium precipitation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
biochemical link	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
automatic report	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
automatic gestures	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
automatic air quality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
activity programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
activity monitors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
academic medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7875	0.4725
instructions	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6746	0.47222
sickkids	BEYOND_CUTOFF	SIMPLE	Good	1	0.4722	0.4722
management protocol	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7868	0.47208
oca	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4711	0.4711
pediatric intensive care	BEYOND_CUTOFF	Normal_NP	Good	1	0.4705	0.4705
final rule	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7838	0.47028000000000003
clinical follow-up	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7831	0.46986
vascular fragility	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
valvular diseases	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
university students	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
treatment model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
treatment adherence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
topical steroids	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
textual complexity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
technical refinements	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
task force ranking	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
target image quality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
symmetrical lesions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
statistical fit	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
sporadic disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
spatial development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
service context	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
scientific writings	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
scientific lotus	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
romanticist vision	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
romantic experiences	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
reward scenario	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
research associates	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
research assistants	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
repair strategies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
renaissance man	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
registry observations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
recurrence risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
radiation treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
quality parameters	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
pulmonary complications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
psychical dynamics	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
provider burden	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
protein identification	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
protein extracts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
privacy concerns	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
principal match	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
practical training	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
potential teaching	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
popular classifications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
physical wealth	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
pharmacist teams	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
perennial questions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
offering explanations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
numerous instruments	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
neural stem cells	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
national policy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
national family	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
multiple tumours	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
molecular damages	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
molecular assays	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
melodic contour	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
medicine sector	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
medication abuse	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
mechanistic entities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
maternal disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
maternal admissions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
malignant stroke	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
learning experience	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
judicial review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
internal culture	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
innovative ideas	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
innovative drugs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
industrial waste	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
incident reports	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
importance cause	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
idealist analyses	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
headache episodes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
fundamental rule	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
fetal interventions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
extremity amputations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
excellent studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
epileptic population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
epidemic season	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
emotional complications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
emergency evaluation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
drug expenditure	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
digital anomalies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
dialysis prevalence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
diagnostic issues	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
diabetes coalition	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
deputy director	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
dental researchers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
dental postcards	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
dental expertise	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
cumulative mortality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
cultural preferences	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
cultural beliefs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
cultural acceptability	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
creation dependence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
cosmetic improvement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
clinical stabilization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
clinical services	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
clinical record	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
chemical insults	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
chain inhibitor	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
cardiac surgeon	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
cancer committee	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
budget considerations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
aggressive patients	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
advocacy efforts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
activity dependence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
acceptable diet	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7823	0.46937999999999996
glucagon-like peptide-1	BEYOND_CUTOFF	Normal_NP	Good	1	0.4688	0.4688
neonatal severe hyperparathyroidism	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7809	0.46854
retirement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6685	0.46795
inundation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6685	0.46795
gamble	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6685	0.46795
faith	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6685	0.46795
escalation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6685	0.46795
drift	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6685	0.46795
awards	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6685	0.46795
actors	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6685	0.46795
suicidal behavior	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7787	0.46721999999999997
california	BEYOND_CUTOFF	SIMPLE	Good	1	0.4671	0.4671
well-being indicators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
viral suppression	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
trial programme	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
transition care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
terminal graduate	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
surgical revision	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
stress perception	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
strategic documents	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
special report	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
similar reports	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
shock children	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
share research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
service sectors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
serious infections	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
sensitive tool	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
sense approaches	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
seasonal trends	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
rural neighbor	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
rigorous evaluation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
research partners	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
rescue therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
repeat exposure	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
relative treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
recovery index	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
program impacts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
profound shock	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
prevention trials	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
practice model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
practice aspirations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
practical tools	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
potential noise	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
potential links	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
potential implications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
political implications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
physician leaders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
physical management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
physical dynamics	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
physical barrier	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
orthopedic aids	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
organic pollutants	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
organic disorders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
optimum nutrition	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
ongoing outcome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
nutrition evidence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
numerous awards	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
new hpv infection	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
municipal business	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
morbidity peak	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
molecular fragments	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
modular review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
metabolic mediators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
mental development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
membrane polarization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
literary supplement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
lexical access	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
knowledge utilization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
islander population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
insular origin	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
insular cortex	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
inhibitor patients	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
infusion reactions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
incidence risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
inadequate care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
inactive carriers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
important mediators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
hospital treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
hospital staff	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
hormone replacement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
hemisphere lesions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
health statistics	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
health preservation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
grain consumption	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
grade approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
global aesthetic	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
glaucoma model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
genetic modifiers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
fruit consumption	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
formative years	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
food administrators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
fibrous capsule	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
family practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
extrinsic risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
external study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
expansion stage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
exit interview	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
excessive tearing	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
estimate model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
diurnal profile	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
disease disparity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
diagnostic capability	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
dental surgeons	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
decision model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
cultural identity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
count concentration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
cortical organization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
continuous medication	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
clinical staff	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
clinical genetics	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
clinical class	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
classical work	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
chronic laryngitis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
care-funded initiative	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
cardiac service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
cancer metabolism	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
calcium excess	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
benefit profile	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
antenatal clinic	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
address diabetes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
access defaults	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
abuse criteria	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7779	0.46674
deficit hyperactivity disorder	BEYOND_CUTOFF	Normal_NP	Good	1	0.4659	0.4659
gastrointestinal tract	BEYOND_CUTOFF	Normal_NP	Good	1	0.4654	0.4654
brain injury	BEYOND_CUTOFF	Normal_NP	Good	1	0.4648	0.4648
adjuvant	BEYOND_CUTOFF	SIMPLE	Good	1	0.4637	0.4637
new year	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7728	0.46368
exploration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6624	0.46368
psychotic episode	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7721	0.46326
pharmacy practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7721	0.46326
literature revision	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7721	0.46326
genetic research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7721	0.46326
pmp	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.462	0.462
mental retardation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7699	0.46194
family impact	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7699	0.46194
grant	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.659	0.4613
virtual engineering	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
various treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
unequal treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
tumor syndrome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
training years	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
teaching tool	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
surgical wait	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
supine breast	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
strategic role	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
static compliance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
spiritual care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
sodium replacement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
sleep parameter	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
sinus syndrome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
service excellence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
secondary rise	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
scorecard hall	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
romantic ideas	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
review authors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
retirement age	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
resident patients	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
release reaction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
practice situations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
potential toxicity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
policy outcomes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
poetic effort	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
personal work	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
pediatrics initiative	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
pancreas cancer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
pacific trust	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
outcome evaluation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
online article	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
negative patients	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
negative mood	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
national meeting	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
muscle electricity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
miraculous events	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
millennium goals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
median observation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
maternal education	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
key predictor	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
ion transporters	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
incident patients	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
illness onset	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
healthy adult	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
health report	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
health reform	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
health impact	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
health coalition	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
health breast	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
growth deficiency	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
graduate education	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
global improvement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
formal defects	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
focal therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
economic situation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
economic evidence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
drug consumption	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
donor transplants	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
disparity gap	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
deviation dose	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
dental abnormalities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
demand windows	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
decision cancer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
cultural norms	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
conical crown	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
color conversion	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
clinical statement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
clinical risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
chronic nature	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
care delivery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
capacity issue	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
bubonic plague	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
bilateral upper	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
behavior scale	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
asbestos usage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
antenatal care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
allergic markers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
age distribution	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
age demographics	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
advance choices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
act characterization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
ace inhibitors	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7684	0.46103999999999995
wild-type	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.4608	0.4608
vascularization	BEYOND_CUTOFF	SIMPLE	Good	1	0.4608	0.4608
vascularity	BEYOND_CUTOFF	SIMPLE	Good	1	0.4608	0.4608
scaphoid	BEYOND_CUTOFF	SIMPLE	Good	1	0.4608	0.4608
neuroscience	BEYOND_CUTOFF	SIMPLE	Good	1	0.4608	0.4608
internet	BEYOND_CUTOFF	SIMPLE	Good	1	0.4608	0.4608
confounders	BEYOND_CUTOFF	SIMPLE	Good	1	0.4608	0.4608
burnetii	BEYOND_CUTOFF	SIMPLE	Good	1	0.4608	0.4608
mesothelioma	BEYOND_CUTOFF	SIMPLE	Good	1	0.4603	0.4603
evidence-base	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.4603	0.4603
clinical roundtable monograph	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.767	0.4602
rem sleep	BEYOND_CUTOFF	Normal_NP	Good	1	0.458	0.458
cytoplasmic	BEYOND_CUTOFF	SIMPLE	Good	1	0.4575	0.4575
cytoplasm	BEYOND_CUTOFF	SIMPLE	Good	1	0.4575	0.4575
prp	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4569	0.4569
negativity	BEYOND_CUTOFF	SIMPLE	Good	1	0.4569	0.4569
neg	BEYOND_CUTOFF	SIMPLE	Good	1	0.4569	0.4569
mbc	BEYOND_CUTOFF	SIMPLE	Good	1	0.4569	0.4569
iap	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4569	0.4569
dcis	BEYOND_CUTOFF	SIMPLE	Good	1	0.4569	0.4569
crs	BEYOND_CUTOFF	SIMPLE	Good	1	0.4569	0.4569
multivariate analyses	BEYOND_CUTOFF	Normal_NP	Good	1	0.4563	0.4563
mental disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7605	0.45629999999999993
youth service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
vigorous debate	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
vascular cells	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
various risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
valve academic	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
trend report	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
trauma match	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
training care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
surgical activity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
study surveys	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
study analyses	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
student stages	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
status populations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
somatic stem	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
sinus disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
severe stroke	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
severe pv ar	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
scale intensity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
root development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
risk projection	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
risk parameters	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
risk definition	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
review depot	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
research note	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
quality patient	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
primary voice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
primary venue	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
possible options	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
policy trends	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
policy decision	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
policy barriers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
outcome issues	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
ordinal scale	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
offer lessons	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
new strategies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
negative bone	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
ministry capability	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
median sample	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
key lifestyle	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
key challenges	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
job opportunities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
integral dose	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
hormone fragments	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
heart defect	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
guide families	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
genital warts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
final approval	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
diverse clinic	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
digital renderings	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
diabetes medications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
detector bin	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
depth deployment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
dental organizations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
current risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
current findings	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
counsel cancer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
contrast visibility	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
cohort model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
cerebral cells	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
board approval	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
anemia management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
adhesive tape	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.759	0.45539999999999997
tractography	BEYOND_CUTOFF	SIMPLE	Good	1	0.4552	0.4552
biotechnological	BEYOND_CUTOFF	SIMPLE	Good	1	0.4552	0.4552
raise	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6496	0.45471999999999996
plugs	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6496	0.45471999999999996
mark	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6496	0.45471999999999996
hype	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6496	0.45471999999999996
hfmd	BEYOND_CUTOFF	SIMPLE	Good	1	0.4547	0.4547
substance abuse	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7561	0.45365999999999995
potential marker	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7561	0.45365999999999995
atrial fibrillation	BEYOND_CUTOFF	Normal_NP	Good	1	0.4535	0.4535
raters	BEYOND_CUTOFF	SIMPLE	Good	1	0.453	0.453
haemophilia registry	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7547	0.45282
virtualization	BEYOND_CUTOFF	SIMPLE	Good	1	0.4524	0.4524
sustainment	BEYOND_CUTOFF	SIMPLE	Good	1	0.4524	0.4524
sustainability	BEYOND_CUTOFF	SIMPLE	Good	1	0.4524	0.4524
optimisation	BEYOND_CUTOFF	SIMPLE	Good	1	0.4524	0.4524
blockers	BEYOND_CUTOFF	SIMPLE	Good	1	0.4524	0.4524
volatile organic compounds	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7532	0.45192
inflammatory bowel disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7532	0.45192
tremens	BEYOND_CUTOFF	SIMPLE	Good	1	0.4513	0.4513
munich	BEYOND_CUTOFF	SIMPLE	Good	1	0.4513	0.4513
morvan	BEYOND_CUTOFF	SIMPLE	Good	1	0.4513	0.4513
jornal	BEYOND_CUTOFF	SIMPLE	Good	1	0.4513	0.4513
escola	BEYOND_CUTOFF	SIMPLE	Good	1	0.4513	0.4513
revascularization	BEYOND_CUTOFF	SIMPLE	Good	1	0.4507	0.4507
work intensity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
voice teaching	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
valve depth	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
valve building	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
union population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
typical rbd	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
trauma lists	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
track child	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
total study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
survey tool	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
staff engagement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
severe aortic	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
service gaps	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
seminal paper	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
school milk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
school food	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
scale studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
savvy manager	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
rural training	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
robust evidence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
risk impact	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
practice goals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
policy documents	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
peer hospitals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
peak prevalence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
oxide dream	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
orbital fat	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
oral preparations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
optimal care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
new thoughts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
new horizons	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
new england	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
neural stem	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
mucous plugs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
life episodes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
key resources	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
key opinion	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
host culture	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
health educators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
grant model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
goal orientation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
frontal lobe	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
fourth edition	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
food safety	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
focal stroke	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
flood inundation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
dental trade	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
dental education	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
current indications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
care reform	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
care experts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
care deficiencies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
cardiac core	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
calcium balance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
asthma educator	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
agency prices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
advance care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
acute intoxication	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
acid injections	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
abuse treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7503	0.45017999999999997
flood	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6423	0.44960999999999995
artifact	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6416	0.4491199999999999
tlr4	BEYOND_CUTOFF	SIMPLE	Good	1	0.4491	0.4491
ncbi	BEYOND_CUTOFF	SIMPLE	Good	1	0.4491	0.4491
health profiles	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7475	0.4485
disease incident	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7475	0.4485
disease incidence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7475	0.4485
interconnection	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6403	0.44820999999999994
cystic fibrosis	BEYOND_CUTOFF	Normal_NP	Good	1	0.448	0.448
pacific islander	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.746	0.4476
ald	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4474	0.4474
unambiguous patient	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7453	0.44717999999999997
phosphate retention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7453	0.44717999999999997
episodic migraine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7453	0.44717999999999997
hepatitis b virus	BEYOND_CUTOFF	Normal_NP	Good	1	0.4468	0.4468
allergic inflammation	BEYOND_CUTOFF	Normal_NP	Good	1	0.4468	0.4468
work studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
valvular ring	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
valve placement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
trade cards	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
staff better	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
room availability	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
review topics	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
rescue medication	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
ominous event	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
muscle ache	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
mass media	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
life training	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
life facets	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
legal document	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
her family	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
health notions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
genetic events	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
gap disparity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
face treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
erotic visions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
energy bins	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
enamel lesions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
custom motion	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
color filters	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
cause permeability	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
care status	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
care queen	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
care habits	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
care excellence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
account age	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7446	0.44676
health inequities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7439	0.44634
disease activity index	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7432	0.44592
xt	BEYOND_CUTOFF	SIMPLE	Good	1	0.4457	0.4457
pk	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4457	0.4457
om	BEYOND_CUTOFF	SIMPLE	Good	1	0.4457	0.4457
open-label	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.4452	0.4452
discontinuation	BEYOND_CUTOFF	SIMPLE	Good	1	0.4452	0.4452
research agenda	BEYOND_CUTOFF	Normal_NP	Good	1	0.4441	0.4441
sanitizer	BEYOND_CUTOFF	SIMPLE	Good	1	0.4435	0.4435
subscale	BEYOND_CUTOFF	SIMPLE	Good	1	0.443	0.443
quantitative approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7382	0.44292
national comprehensive cancer network	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7374	0.44244
intensity-modulated radiation therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7374	0.44244
workup	BEYOND_CUTOFF	SIMPLE	Good	1	0.4424	0.4424
systolic	BEYOND_CUTOFF	SIMPLE	Good	1	0.4424	0.4424
moscow	BEYOND_CUTOFF	SIMPLE	Good	1	0.4424	0.4424
ischemic	BEYOND_CUTOFF	SIMPLE	Good	1	0.4424	0.4424
fluence	BEYOND_CUTOFF	SIMPLE	Good	1	0.4424	0.4424
exosome	BEYOND_CUTOFF	SIMPLE	Good	1	0.4424	0.4424
acetylation	BEYOND_CUTOFF	SIMPLE	Good	1	0.4424	0.4424
acetyl	BEYOND_CUTOFF	SIMPLE	Good	1	0.4424	0.4424
health care delivery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7353	0.44117999999999996
vitamin k	BEYOND_CUTOFF	Normal_NP	Good	1	0.4408	0.4408
work team	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
wish list	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
vision stability	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
study day	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
split face	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
sea basin	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
rural sites	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
peak currents	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
pain sensation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
new treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
network cities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
list prices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
life issues	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
fetal toxicity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
diverse cities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
color vision	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
abuse care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7339	0.44034
haemophilia care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7325	0.4395
granuloma	BEYOND_CUTOFF	SIMPLE	Good	1	0.4391	0.4391
centrifugation	BEYOND_CUTOFF	SIMPLE	Good	1	0.4391	0.4391
nccn expert	BEYOND_CUTOFF	Normal_NP	Good	1	0.4386	0.4386
escherichia	BEYOND_CUTOFF	SIMPLE	Good	1	0.4375	0.4375
clones	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6244	0.43707999999999997
pharmacokinetic	BEYOND_CUTOFF	SIMPLE	Good	1	0.4369	0.4369
severe hyperparathyroidism	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7275	0.4365
health development plan	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7275	0.4365
rem sleep behavior	BEYOND_CUTOFF	Normal_NP	Good	1	0.4364	0.4364
immunosorbent assay	BEYOND_CUTOFF	Normal_NP	Good	1	0.4353	0.4353
histological examination	BEYOND_CUTOFF	Normal_NP	Good	1	0.4353	0.4353
diagnostic accuracy	BEYOND_CUTOFF	Normal_NP	Good	1	0.4353	0.4353
isp	BEYOND_CUTOFF	SIMPLE	Good	1	0.4347	0.4347
bal	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4347	0.4347
prescriber	BEYOND_CUTOFF	SIMPLE	Good	1	0.4342	0.4342
risk management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7225	0.4335
intersection	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6192	0.43343999999999994
ca6	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4331	0.4331
randomisation	BEYOND_CUTOFF	SIMPLE	Good	1	0.4325	0.4325
leukocytes	BEYOND_CUTOFF	SIMPLE	Good	1	0.4325	0.4325
demyelination	BEYOND_CUTOFF	SIMPLE	Good	1	0.4325	0.4325
demyelinating	BEYOND_CUTOFF	SIMPLE	Good	1	0.4325	0.4325
vocal quality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7204	0.43224
root canals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7204	0.43224
clip fixation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7204	0.43224
abrasion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6172	0.43204
pv	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.432	0.432
scientific controversy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7197	0.43182
immersion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6166	0.43162
vol	BEYOND_CUTOFF	SIMPLE	Good	1	0.4314	0.4314
t13	BEYOND_CUTOFF	SIMPLE	Good	1	0.4314	0.4314
nas	BEYOND_CUTOFF	SIMPLE	Good	1	0.4314	0.4314
mmp	BEYOND_CUTOFF	SIMPLE	Good	1	0.4314	0.4314
il6	BEYOND_CUTOFF	SIMPLE	Good	1	0.4314	0.4314
cdc	BEYOND_CUTOFF	SIMPLE	Good	1	0.4314	0.4314
acr	BEYOND_CUTOFF	SIMPLE	Good	1	0.4314	0.4314
paco2	BEYOND_CUTOFF	SIMPLE	Good	1	0.4309	0.4309
intubation	BEYOND_CUTOFF	SIMPLE	Good	1	0.4309	0.4309
ebola	BEYOND_CUTOFF	SIMPLE	Good	1	0.4309	0.4309
health assessment questionnaire	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7176	0.43056
b-type natriuretic peptide	BEYOND_CUTOFF	Normal_NP	Good	1	0.4298	0.4298
improvement initiative	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7162	0.42971999999999994
family medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7162	0.42971999999999994
human papillomavirus	BEYOND_CUTOFF	Normal_NP	Good	1	0.4287	0.4287
intellectual disabilities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7141	0.42845999999999995
enterococci	BEYOND_CUTOFF	SIMPLE	Good	1	0.4282	0.4282
renal transplantation	BEYOND_CUTOFF	Normal_NP	Good	1	0.4276	0.4276
comprehensive cancer network	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.712	0.42719999999999997
readmission	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.61	0.427
subacute	BEYOND_CUTOFF	SIMPLE	Good	1	0.4265	0.4265
maxillae	BEYOND_CUTOFF	SIMPLE	Good	1	0.4265	0.4265
maxilla	BEYOND_CUTOFF	SIMPLE	Good	1	0.4265	0.4265
catabolism	BEYOND_CUTOFF	SIMPLE	Good	1	0.4265	0.4265
catabolic	BEYOND_CUTOFF	SIMPLE	Good	1	0.4265	0.4265
endeavors	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.6088	0.42616
proteomic	BEYOND_CUTOFF	SIMPLE	Good	1	0.426	0.426
proteome	BEYOND_CUTOFF	SIMPLE	Good	1	0.426	0.426
biochemical marker	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7092	0.42552
antiretroviral therapy	BEYOND_CUTOFF	Normal_NP	Good	1	0.4254	0.4254
valvular heart disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7085	0.4251
rehabilitation hospital	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7085	0.4251
transplantation registry	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7078	0.42468
observational study	BEYOND_CUTOFF	Normal_NP	Good	1	0.4244	0.4244
national comprehensive cancer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7071	0.42425999999999997
cultural competence program	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7071	0.42425999999999997
new hpv	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7057	0.42341999999999996
helicobacter	BEYOND_CUTOFF	SIMPLE	Good	1	0.4233	0.4233
cultural competence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7043	0.42258
millennium development goal	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7036	0.42216
cultural issues	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7022	0.42132000000000003
systematic literature	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7008	0.42047999999999996
presidential address	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7008	0.42047999999999996
cost-effective treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7008	0.42047999999999996
orbital connective tissue	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7001	0.42005999999999993
intensity-modulated radiation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.7001	0.42005999999999993
arthropathy	BEYOND_CUTOFF	SIMPLE	Good	1	0.42	0.42
two-thirds	BEYOND_CUTOFF	HYPHENATION	Good	1	0.419	0.419
neoplasia	BEYOND_CUTOFF	SIMPLE	Good	1	0.419	0.419
epithelia	BEYOND_CUTOFF	SIMPLE	Good	1	0.419	0.419
contraindication	BEYOND_CUTOFF	SIMPLE	Good	1	0.419	0.419
life quality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.698	0.41879999999999995
activity index	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6973	0.41838000000000003
migrants	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5965	0.41755
convention	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5965	0.41755
renal transplant	BEYOND_CUTOFF	Normal_NP	Good	1	0.4174	0.4174
pleural effusion	BEYOND_CUTOFF	Normal_NP	Good	1	0.4174	0.4174
dental hygiene	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6953	0.41718
patient-reported outcomes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6946	0.41675999999999996
carbon dioxide concentration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6946	0.41675999999999996
assessment questionnaire	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6946	0.41675999999999996
nitric oxide	BEYOND_CUTOFF	Normal_NP	Good	1	0.4157	0.4157
cs	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4152	0.4152
peripheral blood samples	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6918	0.41507999999999995
outflow tract obstruction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6918	0.41507999999999995
comprehensive approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6918	0.41507999999999995
collaborative research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6918	0.41507999999999995
dyslipidemia	BEYOND_CUTOFF	SIMPLE	Good	1	0.4147	0.4147
scientific knowledge	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6911	0.41466000000000003
foundation guidelines	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6911	0.41466000000000003
transgenes	BEYOND_CUTOFF	SIMPLE	Good	1	0.4141	0.4141
sedimentation	BEYOND_CUTOFF	SIMPLE	Good	1	0.4141	0.4141
appointment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5914	0.41398
suicidal risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6897	0.41381999999999997
nk	BEYOND_CUTOFF	SIMPLE	Good	1	0.4131	0.4131
eu	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4131	0.4131
psychiatric emergency services	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6883	0.41298
anti-inflammatory drugs	BEYOND_CUTOFF	Normal_NP	Good	1	0.4125	0.4125
recent clinical studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.687	0.4122
nutritional intervention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.687	0.4122
experimental strategies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.687	0.4122
rearrangement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5888	0.41215999999999997
side-effect	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.412	0.412
homocysteine	BEYOND_CUTOFF	SIMPLE	Good	1	0.412	0.412
switch	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5882	0.41173999999999994
sensation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5882	0.41173999999999994
qualification	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5882	0.41173999999999994
privatization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5882	0.41173999999999994
liability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5882	0.41173999999999994
holders	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5882	0.41173999999999994
duplication	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5882	0.41173999999999994
declaration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5882	0.41173999999999994
custom	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5882	0.41173999999999994
conjugation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5882	0.41173999999999994
immune-mediated inflammatory diseases	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6849	0.41093999999999997
median progression-free survival	BEYOND_CUTOFF	Normal_NP	Good	1	0.4109	0.4109
tumor suppressor genes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6842	0.41052
statistical approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6842	0.41052
cervical cancer patient	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6842	0.41052
antibiotic prescriptions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6842	0.41052
inhalant	BEYOND_CUTOFF	SIMPLE	Good	1	0.4104	0.4104
oral anticoagulants	BEYOND_CUTOFF	Normal_NP	Good	1	0.4099	0.4099
dual therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6828	0.40968
nh	BEYOND_CUTOFF	SIMPLE	Good	1	0.4093	0.4093
scientific practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6815	0.4089
congenital malformations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6815	0.4089
coagulation disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6815	0.4089
risperidone	BEYOND_CUTOFF	SIMPLE	Good	1	0.4083	0.4083
scientific approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
recommendation grade	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
professional experience	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
orthopaedic surgeon	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
nutritional therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
malignant transformation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
consensus recommendations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
comprehensive training	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
collaborative study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
collaborative nature	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
coagulation parameters	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
biological approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6801	0.40806000000000003
z-score	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.4078	0.4078
microbial	BEYOND_CUTOFF	SIMPLE	Good	1	0.4078	0.4078
centrality	BEYOND_CUTOFF	SIMPLE	Good	1	0.4078	0.4078
osteoarthritis	BEYOND_CUTOFF	SIMPLE	Good	1	0.4072	0.4072
preventive treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.678	0.4068
alcohol consumption	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.678	0.4068
tlr	BEYOND_CUTOFF	SIMPLE	Good	1	0.4067	0.4067
sds	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4067	0.4067
iso	BEYOND_CUTOFF	SIMPLE	Good	1	0.4067	0.4067
dwi	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4067	0.4067
vegetable consumption	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
treatment scenario	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
subjective perception	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
relative distribution	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
progressive disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
orthopaedic trauma	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
millennium development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
mental health clinics	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
important considerations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
hereditary syndromes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
health care reform	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
competence program	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6767	0.40602
il-10	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.4051	0.4051
semi-structured interviews	BEYOND_CUTOFF	Normal_NP	Good	1	0.4046	0.4046
case-control study	BEYOND_CUTOFF	Normal_NP	Good	1	0.404	0.404
antibiotic therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6733	0.40398
heart syndrome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6726	0.40356
hypoglycaemia	BEYOND_CUTOFF	SIMPLE	Good	1	0.4035	0.4035
symptomatic treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6719	0.40314
spontaneous abortions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6719	0.40314
prenatal diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6719	0.40314
haemophilia treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6719	0.40314
genetic characterization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6719	0.40314
cll	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.403	0.403
cardiology	BEYOND_CUTOFF	SIMPLE	Good	1	0.4025	0.4025
treatment programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
treatment benefits	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
traditional treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
theoretical study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
severity criteria	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
reproductive years	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
radiation exposure	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
qualitative evaluation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
provider knowledge	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
prognostic impact	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
professional students	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
literature reports	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
learning opportunity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
in-patient admissions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
hereditary breast	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
guideline development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
clinical hallmark	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
clinical behavior	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6699	0.40194
nccn clinical practice guidelines	BEYOND_CUTOFF	Normal_NP	Good	1	0.4019	0.4019
an eye	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6685	0.40109999999999996
systolic blood	BEYOND_CUTOFF	Normal_NP	Good	1	0.4009	0.4009
prevention programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6678	0.40068
mitigation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5724	0.40068
existence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5724	0.40068
division	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5724	0.40068
close	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5724	0.40068
pl	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.4004	0.4004
respiratory tract	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6671	0.40026
fundamental question	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6671	0.40026
diabetes care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6658	0.39947999999999995
nucleic acid	BEYOND_CUTOFF	Normal_NP	Good	1	0.3993	0.3993
therapeutic implications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
surgical practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
statistical manual	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
spontaneous pain	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
service delivery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
scientific study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
personal opinions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
optimal approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
national library	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
medication management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
maternal therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
intervention trials	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
hospital practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
health literature	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
environmental cues	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
economic consequences	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
disease outbreak	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
dioxide concentration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
current strategies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
coronary syndromes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
clinical resources	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
categorical variable	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
biological fluids	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6651	0.39906
fever virus	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6644	0.39864
urology	BEYOND_CUTOFF	SIMPLE	Good	1	0.3983	0.3983
urological	BEYOND_CUTOFF	SIMPLE	Good	1	0.3983	0.3983
urologic	BEYOND_CUTOFF	SIMPLE	Good	1	0.3983	0.3983
pylori	BEYOND_CUTOFF	SIMPLE	Good	1	0.3983	0.3983
cation	BEYOND_CUTOFF	SIMPLE	Good	1	0.3983	0.3983
ppar	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3972	0.3972
fmri	BEYOND_CUTOFF	SIMPLE	Good	1	0.3972	0.3972
regime	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5673	0.39711
empirical articles	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6617	0.39702
vaccine development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
topical therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
renal insufficiency	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
prognostic implications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
medicine report	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
invasive infections	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
individual risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
genetic programs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
genetic pathways	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
extensive studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
chronic headache	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.661	0.3966
allergic asthma	BEYOND_CUTOFF	Normal_NP	Good	1	0.3951	0.3951
ixodidae	BEYOND_CUTOFF	SIMPLE	Good	1	0.3946	0.3946
enrollment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5636	0.39452
experimenter	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.563	0.39409999999999995
experimentation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.563	0.39409999999999995
fibronectin	BEYOND_CUTOFF	SIMPLE	Good	1	0.3936	0.3936
match	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5617	0.39319
survey respondents	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
surgical residency	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
suppressor genes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
study participants	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
research model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
quality diabetes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
quality assessment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
primary culture	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
population living	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
online databases	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
molecular markers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
injury prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
expensive drugs	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
disease occurrence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
cumulative dose	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
cancer network	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
bilateral swelling	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
advisory panel	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.655	0.393
anti-tnf therapy	BEYOND_CUTOFF	Normal_NP	Good	1	0.3915	0.3915
prevalence study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6523	0.39138
behaviour disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6523	0.39138
treatment centre	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6516	0.39096
economic outcomes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6516	0.39096
veneto dialysis	BEYOND_CUTOFF	Normal_NP	Good	1	0.3909	0.3909
olanzapine	BEYOND_CUTOFF	SIMPLE	Good	1	0.3904	0.3904
treatment arms	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
surgical wards	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
surgical risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
regulatory agencies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
phosphate balance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
paper attempts	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
matter abnormalities	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
key interventions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
hospital mortality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
heart surgery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
health assessment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
global assessment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
clinical issues	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
clinical cancer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
adherent patients	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6503	0.39017999999999997
costa rica	BEYOND_CUTOFF	Normal_NP	Good	1	0.3899	0.3899
academic practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6483	0.38898
tape	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5549	0.38842999999999994
glue	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5549	0.38842999999999994
beam	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5549	0.38842999999999994
synthase	BEYOND_CUTOFF	SIMPLE	Good	1	0.3873	0.3873
ventricular outflow tract	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6449	0.38694
vasoconstrictive	BEYOND_CUTOFF	SIMPLE	Good	1	0.3868	0.3868
vasoconstriction	BEYOND_CUTOFF	SIMPLE	Good	1	0.3868	0.3868
substantiation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5524	0.38667999999999997
disappearance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5524	0.38667999999999997
counselor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5524	0.38667999999999997
constitution	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5524	0.38667999999999997
job satisfaction	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6443	0.38658
blood-brain barrier	BEYOND_CUTOFF	Normal_NP	Good	1	0.3863	0.3863
osteotomy	BEYOND_CUTOFF	SIMPLE	Good	1	0.3858	0.3858
gw	BEYOND_CUTOFF	SIMPLE	Good	1	0.3853	0.3853
av	BEYOND_CUTOFF	SIMPLE	Good	1	0.3853	0.3853
psa	BEYOND_CUTOFF	SIMPLE	Good	1	0.3847	0.3847
guide	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5493	0.38450999999999996
thought leaders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6403	0.38417999999999997
study reports	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6403	0.38417999999999997
primary focus	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6403	0.38417999999999997
health studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6403	0.38417999999999997
health officer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6403	0.38417999999999997
health decision	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6403	0.38417999999999997
current situation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6403	0.38417999999999997
calcium loss	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6403	0.38417999999999997
adult volunteers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6403	0.38417999999999997
surgical plan	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6396	0.38375999999999993
mental health treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6389	0.38334
alternative medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6389	0.38334
distinction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5475	0.38325
discourse	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5475	0.38325
campaign	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5475	0.38325
meta-analyses	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.3822	0.3822
neurological	BEYOND_CUTOFF	SIMPLE	Good	1	0.3817	0.3817
estrogen	BEYOND_CUTOFF	SIMPLE	Good	1	0.3817	0.3817
valvular heart	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6356	0.38136000000000003
health development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6356	0.38136000000000003
federal government	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6356	0.38136000000000003
dental history	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6356	0.38136000000000003
asthma exacerbation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6356	0.38136000000000003
staff training	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.635	0.381
pivotal role	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.635	0.381
physical illnesses	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.635	0.381
model building	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.635	0.381
key parameters	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.635	0.381
health implications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.635	0.381
health clinics	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.635	0.381
dental clinic	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.635	0.381
care outcomes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.635	0.381
fibrinogen	BEYOND_CUTOFF	SIMPLE	Good	1	0.3801	0.3801
klotho	BEYOND_CUTOFF	SIMPLE	Good	1	0.3796	0.3796
rica	BEYOND_CUTOFF	SIMPLE	Good	1	0.3791	0.3791
nicu	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3791	0.3791
renal replacement therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6303	0.37817999999999996
organic carbon	BEYOND_CUTOFF	Normal_NP	Good	1	0.3781	0.3781
practice standards	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6297	0.37782
serology	BEYOND_CUTOFF	SIMPLE	Good	1	0.3776	0.3776
serological	BEYOND_CUTOFF	SIMPLE	Good	1	0.3776	0.3776
albumin	BEYOND_CUTOFF	SIMPLE	Good	1	0.3776	0.3776
melodic intonation therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6284	0.37704
etanercept	BEYOND_CUTOFF	SIMPLE	Good	1	0.377	0.377
tumor marker	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6277	0.37662
target site	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6277	0.37662
sexual role	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6277	0.37662
risk estimates	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6277	0.37662
quality initiative	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6277	0.37662
primary goals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6277	0.37662
care organization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6277	0.37662
care management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6277	0.37662
cardiac events	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6277	0.37662
paediatric patients	BEYOND_CUTOFF	Normal_NP	Good	1	0.376	0.376
recruitment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5371	0.37596999999999997
so2	BEYOND_CUTOFF	SIMPLE	Good	1	0.3755	0.3755
optimal health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6251	0.37506
homology	BEYOND_CUTOFF	SIMPLE	Good	1	0.375	0.375
homolog	BEYOND_CUTOFF	SIMPLE	Good	1	0.375	0.375
tokyo	BEYOND_CUTOFF	SIMPLE	Good	1	0.3745	0.3745
pixel	BEYOND_CUTOFF	SIMPLE	Good	1	0.3745	0.3745
trigger	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5347	0.37428999999999996
suggestions	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5347	0.37428999999999996
retraction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5347	0.37428999999999996
plateau	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5347	0.37428999999999996
employee	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5347	0.37428999999999996
default	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5347	0.37428999999999996
condensation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5347	0.37428999999999996
compensation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5347	0.37428999999999996
seizure onset	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6238	0.37428
model assumptions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6238	0.37428
final appraisal	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6238	0.37428
erp	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.373	0.373
dbp	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.373	0.373
new mexico	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6211	0.37266
fibril	BEYOND_CUTOFF	SIMPLE	Good	1	0.3725	0.3725
hp	BEYOND_CUTOFF	SIMPLE	Good	1	0.372	0.372
ear	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.531	0.3717
new studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6192	0.37151999999999996
care utilization	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6192	0.37151999999999996
sleep behavior disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6185	0.37110000000000004
haart	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.371	0.371
check	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5292	0.37044
methylation	BEYOND_CUTOFF	SIMPLE	Good	1	0.3704	0.3704
aromaticity	BEYOND_CUTOFF	SIMPLE	Good	1	0.3704	0.3704
myopathy	BEYOND_CUTOFF	SIMPLE	Good	1	0.3699	0.3699
dysregulation	BEYOND_CUTOFF	SIMPLE	Good	1	0.3699	0.3699
collagen	BEYOND_CUTOFF	SIMPLE	Good	1	0.3699	0.3699
evidence-based practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6159	0.36954
vka	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3694	0.3694
no2	BEYOND_CUTOFF	SIMPLE	Good	1	0.3694	0.3694
ffi	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3694	0.3694
health concern	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6146	0.36876000000000003
aesthetic dermatology	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6139	0.36834
hcv	BEYOND_CUTOFF	SIMPLE	Good	1	0.3679	0.3679
pharmacological management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6126	0.36756
environmental protection	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6126	0.36756
interrelation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.525	0.3675
blood lactate	BEYOND_CUTOFF	Normal_NP	Good	1	0.3674	0.3674
intrauterine growth retardation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6113	0.36677999999999994
volunteer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5238	0.36666
informants	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5238	0.36666
health survey	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6107	0.36642
nz	BEYOND_CUTOFF	SIMPLE	Good	1	0.3659	0.3659
scientific literature	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6094	0.36564
mental health service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6094	0.36564
voice quality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6088	0.36528
key mediator	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6088	0.36528
opg	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3649	0.3649
scholarship	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5208	0.36456
tavr	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3644	0.3644
wrinkle scale	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6062	0.36372
valve disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6062	0.36372
illness score	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6062	0.36372
cancer incidence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6062	0.36372
constipation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5196	0.36371999999999993
thv	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3629	0.3629
sga	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3629	0.3629
treatment recommendations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6042	0.36251999999999995
survey questionnaire	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6042	0.36251999999999995
laboratory investigation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6042	0.36251999999999995
hypercalcemia	BEYOND_CUTOFF	SIMPLE	Good	1	0.3624	0.3624
cell lymphoma	BEYOND_CUTOFF	Normal_NP	Good	1	0.3624	0.3624
peripheral nerve	BEYOND_CUTOFF	Normal_NP	Good	1	0.3619	0.3619
monoclonal antibody	BEYOND_CUTOFF	Normal_NP	Good	1	0.3609	0.3609
statistical analyses	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.601	0.3606
molecular diagnostics	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.601	0.3606
management practices	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.601	0.3606
intonation therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.601	0.3606
historical development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.601	0.3606
historical context	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.601	0.3606
bacterial pathogen	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.601	0.3606
protein-protein interaction	BEYOND_CUTOFF	Normal_NP	Good	1	0.3604	0.3604
valve replacement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.6004	0.36024
reductase	BEYOND_CUTOFF	SIMPLE	Good	1	0.3594	0.3594
osteocytes	BEYOND_CUTOFF	SIMPLE	Good	1	0.3594	0.3594
angiogenesis	BEYOND_CUTOFF	SIMPLE	Good	1	0.3589	0.3589
index date	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5965	0.3579
theoretical foundation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5959	0.35753999999999997
research approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5959	0.35753999999999997
metabolic syndrome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5959	0.35753999999999997
hospital discharge	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5959	0.35753999999999997
junction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.51	0.357
research team	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5946	0.35676
split	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5094	0.35657999999999995
dementia	BEYOND_CUTOFF	SIMPLE	Good	1	0.3564	0.3564
antioxidant	BEYOND_CUTOFF	SIMPLE	Good	1	0.3564	0.3564
tumor cell death	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5939	0.35634
technical assistance	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5939	0.35634
systematic study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5939	0.35634
radioactive waste	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5939	0.35634
pulmonary disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5939	0.35634
psychotic disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5939	0.35634
practice environment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5939	0.35634
demographic variables	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5939	0.35634
personal goals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.592	0.35519999999999996
fetal death	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.592	0.35519999999999996
tv	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3549	0.3549
treatment decision	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5907	0.35442
software package	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5907	0.35442
school children	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5907	0.35442
personal experience	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5907	0.35442
medication guides	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5907	0.35442
ethnic approaches	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5907	0.35442
continuous variable	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5907	0.35442
cerebral artery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5907	0.35442
isolation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5059	0.35413
embryonic stem cell	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5901	0.35406
macrophage	BEYOND_CUTOFF	SIMPLE	Good	1	0.3534	0.3534
oversight	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5041	0.35286999999999996
malnutrition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.5041	0.35286999999999996
uterine artery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5869	0.35213999999999995
technical skills	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5869	0.35213999999999995
surgical removal	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5869	0.35213999999999995
special attention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5869	0.35213999999999995
serious health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5869	0.35213999999999995
mucous membrane	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5869	0.35213999999999995
leadership role	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5869	0.35213999999999995
final diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5869	0.35213999999999995
cardiac disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5869	0.35213999999999995
preoperative	BEYOND_CUTOFF	SIMPLE	Good	1	0.352	0.352
nephron	BEYOND_CUTOFF	SIMPLE	Good	1	0.352	0.352
depolarization	BEYOND_CUTOFF	SIMPLE	Good	1	0.352	0.352
conformational	BEYOND_CUTOFF	SIMPLE	Good	1	0.352	0.352
myocardial infarction	BEYOND_CUTOFF	Normal_NP	Good	1	0.3515	0.3515
mtor	BEYOND_CUTOFF	SIMPLE	Good	1	0.351	0.351
il-4	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.351	0.351
bipolar disorder	BEYOND_CUTOFF	Normal_NP	Good	1	0.3505	0.3505
adenocarcinoma	BEYOND_CUTOFF	SIMPLE	Good	1	0.3505	0.3505
aortic stenosis	BEYOND_CUTOFF	Normal_NP	Good	1	0.35	0.35
mammography	BEYOND_CUTOFF	SIMPLE	Good	1	0.3495	0.3495
dc	BEYOND_CUTOFF	SIMPLE	Good	1	0.349	0.349
embase	BEYOND_CUTOFF	SIMPLE	Good	1	0.3485	0.3485
anions	BEYOND_CUTOFF	SIMPLE	Good	1	0.3485	0.3485
dr	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.348	0.348
urinary bladder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5799	0.34793999999999997
specialty care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5799	0.34793999999999997
severity scale	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5799	0.34793999999999997
radiation dose	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5799	0.34793999999999997
median interval	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5799	0.34793999999999997
health authority	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5799	0.34793999999999997
genetic alterations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5799	0.34793999999999997
clinical tool	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5799	0.34793999999999997
post-traumatic stress disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5793	0.34758
judgment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4965	0.34754999999999997
disposition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4965	0.34754999999999997
creation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4965	0.34754999999999997
metastases	BEYOND_CUTOFF	SIMPLE	Good	1	0.3475	0.3475
bioavailable	BEYOND_CUTOFF	SIMPLE	Good	1	0.3466	0.3466
bioavailability	BEYOND_CUTOFF	SIMPLE	Good	1	0.3466	0.3466
neutrophil	BEYOND_CUTOFF	SIMPLE	Good	1	0.3461	0.3461
socioeconomic status	BEYOND_CUTOFF	Normal_NP	Good	1	0.3456	0.3456
primary cancer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5742	0.34452
pain syndrome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5742	0.34452
oral presentations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5742	0.34452
hospital care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5742	0.34452
fatal outcome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5742	0.34452
ethnic minority	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5742	0.34452
death certificate	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5742	0.34452
cancer death	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5742	0.34452
pipeline	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4918	0.34426
lymphocyte	BEYOND_CUTOFF	SIMPLE	Good	1	0.3441	0.3441
trauma career	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.573	0.34379999999999994
trauma care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.573	0.34379999999999994
job search	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.573	0.34379999999999994
closure	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4901	0.34307
adjustments	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4901	0.34307
routine clinical practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5717	0.34302
culturally competent care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5717	0.34302
scholar	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4889	0.34223
sampler	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4889	0.34223
prolongation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4889	0.34223
overexpression	BEYOND_CUTOFF	SIMPLE	Good	1	0.3422	0.3422
overexpressed	BEYOND_CUTOFF	SIMPLE	Good	1	0.3422	0.3422
quality indicators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5698	0.34187999999999996
maternal age	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5698	0.34187999999999996
rett	BEYOND_CUTOFF	SIMPLE	Good	1	0.3417	0.3417
oahu	BEYOND_CUTOFF	SIMPLE	Good	1	0.3417	0.3417
nrem	BEYOND_CUTOFF	SIMPLE	Good	1	0.3417	0.3417
organic compounds	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5692	0.34152
intervention program	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.568	0.34079999999999994
sti	BEYOND_CUTOFF	SIMPLE	Good	1	0.3402	0.3402
health plan	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5661	0.33966
css	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3393	0.3393
post-traumatic stress	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5642	0.33852
endothelial cell	BEYOND_CUTOFF	Normal_NP	Good	1	0.3383	0.3383
youth smoking	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.563	0.33779999999999993
viral load	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.563	0.33779999999999993
target cells	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.563	0.33779999999999993
risk model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.563	0.33779999999999993
median duration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.563	0.33779999999999993
key informants	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.563	0.33779999999999993
drug treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.563	0.33779999999999993
es	BEYOND_CUTOFF	SIMPLE	Good	1	0.3373	0.3373
aggression	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4814	0.33698
grounding	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4802	0.33614
ground	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4802	0.33614
fourier	BEYOND_CUTOFF	SIMPLE	Good	1	0.3359	0.3359
visual analogue scale	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5592	0.33552
technical difficulty	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5592	0.33552
wrinkle	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4791	0.33537
scheme	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4791	0.33537
recession	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4791	0.33537
globalization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4791	0.33537
common	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4791	0.33537
budget	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4791	0.33537
attendant	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4791	0.33537
microorganisms	BEYOND_CUTOFF	SIMPLE	Good	1	0.3344	0.3344
haemorrhagic	BEYOND_CUTOFF	SIMPLE	Good	1	0.3344	0.3344
thromboembolism	BEYOND_CUTOFF	SIMPLE	Good	1	0.334	0.334
thromboembolic	BEYOND_CUTOFF	SIMPLE	Good	1	0.334	0.334
squamous cell	BEYOND_CUTOFF	Normal_NP	Good	1	0.334	0.334
systematic approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5561	0.33366
preventive strategies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5561	0.33366
dti	BEYOND_CUTOFF	SIMPLE	Good	1	0.3325	0.3325
thoracic	BEYOND_CUTOFF	SIMPLE	Good	1	0.332	0.332
coagulant	BEYOND_CUTOFF	SIMPLE	Good	1	0.332	0.332
rapamycin	BEYOND_CUTOFF	SIMPLE	Good	1	0.3316	0.3316
root cause	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5524	0.33144
treatment guidelines	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5518	0.33108
treatment efficacy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5518	0.33108
subcutaneous tissue	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5518	0.33108
significant correlations	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5518	0.33108
research literature	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5518	0.33108
biological pathway	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5518	0.33108
emergency service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5512	0.33072
probiotic	BEYOND_CUTOFF	SIMPLE	Good	1	0.3306	0.3306
conductance	BEYOND_CUTOFF	SIMPLE	Good	1	0.3306	0.3306
drug abuse	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5506	0.33036
fetus	BEYOND_CUTOFF	SIMPLE	Good	1	0.3301	0.3301
research collaboration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5487	0.32921999999999996
congenital defect	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5487	0.32921999999999996
squamous cell carcinoma	BEYOND_CUTOFF	Normal_NP	Good	1	0.3287	0.3287
oral care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5475	0.32849999999999996
onset age	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5475	0.32849999999999996
hybridization	BEYOND_CUTOFF	SIMPLE	Good	1	0.3282	0.3282
hybridity	BEYOND_CUTOFF	SIMPLE	Good	1	0.3282	0.3282
atp	BEYOND_CUTOFF	SIMPLE	Good	1	0.3278	0.3278
aor	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3278	0.3278
survival benefit	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5463	0.32778
potential candidate	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5463	0.32778
glucose concentration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5463	0.32778
further investigation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5463	0.32778
disease diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5463	0.32778
critical appraisal	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5463	0.32778
clinical context	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5463	0.32778
gathering	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4676	0.32732
physical activity questionnaire	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.545	0.327
inducer	BEYOND_CUTOFF	SIMPLE	Good	1	0.3249	0.3249
prognostic marker	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5414	0.32483999999999996
legal framework	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5414	0.32483999999999996
genetic counseling	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5414	0.32483999999999996
clinical assessment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5414	0.32483999999999996
verification	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4637	0.32459
stores	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4637	0.32459
relocation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4637	0.32459
il-1	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.324	0.324
anticoagulants	BEYOND_CUTOFF	SIMPLE	Good	1	0.323	0.323
rationale	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4608	0.32255999999999996
precipitation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4608	0.32255999999999996
demonstration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4608	0.32255999999999996
inspection	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4592	0.32144
clinical onset	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5353	0.32117999999999997
ab	BEYOND_CUTOFF	SIMPLE	Good	1	0.3211	0.3211
perfusion	BEYOND_CUTOFF	SIMPLE	Good	1	0.3207	0.3207
agreement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4575	0.32025
ischemic stroke	BEYOND_CUTOFF	Normal_NP	Good	1	0.3202	0.3202
severity index	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5334	0.32004
dv	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3197	0.3197
oral health care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5328	0.31968
behavior disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5328	0.31968
mutant	BEYOND_CUTOFF	SIMPLE	Good	1	0.3183	0.3183
sinus surgery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5304	0.31823999999999997
serious complications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5304	0.31823999999999997
reflux disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5304	0.31823999999999997
primary treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5304	0.31823999999999997
health department	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5304	0.31823999999999997
competent care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5304	0.31823999999999997
prospective cohort study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5298	0.31788
folate	BEYOND_CUTOFF	SIMPLE	Good	1	0.3178	0.3178
infarction	BEYOND_CUTOFF	SIMPLE	Good	1	0.3174	0.3174
ps	BEYOND_CUTOFF	SIMPLE	Good	1	0.3169	0.3169
ce	BEYOND_CUTOFF	SIMPLE	Good	1	0.3169	0.3169
orthodontic treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.528	0.3168
thought	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4524	0.31668
simplification	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4524	0.31668
primary	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4524	0.31668
impression	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4524	0.31668
diagnoses	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4524	0.31668
confirmation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4524	0.31668
health treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5274	0.31644
ethical issues	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5274	0.31644
clinical indicators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5274	0.31644
clinical indications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5274	0.31644
heterogeneity	BEYOND_CUTOFF	SIMPLE	Good	1	0.3164	0.3164
health care professionals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5268	0.31608
skeletal muscle	BEYOND_CUTOFF	Normal_NP	Good	1	0.316	0.316
primary care provider	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5262	0.31572
nfle	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3155	0.3155
health care team	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5256	0.31536
development plan	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5256	0.31536
key piece	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.525	0.315
obstruction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4496	0.31472
muscle tone	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5244	0.31464
pace	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4491	0.31437
housing	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4491	0.31437
house	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4491	0.31437
game	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4491	0.31437
exit	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4491	0.31437
edition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4491	0.31437
qol	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3141	0.3141
histology	BEYOND_CUTOFF	SIMPLE	Good	1	0.3136	0.3136
histological	BEYOND_CUTOFF	SIMPLE	Good	1	0.3136	0.3136
histologic	BEYOND_CUTOFF	SIMPLE	Good	1	0.3136	0.3136
theoretical framework	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5226	0.31355999999999995
embryonic stem	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.522	0.3132
bp	BEYOND_CUTOFF	SIMPLE	Good	1	0.3127	0.3127
study sample	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5208	0.31248000000000004
primary site	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5208	0.31248000000000004
average	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4463	0.31240999999999997
rp	BEYOND_CUTOFF	SIMPLE	Good	1	0.3122	0.3122
pt	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3122	0.3122
retrospective review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5202	0.31212
conceptual framework	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5202	0.31212
cueing	BEYOND_CUTOFF	SIMPLE	Good	1	0.3118	0.3118
atopic dermatitis	BEYOND_CUTOFF	Normal_NP	Good	1	0.3104	0.3104
rendering	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4424	0.30968
linkage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4424	0.30968
lesson	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4424	0.30968
switzerland	BEYOND_CUTOFF	SIMPLE	Good	1	0.3095	0.3095
disinfection	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4419	0.30933
disinfectant	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4419	0.30933
enzyme-linked immunosorbent assay	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5136	0.30815999999999993
face	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4397	0.30778999999999995
therapist	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4391	0.30737
fatty acid	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5118	0.30708
follow-up visit	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5106	0.30636
gastric cancer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5071	0.30426
icc	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3039	0.3039
treatment success	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5065	0.30389999999999995
treatment regimen	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5065	0.30389999999999995
secondary prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5065	0.30389999999999995
population health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5065	0.30389999999999995
inflammatory markers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5065	0.30389999999999995
pulmonary arterial hypertension	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5047	0.30282000000000003
supervision	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4325	0.30274999999999996
paralysis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4325	0.30274999999999996
distress	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4325	0.30274999999999996
destruction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4325	0.30274999999999996
catalyst	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4325	0.30274999999999996
guam	BEYOND_CUTOFF	SIMPLE	Good	1	0.3026	0.3026
theoretical basis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5035	0.3021
knowledge translation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5035	0.3021
congenital heart	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.5035	0.3021
avp	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.3021	0.3021
tubule	BEYOND_CUTOFF	SIMPLE	Good	1	0.3017	0.3017
relaxation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4309	0.30163
reach	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4309	0.30163
intoxication	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4303	0.30121
kinase	BEYOND_CUTOFF	SIMPLE	Good	1	0.3007	0.3007
repositioning	BEYOND_CUTOFF	SIMPLE	Good	1	0.3003	0.3003
co2	BEYOND_CUTOFF	SIMPLE	Good	1	0.2998	0.2998
care professionals	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4994	0.29964
specialty	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4271	0.29896999999999996
transcriptional	BEYOND_CUTOFF	SIMPLE	Good	1	0.2989	0.2989
submission	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4265	0.29855
persistence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4265	0.29855
echocardiography	BEYOND_CUTOFF	SIMPLE	Good	1	0.298	0.298
ha	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2976	0.2976
renal replacement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4959	0.29753999999999997
treatment plan	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4953	0.29718
inverse correlation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4953	0.29718
service providers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4947	0.29682
policy development	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4947	0.29682
hemodialysis patients	BEYOND_CUTOFF	Normal_NP	Good	1	0.2967	0.2967
st	BEYOND_CUTOFF	SIMPLE	Good	1	0.2962	0.2962
vas	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2953	0.2953
donator	BEYOND_CUTOFF	SIMPLE	Good	1	0.2948	0.2948
lack	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4211	0.29477
health science	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4912	0.29472
dialysis patients	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4912	0.29472
clinical utility	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4912	0.29472
key indicators	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4889	0.29334
hyperparathyroidism	BEYOND_CUTOFF	SIMPLE	Good	1	0.293	0.293
suicide risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4883	0.29298
health staff	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4883	0.29298
calibration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4184	0.29288
repeatability	BEYOND_CUTOFF	SIMPLE	Good	1	0.2921	0.2921
millennium	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4163	0.29141
constraint	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4163	0.29141
mitigation strategies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4854	0.29124
wg	BEYOND_CUTOFF	SIMPLE	Good	1	0.2908	0.2908
tumor tissue	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4843	0.29058
cancer risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4843	0.29058
adult population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4843	0.29058
vegf	BEYOND_CUTOFF	SIMPLE	Good	1	0.2904	0.2904
outbreak	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4141	0.28987
anova	BEYOND_CUTOFF	SIMPLE	Good	1	0.2895	0.2895
rhinitis	BEYOND_CUTOFF	SIMPLE	Good	1	0.289	0.289
hla	BEYOND_CUTOFF	SIMPLE	Good	1	0.2886	0.2886
outflow tract	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4808	0.28848
clinical situation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4808	0.28848
haemostasis	BEYOND_CUTOFF	SIMPLE	Good	1	0.2877	0.2877
trust	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4104	0.28728
trace	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4104	0.28728
motives	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4104	0.28728
inhalation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4104	0.28728
canal	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4104	0.28728
multidisciplinary approach	BEYOND_CUTOFF	Normal_NP	Good	1	0.2872	0.2872
af	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2868	0.2868
metabolic pathways	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4773	0.28637999999999997
subset	BEYOND_CUTOFF	SIMPLE	Good	1	0.2863	0.2863
neurons	BEYOND_CUTOFF	SIMPLE	Good	1	0.2863	0.2863
gene mutation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4768	0.28608
carrier	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4078	0.28546
psychiatric disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4756	0.28536
risk evaluation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4751	0.28506
internal consistency	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4745	0.28469999999999995
internal consistence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4745	0.28469999999999995
inflammatory cell	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4745	0.28469999999999995
adhesion molecules	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4745	0.28469999999999995
dream	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4062	0.28434
cohesion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.4062	0.28434
temporal lobe	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4728	0.28368
health research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4716	0.28296
clinical observation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4716	0.28296
allelic	BEYOND_CUTOFF	SIMPLE	Good	1	0.2828	0.2828
allele	BEYOND_CUTOFF	SIMPLE	Good	1	0.2828	0.2828
dietary intake	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4699	0.28193999999999997
rituximab	BEYOND_CUTOFF	SIMPLE	Good	1	0.2819	0.2819
ankylosing spondylitis	BEYOND_CUTOFF	Normal_NP	Good	1	0.2806	0.2806
vascular complications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4665	0.2799
research study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4665	0.2799
numerous studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4665	0.2799
resuscitation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3998	0.27986
inductance	BEYOND_CUTOFF	SIMPLE	Good	1	0.2797	0.2797
window	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3983	0.27880999999999995
referral	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3983	0.27880999999999995
acceptance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3983	0.27880999999999995
training program	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4642	0.27852
usage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3972	0.27803999999999995
play	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3972	0.27803999999999995
cast	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3972	0.27803999999999995
cardiac surgery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4631	0.27786
pharmacological treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4625	0.2775
genbank	BEYOND_CUTOFF	SIMPLE	Good	1	0.2775	0.2775
research findings	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4614	0.27684
toxin injections	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4603	0.27618
opinion leaders	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4603	0.27618
suppression	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3941	0.27587
psychiatric emergency	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4597	0.27582
psychiatric emergence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4597	0.27582
cancer prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4586	0.27516
cell carcinoma	BEYOND_CUTOFF	Normal_NP	Good	1	0.2749	0.2749
polymorphism	BEYOND_CUTOFF	SIMPLE	Good	1	0.274	0.274
polymorph	BEYOND_CUTOFF	SIMPLE	Good	1	0.274	0.274
vaccination coverage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4563	0.27377999999999997
professor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3904	0.27328
complaint	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3904	0.27328
psychotic illness	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4552	0.27312
gc	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2727	0.2727
belief	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3894	0.27258
experimental study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4541	0.27246
start	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3884	0.27188
spondylitis	BEYOND_CUTOFF	SIMPLE	Good	1	0.2714	0.2714
synergy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3873	0.27110999999999996
immobilization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3873	0.27110999999999996
consistence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3873	0.27110999999999996
rna	BEYOND_CUTOFF	SIMPLE	Good	1	0.2706	0.2706
intervention strategies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4485	0.2691
mexico	BEYOND_CUTOFF	SIMPLE	Good	1	0.2688	0.2688
con	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3837	0.26859
high-risk	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.2684	0.2684
clinical benefit	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4468	0.26808
ph	BEYOND_CUTOFF	SIMPLE	Good	1	0.268	0.268
market	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3827	0.26788999999999996
exclusion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3827	0.26788999999999996
conference	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3827	0.26788999999999996
fibromyalgia	BEYOND_CUTOFF	SIMPLE	Good	1	0.2671	0.2671
plasma concentration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4441	0.26646
stimulator	BEYOND_CUTOFF	SIMPLE	Good	1	0.2658	0.2658
end-stage renal disease	BEYOND_CUTOFF	Normal_NP	Good	1	0.265	0.265
chronic heart	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4413	0.26478
previous studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4402	0.26411999999999997
oxygen therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4402	0.26411999999999997
arterial blood	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4402	0.26411999999999997
payors	BEYOND_CUTOFF	SIMPLE	Good	1	0.2637	0.2637
ck-mb	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.2637	0.2637
comprehensive assessment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.438	0.2628
trauma patient	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4375	0.2625
toxic substances	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4375	0.2625
oral disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4375	0.2625
clinical event	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4375	0.2625
station	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.375	0.26249999999999996
degeneration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.375	0.26249999999999996
sweat	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3745	0.26215
irrigation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3745	0.26215
esrd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.262	0.262
reproduction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.374	0.2618
health belief	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4358	0.26148
disease onset	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4358	0.26148
analogue scale	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4358	0.26148
staphylococcus aureus	BEYOND_CUTOFF	Normal_NP	Good	1	0.2599	0.2599
non-hodgkin lymphoma	BEYOND_CUTOFF	Normal_NP	Good	1	0.2599	0.2599
price	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.371	0.2597
preference	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3704	0.25928
insult	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3704	0.25928
hygienist	BEYOND_CUTOFF	SIMPLE	Good	1	0.259	0.259
survivors	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3689	0.25823
postoperative complication	BEYOND_CUTOFF	Normal_NP	Good	1	0.2582	0.2582
pth	BEYOND_CUTOFF	SIMPLE	Good	1	0.2577	0.2577
trimester	BEYOND_CUTOFF	SIMPLE	Good	1	0.2573	0.2573
innovative approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4287	0.25722
developmental delay	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4287	0.25722
expenditure	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3674	0.25717999999999996
organ damage	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4282	0.25692
health issue	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4282	0.25692
decision-makers	BEYOND_CUTOFF	HYPHENATION	Good	1	0.2569	0.2569
phpt	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2565	0.2565
instrumented	BEYOND_CUTOFF	SIMPLE	Good	1	0.2561	0.2561
code	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3654	0.25578
erosion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3644	0.25508
date	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3644	0.25508
binds	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3644	0.25508
school district	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4249	0.25494
oxygen delivery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4249	0.25494
diagnostic tool	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4249	0.25494
cin	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2548	0.2548
total cholesterol	BEYOND_CUTOFF	Normal_NP	Good	1	0.2544	0.2544
critical care medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4238	0.25428
neural network	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4227	0.25362
abdominal pain	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4227	0.25362
vasopressin	BEYOND_CUTOFF	SIMPLE	Good	1	0.2535	0.2535
hypersensitivity	BEYOND_CUTOFF	SIMPLE	Good	1	0.2535	0.2535
respiratory distress	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4222	0.25332
natriuretic peptide	BEYOND_CUTOFF	Normal_NP	Good	1	0.2531	0.2531
cytometry	BEYOND_CUTOFF	SIMPLE	Good	1	0.2527	0.2527
aortic regurgitation	BEYOND_CUTOFF	Normal_NP	Good	1	0.2523	0.2523
audit	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3599	0.25193
serum calcium	BEYOND_CUTOFF	Normal_NP	Good	1	0.2519	0.2519
retrospective study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4195	0.2517
prognostication	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3594	0.25157999999999997
escherichia coli	BEYOND_CUTOFF	Normal_NP	Good	1	0.2515	0.2515
endocrine disorder	BEYOND_CUTOFF	Normal_NP	Good	1	0.2515	0.2515
basal cell	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.419	0.25139999999999996
counterpart	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3589	0.25123
bev	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.8369	0.25106999999999996
dentine	BEYOND_CUTOFF	SIMPLE	Good	1	0.251	0.251
dentin	BEYOND_CUTOFF	SIMPLE	Good	1	0.251	0.251
conversion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3584	0.25088
conversation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3584	0.25088
candidate gene	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4174	0.25044
hepatitis b	BEYOND_CUTOFF	Normal_NP	Good	1	0.2502	0.2502
recurrence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3569	0.24982999999999997
hr	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2498	0.2498
serum marker	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4163	0.24978
care model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4163	0.24978
hypoperfusion	BEYOND_CUTOFF	SIMPLE	Good	1	0.249	0.249
critical role	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4147	0.24881999999999999
glutathione	BEYOND_CUTOFF	SIMPLE	Good	1	0.2485	0.2485
laboratory study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4136	0.24816
asbestos	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.8271	0.24812999999999996
restoration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3544	0.24807999999999997
orientation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3544	0.24807999999999997
commitment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3544	0.24807999999999997
buffer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3544	0.24807999999999997
vdtr	BEYOND_CUTOFF	SIMPLE	Good	1	0.2477	0.2477
autism spectrum	BEYOND_CUTOFF	Normal_NP	Good	1	0.2473	0.2473
fit	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.353	0.24709999999999996
ckd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2469	0.2469
tg	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2465	0.2465
conformation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.352	0.24639999999999998
epidermal growth factor receptor	BEYOND_CUTOFF	Normal_NP	Good	1	0.2457	0.2457
comprehensive review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4088	0.24528
website	BEYOND_CUTOFF	SIMPLE	Good	1	0.2452	0.2452
all-cause mortality	BEYOND_CUTOFF	Normal_NP	Good	1	0.2444	0.2444
risk women	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4072	0.24431999999999998
dyslexia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.8135	0.24405
aluminum	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.8135	0.24405
kazakhstan	BEYOND_CUTOFF	SIMPLE	Good	1	0.244	0.244
yield	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3485	0.24394999999999997
stance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3485	0.24394999999999997
smoke	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3485	0.24394999999999997
sedation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3485	0.24394999999999997
peroxidation	BEYOND_CUTOFF	SIMPLE	Good	1	0.2436	0.2436
dentifrice	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.8113	0.24339
nccn clinical practice	BEYOND_CUTOFF	Normal_NP	Good	1	0.2428	0.2428
arterial hypertension	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.404	0.2424
median survival	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4035	0.2421
prostheses	BEYOND_CUTOFF	SIMPLE	Good	1	0.2416	0.2416
package	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3451	0.24157
photographs	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.8031	0.24093
clinical efficacy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4014	0.24083999999999997
papillomavirus	BEYOND_CUTOFF	SIMPLE	Good	1	0.2407	0.2407
strategic plan	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.4009	0.24053999999999998
synovitis	BEYOND_CUTOFF	SIMPLE	Good	1	0.2403	0.2403
insight	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3432	0.24023999999999998
erythema	BEYOND_CUTOFF	SIMPLE	Good	1	0.2399	0.2399
drug developers	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3993	0.23958
blood glucose	BEYOND_CUTOFF	Normal_NP	Good	1	0.2395	0.2395
screening guide	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.9573	0.239325
bnp	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2387	0.2387
vascular disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3977	0.23862
rheumatic diseases	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3967	0.23801999999999998
protein synthesis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3967	0.23801999999999998
engine	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3398	0.23786
esc	BEYOND_CUTOFF	SIMPLE	Good	1	0.2375	0.2375
congress	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3388	0.23715999999999998
peep	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7897	0.23690999999999998
mu	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.789	0.2367
license	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3378	0.23645999999999998
attack	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3378	0.23645999999999998
care service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3936	0.23615999999999998
attitude	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3369	0.23582999999999996
likelihood	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7853	0.23559
carbon dioxide	BEYOND_CUTOFF	Normal_NP	Good	1	0.2355	0.2355
aggressive behavior	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3925	0.2355
consumer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3364	0.23547999999999997
primary outcome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.392	0.2352
polytechnic	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7838	0.23514000000000002
attempt	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3359	0.23512999999999998
antipsychotic	BEYOND_CUTOFF	SIMPLE	Good	1	0.2351	0.2351
physical therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3915	0.2349
internal medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3915	0.2349
co-morbidity	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.2347	0.2347
madrid	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7816	0.23447999999999997
linker	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7816	0.23447999999999997
therapeutic modality	BEYOND_CUTOFF	Normal_NP	Good	1	0.2335	0.2335
philanthropist	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7779	0.23337
ppv	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2331	0.2331
introduction of complementary food	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.9322	0.23305
law	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3325	0.23274999999999998
experimental model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3878	0.23267999999999997
coagulation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.332	0.2324
coli	BEYOND_CUTOFF	SIMPLE	Good	1	0.2323	0.2323
sapien	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7736	0.23207999999999998
pseudomonas	BEYOND_CUTOFF	SIMPLE	Good	1	0.2319	0.2319
clinical research	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3863	0.23177999999999999
conduction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3306	0.23142
primary infected	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.925	0.23125
idiopathic	BEYOND_CUTOFF	SIMPLE	Good	1	0.2311	0.2311
veneto	BEYOND_CUTOFF	SIMPLE	Good	1	0.2307	0.2307
complementary feeding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.9226	0.23065
treatment goal	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3842	0.23051999999999997
superstructure	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7684	0.23051999999999997
care medicine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3842	0.23051999999999997
allergic disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3832	0.22991999999999999
occurrence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3282	0.22973999999999997
inversion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3282	0.22973999999999997
hybrid	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3282	0.22973999999999997
expansion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3282	0.22973999999999997
cooperation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3282	0.22973999999999997
graduate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3268	0.22875999999999996
exhibit	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3268	0.22875999999999996
display	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3268	0.22875999999999996
displacement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3268	0.22875999999999996
alliance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3268	0.22875999999999996
mental health care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3811	0.22865999999999997
dissemination	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3254	0.22778
underdevelopment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.759	0.22769999999999999
clearinghouse	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.759	0.22769999999999999
high-risk patients	BEYOND_CUTOFF	Normal_NP	Good	1	0.2275	0.2275
streptococcus	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7583	0.22748999999999997
mobilization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3249	0.22743
tumor necrosis	BEYOND_CUTOFF	Normal_NP	Good	1	0.2271	0.2271
enzymatic activity	BEYOND_CUTOFF	Normal_NP	Good	1	0.2271	0.2271
distribution of microbiological aerosol	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.9075	0.226875
wrist	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7554	0.22662
respiration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3235	0.22644999999999998
pharynx	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7539	0.22616999999999998
holland	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7539	0.22616999999999998
galleries	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7539	0.22616999999999998
cadmium	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7539	0.22616999999999998
hispanic	BEYOND_CUTOFF	SIMPLE	Good	1	0.2259	0.2259
clinical skill	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3765	0.2259
odds	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3225	0.22574999999999998
empirical study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.376	0.2256
semantic integration of gene expression	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.902	0.2255
inpatient	BEYOND_CUTOFF	SIMPLE	Good	1	0.2255	0.2255
infusion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3216	0.22512
breast mri	BEYOND_CUTOFF	Normal_NP	Good	1	0.2251	0.2251
pathologist	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7503	0.22508999999999998
mass spectrometry	BEYOND_CUTOFF	Normal_NP	Good	1	0.2247	0.2247
chemical loss of vocs	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8973	0.224325
reabsorption	BEYOND_CUTOFF	SIMPLE	Good	1	0.2243	0.2243
primary prevention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3735	0.2241
potential markers of neurodegeneration	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8957	0.223925
hyperactivity disorder	BEYOND_CUTOFF	Normal_NP	Good	1	0.2239	0.2239
geneticists	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7446	0.22338
placement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3188	0.22315999999999997
anxiety disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3715	0.2229
machine	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3183	0.22281
study of regional asthma management	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.891	0.22275
agency for healthcare research	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.891	0.22275
fever	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3178	0.22246
colonization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3178	0.22246
neonate	BEYOND_CUTOFF	SIMPLE	Good	1	0.222	0.222
neonatal	BEYOND_CUTOFF	SIMPLE	Good	1	0.222	0.222
patient assessment of constipation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8878	0.22195
theatre	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7389	0.22167
labour	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7389	0.22167
fellow	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7389	0.22167
primary endpoint	BEYOND_CUTOFF	Normal_NP	Good	1	0.2212	0.2212
concentrations of acidic gases	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8847	0.221175
growth factor receptor	BEYOND_CUTOFF	Normal_NP	Good	1	0.2208	0.2208
semantic integration of gene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8824	0.2206
cystic	BEYOND_CUTOFF	SIMPLE	Good	1	0.2204	0.2204
neurologists	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7346	0.22038
track	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3146	0.22021999999999997
reflecting inequalities	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8808	0.2202
synchrony	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7339	0.22017
sanctuary	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7339	0.22017
preceptors	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7339	0.22017
leukaemia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7339	0.22017
fulbright	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7339	0.22017
antithesis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7339	0.22017
conical crown morphology of the maxillary incisors	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8754	0.21885
health care provider	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3639	0.21834
cue	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3118	0.21826
treatment effects of intradermal botulinum toxin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8722	0.21805
recommendations for the inter-hospital transport	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8722	0.21805
genetic characterization of the syr-darya valley	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8722	0.21805
emergency department visits for pediatric asthma	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8722	0.21805
pathognomonic features of nocturnal frontal lobe	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8715	0.217875
inflection point of static pressure-volume loop	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8715	0.217875
genetic characterization of the wad medani virus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8715	0.217875
coordination of occupational therapeutic service	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8715	0.217875
health policy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3624	0.21744
mtc	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2173	0.2173
relevant clinical issues for psychiatric emergency	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8691	0.217275
nutritional recommendations for optimal health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8691	0.217275
important mediators of pathologic bone metabolism	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8691	0.217275
clinical onset of the neurodegenerative disease	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8691	0.217275
androgen-deprivation therapy for prostate cancer	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8691	0.217275
allied health literature	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8684	0.2171
hd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2169	0.2169
new treatment paradigms for optimizing survival	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8668	0.2167
formulations of second-generation antipsychotics	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8668	0.2167
diagnostic approach of intracellular bacteria	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8668	0.2167
immunological	BEYOND_CUTOFF	SIMPLE	Good	1	0.2165	0.2165
immunologic	BEYOND_CUTOFF	SIMPLE	Good	1	0.2165	0.2165
tennessee	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7204	0.21612
sparsity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7204	0.21612
postcards	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7204	0.21612
hallmark	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7204	0.21612
antiseptic	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7204	0.21612
ancestry	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7204	0.21612
secondary forms of rem sleep behavior disorder	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8637	0.215925
haemophilia registry of the medical committee	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8637	0.215925
diagnostic criteria for substance use disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8637	0.215925
criteria for project cities	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.863	0.21575
rash	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7183	0.21549000000000001
logistic regression model	BEYOND_CUTOFF	Normal_NP	Good	1	0.2154	0.2154
temporal consistency of the primary symptoms	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8614	0.21535
genomic endophenotypes of attention deficit	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8614	0.21535
cardiac surgery for structural heart disease	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8614	0.21535
therapeutic targets for hematologic malignancies	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
theological doctrine of creation ex nihilo	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
primary treatment method for chronic heart	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
nutrition evidence for public health decision	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
introduction of the comprehensive strategy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
genetic characterization of the wad medani	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
differential diagnosis of psychotic episodes	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
consideration of medication abuse criteria	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
clinical signs of temporomandibular disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
clinical evidence of the objective benefits	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
chemical loss of volatile organic compounds	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
anatomic characteristics of the valvular ring	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8606	0.21515
storm	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7169	0.21506999999999998
delta	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7169	0.21506999999999998
administration of lais	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8591	0.214775
health benefit	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3579	0.21474
interference	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3067	0.21468999999999996
bisphosphonate	BEYOND_CUTOFF	SIMPLE	Good	1	0.2146	0.2146
treatment paradigms for optimizing survival	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8583	0.214575
practical tools for healthcare practitioners	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8583	0.214575
particle size distribution of microbiological	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8583	0.214575
manifestation of hermansky-pudlak syndrome	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8583	0.214575
deterioration of the maternal endothelium	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8583	0.214575
clinical effectiveness of botulinum toxin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8583	0.214575
cancer tissue indices of oxidative stress	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8583	0.214575
supportive care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3574	0.21444
maturity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3062	0.21434
maturation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3062	0.21434
invasion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3062	0.21434
scientific evidence of prophylaxis treatment	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
quality control of the haemophilia treatment	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
prescription of antibiotic dicloxacillin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
potential prevention of calcium precipitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
potential pharmacological effects of vka	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
partnership structures for public health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
outreach	BEYOND_CUTOFF	SIMPLE	Good	1	0.2142	0.2142
kinetic characterization of non-mass lesions	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
family medicine resident physician initiated	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8568	0.2142
epidemiologic picture of a disease incident	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
ecological aspects of executive dysfunction	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
dissemination of dental hygiene research	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
digital renderings of the physical dynamics	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
contribution of secondary organic carbon	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
clinical value of second-look ultrasound	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
clinical practice guidelines for oncology	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
bilateral swellings of the parotid glands	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8568	0.2142
univariate analyses for recurrence risk	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
topical aspects of occupational medicine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
primary cause of end-stage renal disease	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
pathological alternations of the retina	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
negative effects of peroxisome proliferator	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
manifestation of the non-osmotic release	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
management system for continuous improvement	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
isolation rate of bilophila wadsworthia	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
insensitive measurement of her2 expression	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
comparing epirubicin-containing triplets	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.856	0.214
characterization of the wad medani virus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
cancellation rates for elective surgery	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.856	0.214
decompensation	BEYOND_CUTOFF	SIMPLE	Good	1	0.2138	0.2138
critical care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3559	0.21353999999999998
fishing	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.3049	0.21342999999999998
stress disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3554	0.21323999999999999
oa	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.213	0.213
treatment approach for secondary eruption	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
systematic significance of the entanglement	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
social aspects of cancer health disparities	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
scientific account of linguistic cohesiveness	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
prognostic marker of cardiovascular event	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
preliminary incubation of mitochondria	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
peripheral blood samples for dna study	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
normative account of epistemic subjectivity	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
negative repercussions of nitrous oxide	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
intravenous administration of ibandronate	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
inappropriate control of eb virus replication	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
hypertension status of native hawaiians	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
diagnostic criteria of chronic migraine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
cytoplasm of uterine smooth muscle cells	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
clinical trials for hematologic disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8514	0.21285
ontario	BEYOND_CUTOFF	SIMPLE	Good	1	0.2127	0.2127
treatment options for alopecia areata	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
systematic studies of botulinum toxin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
secondary forms of rem sleep behavior	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
primary goals of osteoporosis therapy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
plasma ratios of essential fatty acids	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
patient assessment of constipation quality	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
laboratory surveillance for influenza	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
important mediators of pathologic bone	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
derivative daughter cells of neoplastic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
critical members of the research team	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
conceptions of nature influence media	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
concentration of air particulate matter	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
clinical presentation of bullous rash	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
clinical application of hbsag quantification	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8507	0.212675
chronic heart failure follow-up reducing	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8507	0.212675
scanning microscopy	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8499	0.212475
identified challenges	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8499	0.212475
confocal laser scanning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8499	0.212475
share	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.303	0.21209999999999998
visualization of ecological contamination	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
talk story discussion groups expressed	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8476	0.2119
prototype strain of burv leiv-krg760	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
prognostic impact of aortic regurgitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
nutrition evidence for public health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
introduction of health impact assessment	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
inactivation of tumor suppressor genes	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
disorganisation dimension corresponding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8476	0.2119
continuous surveillance system for aes	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
complications of replacement therapy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
comparative risk of microalbuminuria	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
cardiac surgery for structural heart	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
baseline severity of chronic constipation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
advent of the focal infection theory	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
abrasiveness of the acidic dentifrices	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8476	0.2119
triplets	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
theiler	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
syllable	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
prolapse	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
privacy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
portico	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
nicolaus	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
leaflets	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
kaufman	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
johnson	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
homicide	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
hermann	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
harvard	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
georgia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
dentists	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
credibility	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
citizens	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
cannabis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
academy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.7057	0.21170999999999998
theological doctrine of creation ex	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
surgery for structural heart disease	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
stratified epidemiological investigations	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8461	0.211525
scientific study of social artifacts	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
retrospective review of trauma lists	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
recommendation for pregnancy termination	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
qualitative evaluation of satisfaction	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
primary outcome of a platelet count	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
neurodevelopmental disorders including	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8461	0.211525
isolation rates of parvimonas micra	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
identification of filamentous fungi	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
genetic characterization of the wad	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
expectations for non-inhibitor patients	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
empirico-transcendentalism reconsidered	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8461	0.211525
dissemination of bacterial pathogens	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
consideration of the practical implications	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8461	0.211525
including endocrine	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8445	0.211125
balanced scorecard	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8445	0.211125
transitory nature of mental disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
savvy manager of research collaborators	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
relative risks of clinical vertebral	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
recommendations for optimal health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
potential candidates for lai treatment	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
paradoxical occurrence of anti-tnf	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
manifestations of oxidative stress	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
inherited hermansky-pudlak syndrome	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8438	0.21095
infiltrations of onabotulinumtoxin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
ethical guidelines for human genome	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
economic aspects of mr-mammography	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
doctoral degrees for dental hygiene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
developmentally appropriate transfer	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8438	0.21095
clinical usefulness of the classifications	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
classification tree for differentiation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
characterization of the breakpoints	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
calibrated automated thrombography	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8438	0.21095
adolescents with special healthcare	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8438	0.21095
valve therapy for mitral regurgitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
samoa department of health breast	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
psychological account of objectification	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
privileging of subjective perception	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
primary focus of functional genomics	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
multidisciplinary approach involving	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8422	0.21055
loss of volatile organic compounds	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
integral parameter of work intensity	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
evidence of the objective benefits	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
epidemiologic picture of a disease	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
cytoplasm of uterine smooth muscle	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
criteria for substance use disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
considerations for policy developments	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
clinical manifestations of asthma	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
classification of language disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
autonomous community of cantabria	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8422	0.21055
advanced pharmacy practice experience	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8422	0.21055
aortic	BEYOND_CUTOFF	SIMPLE	Good	1	0.2104	0.2104
vitro bleeding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8407	0.210175
expressed concern	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.84	0.21
curriculum	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6994	0.20982
suboptimal quality of cancer care	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
rural neighbor islands of hawaii	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
renderings of the physical dynamics	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
registry of the medical committee	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
potential success of lai therapy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
peripheral blood samples for dna	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
pathogenesis of nocturnal seizures	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
orthodontic treatment for closure	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
laboratory tests of bullous rash	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
inappropriate control of eb virus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
inactivation of tumor suppressor	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
implementation of a low-cost science	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
identification of inactive carriers	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
drug component for a rvwf-rfviii	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
critical members of the research	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
contrast sensitivity of ct scanners	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
consideration of medication abuse	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
concentrations of organic carbon	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
complication of episodic migraine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
characterization of non-mass lesions	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
cancer research center of hawaii	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
abrasiveness of acidic dentifrices	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8392	0.2098
health risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3495	0.20969999999999997
disease activity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3495	0.20969999999999997
deposits	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2994	0.20958
deposition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2994	0.20958
tools for healthcare practitioners	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
therapeutic strategies for aortic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
social aspects of cancer health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
serum marker of vascular disease	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
risk factors for seizure recurrence	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
reimbursement for health services	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
prognostic value of the biomarker	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
practice guidelines for oncology	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
overview of the clinical experiences	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
optimization of economic outcomes	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
mobilization of the trauma patient	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
median age of dyskinesias onset	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
interpretation of the recommendation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
insensitive measurement of her2	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
improved neonatal intensive care	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8377	0.209425
implications of the jupiter trial	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
implementation of antitumor activity	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
cystic fibrosis foundation working	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8377	0.209425
biochemical effects of estrogens	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
back-end for statistical analyses	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8377	0.209425
ganglia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.698	0.20939999999999998
transcript	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2989	0.20923
pharmacotherapy	BEYOND_CUTOFF	SIMPLE	Good	1	0.2092	0.2092
vessel	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2985	0.20894999999999997
pbs	BEYOND_CUTOFF	SIMPLE	Good	1	0.2088	0.2088
substitution of von willebrand	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
significance of brain metastases	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
remembrances of a uk scientist	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
recommendations for mp definition	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
prevention of calcium precipitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
potential links of pathogenesis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
pharmacological effects of vka	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
follow-up problems of the hfmd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
credibility for quality improvement	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
concentrations of chloride ion	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
c-13 studies of cancer metabolism	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
biologic behavior of tumor cells	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
autonomous region of cantabria	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
administration of nitrous oxide	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8346	0.20865
dl	BEYOND_CUTOFF	SIMPLE	Good	1	0.2085	0.2085
serologic screening	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8339	0.208475
screening services	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8339	0.208475
therapeutic efficacy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3471	0.20826
repercussions of nitrous oxide	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
recommended treatment parameters	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8324	0.2081
recommendations for stakeholders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
preservation of public health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
practical implications of rems	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
ontology for the gene expression	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
observatory for mental health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
negative effects of peroxisome	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
low-income countries confronting	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8324	0.2081
isolation rate of enterococcus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
introduction of health impact	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
haemophilic arthropathy reducing	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8324	0.2081
evolution of episodic migraine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
evidence of prophylaxis treatment	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
displacement of viral genotype	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
diagnostic criteria for substance	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
diagnosis of psychotic episodes	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
demonstrated vessel irregularity	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8324	0.2081
concentration of air particulate	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
catalytic effect of potassium	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
balanced scorecard philosophy	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8324	0.2081
administration of bisphosphonates	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8324	0.2081
fruits	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2971	0.20796999999999996
fruit	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2971	0.20796999999999996
cop	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6925	0.20775
study effectiveness of ddavp	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
severity criteria of symptoms	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
secondary forms of rem sleep	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
root causes of health disparities	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
risk impact of hp sero-status	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
presentation of ladd syndrome	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
presentation of bullous rash	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
potential candidates for lai	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
nursing supervisor interview	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8308	0.2077
neurologically impaired patients	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8308	0.2077
molecular assembly of synapses	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
manager of research collaborators	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
isolation rates of parvimonas	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
introduction of second-generation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
ethical guidelines for human	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
environmental factors including	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8308	0.2077
consequences of the diaspora	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
complementarity of interventions	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
classifications of interventions	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
cerebrovascular events complicating	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8308	0.2077
automated peritoneal dialysis	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8308	0.2077
assessment of cancer therapy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
analyses for recurrence risk	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8308	0.2077
wait	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6904	0.20712
alba	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6904	0.20712
resolution	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2958	0.20706
therapeutic features of rbd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
significance of the entanglement	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
severity of chronic constipation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
risk factors for cardiac events	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
resources for program evaluation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
participation of calmodulin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
marker of cardiovascular event	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
key elements of the project	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
isolation rate of bilophila	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
interaction effect for ethnicity	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
inappropriate control of eb	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
health care services included	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8278	0.20695
goals of specialty pharmacy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
department of health breast	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
criteria of chronic migraine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
contrast sensitivity for ct	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
constipation quality of life	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
conceptions of nature influence	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
clinical study of pentraxin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
autosomal recessive inherited	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8278	0.20695
anemia management of anemia	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8278	0.20695
chronic pain	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3446	0.20676
ankylosis	BEYOND_CUTOFF	SIMPLE	Good	1	0.2066	0.2066
valve replacement for aortic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
treatment efficacy of btxa	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
theological doctrine of creation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
surveillance for influenza	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
review process of cpr carts	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
rational use of subsidiary	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
primary venue for dissemination	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
prevalence studies of imid	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
placental functions including	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8263	0.206575
picture of a disease incident	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
neighbor islands of hawaii	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
mutation analysis of prrt2	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
models of service delivery	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
investigation of transmission	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
integral parameter of work	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
estimated in-hospital mortality	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8263	0.206575
dental use of nitrous oxide	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
contrast sensitivity of ct	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
complete secondary therapy	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8263	0.206575
clinical effects of bont-a	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
alternations of the retina	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
administration of ibandronate	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8263	0.206575
donation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2948	0.20636
zealot	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
toyota	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
syntax	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
stupor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
retina	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
mother	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
lyndon	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
latino	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
fragility	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
fontan	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
causality	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
better	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6877	0.20631
latency	BEYOND_CUTOFF	SIMPLE	Good	1	0.2062	0.2062
including diet	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8248	0.2062
receptor activator	BEYOND_CUTOFF	Normal_NP	Good	1	0.2058	0.2058
receptor activation	BEYOND_CUTOFF	Normal_NP	Good	1	0.2058	0.2058
treatment methods for chf	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
surveillance system for aes	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
studies of cancer metabolism	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
strategic role of fiocruz	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
savvy manager of research	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
research center of hawaii	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
prostate cancer for adaptation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
organization of presynaptic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
marker of vascular disease	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
isolated hyperparathyroidism	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8218	0.20545
implications of the jupiter	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
health system for the psi	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
considerations for policy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
classification of language	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
cancer therapy for breast	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
automatic gestures mimicking	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8218	0.20545
agency for sanitary security	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8218	0.20545
reimbursement for health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
recommendation for pregnancy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
prototype strain of burv	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
potential success of lai	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
participation of the icu	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
parameter of work intensity	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
mimicking daily-life activities	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8195	0.204875
manifestations of asthma	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
legal basis for care-agreements	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
journal of dental hygiene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
incorporation of calcium	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
evidence base for health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
drug development for hiv	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
concentrations of phosphate	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
airtum database stratified	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8195	0.204875
absence of formal defects	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8195	0.204875
repeats	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2921	0.20447
repeat	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2921	0.20447
review article	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3407	0.20442
program evaluation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3407	0.20442
mass concentration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3407	0.20442
disease management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3407	0.20442
strategic documents giving	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8173	0.204325
risk factors for seizure	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8173	0.204325
prolapse of orbital fat	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8173	0.204325
prescribing observatory	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8173	0.204325
nature of mental disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8173	0.204325
mr angiography demonstrated	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8173	0.204325
included booster injections	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8173	0.204325
event data of golimumab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8173	0.204325
complications of replacement	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8173	0.204325
causes of health disparities	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8173	0.204325
automated thrombography	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8173	0.204325
alteration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2917	0.20419
utility effects of bmi	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8158	0.20395
secondary forms of rem	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8158	0.20395
recommendations for mp	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8158	0.20395
manifestations of phpt	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8158	0.20395
manifestations of oxidative	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8158	0.20395
manifestations of adhd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8158	0.20395
ipc for chronic diseases	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8158	0.20395
introduction of health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8158	0.20395
detecting suicide risk	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8158	0.20395
concentrations of hno3	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8158	0.20395
balanced scorecard hall	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8158	0.20395
accelerated breast mri	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8158	0.20395
bracelet	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6787	0.20360999999999999
modulated ct	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8143	0.203575
led taurellus	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8143	0.203575
treating hyponatremia	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.812	0.203
significance of brain	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
root causes of health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
risk factors for cstf	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
review process of cpr	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
review of trauma lists	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
quality of cancer care	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
nonprewhitening matched	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.812	0.203
model observer correlated	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.812	0.203
masseter muscle separated	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.812	0.203
incidence rate of rrt	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
gastric cancer screening	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.812	0.203
completed pipaq-short	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.812	0.203
cohort of cancer patients	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
behavior of tumor cells	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
administration of pth	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
administration of avp	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.812	0.203
spectrum of manifestations	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8083	0.202075
risk factors for cvd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8083	0.202075
representing transplants	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8083	0.202075
remembrances of a uk	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8083	0.202075
presentation of ladd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8083	0.202075
ontology for the gene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8083	0.202075
incorporation of rems	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8083	0.202075
distribution of eeep	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8083	0.202075
dimension corresponding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8083	0.202075
deterioration of living	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8083	0.202075
consideration of medication	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8083	0.202075
preventive treatment of chronic migraine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8068	0.2017
non-invasively	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.2017	0.2017
non-invasive	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.2017	0.2017
multicenter	BEYOND_CUTOFF	SIMPLE	Good	1	0.2017	0.2017
continuum	BEYOND_CUTOFF	SIMPLE	Good	1	0.2017	0.2017
key role	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3359	0.20153999999999997
accomplishment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2877	0.20138999999999999
py	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6712	0.20136
physical examination	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3349	0.20093999999999998
rco	BEYOND_CUTOFF	SIMPLE	Good	1	0.2006	0.2006
upper	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
sizer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
queen	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
plague	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
olsen	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
magnus	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
leigh	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
facets	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
empire	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
drama	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
court	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
beginnings	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6685	0.20054999999999998
work group identified	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
ventricular remodeling	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
tree for differentiation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8016	0.2004
substitution of von	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8016	0.2004
stimulated platelets	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
reducing child mortality	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
participatory modeling	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
menorrhagia persisted	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
key mediator of pth	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8016	0.2004
integrated approaches	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
implications of rems	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8016	0.2004
implantable monitoring	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
fluence field modulated	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
distribution of tlr	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8016	0.2004
confronting shortage	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
amplitude accompanied	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
accompanied decrease	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8016	0.2004
absolute risk of mp	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8016	0.2004
rs	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.2002	0.2002
updated compendium	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
transmitted diseases	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
started data enrollment	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
standardized incidence	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
repeated brain mri	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
proportion correct	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
pre-operative planning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
potential precipitating	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
nursing supervisor	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
introduction of oral	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.8001	0.200025
interstage monitoring	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
high-dose prescribing	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
enteroviruses differed	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
eneas study screening	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
densitometric scanning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
daptmomycin received	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
approved recommendations	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
appropriate transfer	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
accelerated breast	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.8001	0.200025
desert	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6665	0.19995
sensor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.285	0.19949999999999998
reimbursement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2846	0.19922
eeg	BEYOND_CUTOFF	SIMPLE	Good	1	0.1991	0.1991
triglycerides	BEYOND_CUTOFF	SIMPLE	Good	1	0.1987	0.1987
lcas treated	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7941	0.198525
screening resources	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7927	0.198175
risk impact of hp	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.7927	0.198175
remodeling statins	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7927	0.198175
reducing readmissions	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7927	0.198175
recommended treatment	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7927	0.198175
predicting morbidity	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7927	0.198175
final year of appe	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.7927	0.198175
filter with an eye	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.7927	0.198175
existing guidelines	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7927	0.198175
epinephrine bleeding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7927	0.198175
database stratified	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7927	0.198175
complicating tavi	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7927	0.198175
aggregation induced	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7927	0.198175
flu	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6597	0.19790999999999997
cho	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6597	0.19790999999999997
protein expression	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3297	0.19782
radiological	BEYOND_CUTOFF	SIMPLE	Good	1	0.1976	0.1976
von willebrand	BEYOND_CUTOFF	Normal_NP	Good	1	0.1972	0.1972
immunization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2815	0.19704999999999998
non-adherent	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.1969	0.1969
non-adherence	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.1969	0.1969
staff understanding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
sensing receptor	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
screening interval	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
revealed concerns	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
onset age of pkd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.7875	0.196875
licensing authorities	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
involving restorative	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
hereditary bleeding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
funding research	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
established teams	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
dissolving decision	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
detecting suicide	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
correlated templates	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
compressive sensing	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
complete resolution	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
automated assessment	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
antenatal screening	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7875	0.196875
monograph	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6556	0.19668
multicenter study	BEYOND_CUTOFF	Normal_NP	Good	1	0.1965	0.1965
ethnic approaches to community health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.786	0.1965
error	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2801	0.19607
induction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2797	0.19579
professional practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3263	0.19577999999999998
subjective scoring	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7823	0.195575
specialized care	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7823	0.195575
reported improvements	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7823	0.195575
received approval	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7823	0.195575
outcomes included	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7823	0.195575
outcome monitoring	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7823	0.195575
included perioral	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7823	0.195575
existing reviews	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7823	0.195575
apoptosis triggering	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7823	0.195575
primary cause	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3259	0.19554000000000002
extract	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2793	0.19551
representation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2788	0.19515999999999997
warts	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6496	0.19487999999999997
tenses	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6496	0.19487999999999997
opacities	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6496	0.19487999999999997
lotus	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6496	0.19487999999999997
hugh	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6496	0.19487999999999997
elites	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6496	0.19487999999999997
chop	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6496	0.19487999999999997
oral health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3244	0.19464
impairment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.278	0.1946
screening cancer	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7779	0.194475
repeated brain	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7779	0.194475
newborn screening	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7779	0.194475
ground monitoring	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7779	0.194475
binding pocket	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7779	0.194475
rankl	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1939	0.1939
maps	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2766	0.19362
map	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2766	0.19362
donor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2762	0.19333999999999998
organ donation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3221	0.19326
pao	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6436	0.19307999999999997
microenvironment	BEYOND_CUTOFF	SIMPLE	Good	1	0.1925	0.1925
treating crow	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
screening option	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
including autism	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
included lack	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
impaired patients	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
immunohistochemistry	BEYOND_CUTOFF	SIMPLE	Good	1	0.1921	0.1921
fviii monitoring	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
dedicated pet	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
concept deriving	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
chemical peeling	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
bleeding tendency	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
airway including	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7684	0.1921
feeding practices	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7655	0.191375
nerve	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2719	0.19032999999999997
aureus	BEYOND_CUTOFF	SIMPLE	Good	1	0.1903	0.1903
ipc	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1899	0.1899
replaced ecx	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.759	0.18975
muscle separated	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.759	0.18975
munich started	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.759	0.18975
included ca2	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.759	0.18975
improving quality	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.759	0.18975
filtered fluence	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.759	0.18975
paediatric	BEYOND_CUTOFF	SIMPLE	Good	1	0.1896	0.1896
aerosol	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6317	0.18951
treatment of chronic migraine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.7568	0.1892
city health development planning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7568	0.1892
aortic valve	BEYOND_CUTOFF	Normal_NP	Good	1	0.1892	0.1892
refractory	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6277	0.18831
inadequacy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6277	0.18831
compendium	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6277	0.18831
ammonia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6264	0.18791999999999998
reducing quality	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7503	0.187575
proposed goals	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7503	0.187575
nccn launched	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7503	0.187575
managed care	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7503	0.187575
launched initiatives	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7503	0.187575
including rs	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7503	0.187575
food poisoning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7503	0.187575
feeding indicators	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7503	0.187575
radical	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6244	0.18732
similarity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2675	0.18725
tims	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
tam	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
sir	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
pol	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
pits	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
ova	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
mods	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
man	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
lip	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
lie	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
fam	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
alo	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
ache	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
abu	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6224	0.18671999999999997
adp	BEYOND_CUTOFF	SIMPLE	Good	1	0.1867	0.1867
cardiovascular risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3109	0.18654
responders	BEYOND_CUTOFF	SIMPLE	Good	1	0.1863	0.1863
hpv screening	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7446	0.18615
grant funding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7446	0.18615
evs included	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7446	0.18615
eox replaced	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7446	0.18615
binding dyes	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7446	0.18615
stimulation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2658	0.18605999999999998
theme	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6198	0.18594
irregularity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6192	0.18575999999999998
drug administration	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.309	0.18539999999999998
health care service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3081	0.18486
coronary intervention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3081	0.18486
prize	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2637	0.18458999999999998
debate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2637	0.18458999999999998
cancer care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3076	0.18455999999999997
formulae	BEYOND_CUTOFF	SIMPLE	Good	1	0.1842	0.1842
enterprise	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.612	0.18359999999999999
monotherapy	BEYOND_CUTOFF	SIMPLE	Good	1	0.1835	0.1835
ae screening	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7339	0.183475
adp bleeding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7339	0.183475
statistical manual of mental disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.7332	0.1833
collaborative nature of the project	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.7332	0.1833
correlation coefficient	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3053	0.18318
exercise	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2616	0.18311999999999998
optimization	BEYOND_CUTOFF	SIMPLE	Good	1	0.1831	0.1831
titanium	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6088	0.18264
prototype	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6088	0.18264
independence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6088	0.18264
attributes	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6088	0.18264
aetiology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6088	0.18264
instability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6081	0.18242999999999998
neuroimaging	BEYOND_CUTOFF	SIMPLE	Good	1	0.1824	0.1824
neuroimage	BEYOND_CUTOFF	SIMPLE	Good	1	0.1824	0.1824
health development planning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7275	0.181875
pei	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.6036	0.18108
voice	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2586	0.18102
spinal cord	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.3012	0.18072000000000002
real-time pcr	BEYOND_CUTOFF	Normal_NP	Good	1	0.1806	0.1806
vascular access for hemodialysis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.7211	0.180275
tmj locking	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7204	0.1801
eeg slowing	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7204	0.1801
cervical cancer screening	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7197	0.179925
loop	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5997	0.17991
progression-free survival	BEYOND_CUTOFF	Normal_NP	Good	1	0.1799	0.1799
treat	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5991	0.17972999999999997
approaches to community health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.7176	0.1794
aphasia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5978	0.17934
television	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5965	0.17895
inquiry	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2552	0.17863999999999997
denominator	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2552	0.17863999999999997
predictor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.254	0.17779999999999999
haemophilia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.592	0.17759999999999998
psoriasis	BEYOND_CUTOFF	SIMPLE	Good	1	0.1775	0.1775
cultural competence programming	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7071	0.176775
taylor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5882	0.17645999999999998
sheath	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5882	0.17645999999999998
pocket	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5882	0.17645999999999998
notions	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5882	0.17645999999999998
clients	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5882	0.17645999999999998
autism	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5882	0.17645999999999998
analog	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5882	0.17645999999999998
smids fed	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.7057	0.176425
hemodialysis	BEYOND_CUTOFF	SIMPLE	Good	1	0.1761	0.1761
health disparity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2935	0.17609999999999998
therapy for prostate cancer	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.7036	0.1759
dysplasia	BEYOND_CUTOFF	SIMPLE	Good	1	0.1757	0.1757
chronic kidney disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2926	0.17556000000000002
necrosis	BEYOND_CUTOFF	SIMPLE	Good	1	0.1754	0.1754
cytology	BEYOND_CUTOFF	SIMPLE	Good	1	0.1754	0.1754
cytological	BEYOND_CUTOFF	SIMPLE	Good	1	0.1754	0.1754
larynx	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5844	0.17532
stakeholder	BEYOND_CUTOFF	SIMPLE	Good	1	0.175	0.175
epidermal growth	BEYOND_CUTOFF	Normal_NP	Good	1	0.1747	0.1747
washing	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5806	0.17418
mr-mammography	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.174	0.174
chronic kidney	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2899	0.17393999999999998
equity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2481	0.17367
manual of mental disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.6946	0.17365
cutaneous	BEYOND_CUTOFF	SIMPLE	Good	1	0.1726	0.1726
epidemiological study	BEYOND_CUTOFF	Normal_NP	Good	1	0.1723	0.1723
beijing	BEYOND_CUTOFF	SIMPLE	Good	1	0.1719	0.1719
testis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5724	0.17172
patch	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5724	0.17172
orange	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5724	0.17172
happiness	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5724	0.17172
chest	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5724	0.17172
avenue	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5724	0.17172
justification	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2452	0.17164
deployment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2452	0.17164
troponin	BEYOND_CUTOFF	SIMPLE	Good	1	0.1716	0.1716
paclitaxel	BEYOND_CUTOFF	SIMPLE	Good	1	0.1712	0.1712
pharmacy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5705	0.17115
participants completed	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6842	0.17105
uncertainty	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5698	0.17093999999999998
cvd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1709	0.1709
her2	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1705	0.1705
pneumoniae	BEYOND_CUTOFF	SIMPLE	Good	1	0.1702	0.1702
renal calcium handling	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6801	0.170025
participants reporting	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6801	0.170025
participants reported	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6801	0.170025
health interventions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2832	0.16992
personnel	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2424	0.16968
competence programming	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6767	0.169175
cross-section	BEYOND CUTOFF and FILTERED OUT	HYPHENATION	Bad	0.3	0.563	0.16889999999999997
consortium	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.563	0.16889999999999997
pfs	BEYOND_CUTOFF	SIMPLE	Good	1	0.1688	0.1688
accreditation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2391	0.16737
institutional review board	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2784	0.16704
emg	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1668	0.1668
app	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5555	0.16665
rescue	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2379	0.16652999999999998
wards	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5549	0.16646999999999998
vial	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5549	0.16646999999999998
tears	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5549	0.16646999999999998
crow	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5549	0.16646999999999998
cards	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5549	0.16646999999999998
multilevel modeling	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6651	0.166275
exacerbation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2371	0.16597
spectrometry	BEYOND_CUTOFF	SIMPLE	Good	1	0.1658	0.1658
intermediate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5524	0.16572
chemistry	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5524	0.16572
menstrual bleeding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.661	0.16525
quality care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2753	0.16518
dentistry	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5506	0.16518
chronic care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2753	0.16518
ed	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.55	0.165
replacement therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2745	0.1647
symbiosis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5475	0.16424999999999998
permeability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5475	0.16424999999999998
lifestyle	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5475	0.16424999999999998
insomnia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5475	0.16424999999999998
opioid	BEYOND_CUTOFF	SIMPLE	Good	1	0.1641	0.1641
gases	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5469	0.16407000000000002
scanner	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2343	0.16401
address	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2339	0.16373
pd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1637	0.1637
motion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5456	0.16368
bleeding disorder	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6516	0.1629
dt	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1627	0.1627
treating patients	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6503	0.162575
calcium handling	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6503	0.162575
antibiotic	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5407	0.16221
proficiency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5347	0.16040999999999997
filtrate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5347	0.16040999999999997
etiology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5347	0.16040999999999997
vaccine	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2291	0.16036999999999998
vaccination	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2291	0.16036999999999998
molecular biology	BEYOND_CUTOFF	Normal_NP	Good	1	0.1601	0.1601
bone remodelling	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6403	0.160075
bone remodeling	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6403	0.160075
adjusted odds	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6403	0.160075
hypertrophy	BEYOND_CUTOFF	SIMPLE	Good	1	0.1597	0.1597
hypertrophied	BEYOND_CUTOFF	SIMPLE	Good	1	0.1597	0.1597
pro	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.531	0.1593
mas	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.531	0.1593
erg	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.531	0.1593
surgical complications	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2654	0.15924000000000002
emergency room	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2654	0.15924000000000002
consensus statement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2654	0.15924000000000002
discipline	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2267	0.15869
filter	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2263	0.15841
coronary heart disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2633	0.15797999999999998
hpv	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1577	0.1577
agonist	BEYOND_CUTOFF	SIMPLE	Good	1	0.1574	0.1574
visibility	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5238	0.15714
vehicle	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5238	0.15714
sanger	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5238	0.15714
potency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5238	0.15714
fillers	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5238	0.15714
haemoglobin	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5208	0.15624000000000002
dissatisfaction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2227	0.15589
lavage	BEYOND_CUTOFF	SIMPLE	Good	1	0.1558	0.1558
director	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2224	0.15567999999999999
dye	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5178	0.15534
evaluation of satisfaction	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.6205	0.155125
medline	BEYOND_CUTOFF	SIMPLE	Good	1	0.1551	0.1551
contour	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5166	0.15497999999999998
focus group discussions	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2582	0.15491999999999997
rapid pacing	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.6192	0.1548
epithelium	BEYOND_CUTOFF	SIMPLE	Good	1	0.1548	0.1548
vascular calcification	BEYOND_CUTOFF	Normal_NP	Good	1	0.1545	0.1545
camera	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5148	0.15444
review board	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2569	0.15414
partnership	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.22	0.154
vegetative	BEYOND_CUTOFF	SIMPLE	Good	1	0.1538	0.1538
salinity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5124	0.15372
saline	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5124	0.15372
edema	BEYOND_CUTOFF	SIMPLE	Good	1	0.1535	0.1535
rejuvenation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2192	0.15344
dependent	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2188	0.15316
dependency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2188	0.15316
dependence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2188	0.15316
writing	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5094	0.15281999999999998
vitality	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5094	0.15281999999999998
union	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5094	0.15281999999999998
strips	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5094	0.15281999999999998
radius	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5094	0.15281999999999998
grain	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5094	0.15281999999999998
arena	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5094	0.15281999999999998
accidents	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5094	0.15281999999999998
foundation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2181	0.15266999999999997
surgical approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2544	0.15264
literature search	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2544	0.15264
endpoint	BEYOND_CUTOFF	SIMPLE	Good	1	0.1525	0.1525
metastasis	BEYOND_CUTOFF	SIMPLE	Good	1	0.1522	0.1522
ldh	BEYOND_CUTOFF	SIMPLE	Good	1	0.1519	0.1519
hemisphere	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5041	0.15123
curricula	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5041	0.15123
byproduct	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.5041	0.15123
endothelium	BEYOND_CUTOFF	SIMPLE	Good	1	0.1512	0.1512
clinical symptom	BEYOND_CUTOFF	Normal_NP	Good	1	0.1509	0.1509
absolute	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.7539	0.15078000000000003
translocation	BEYOND_CUTOFF	SIMPLE	Good	1	0.1506	0.1506
surgical treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2506	0.15036
os	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1502	0.1502
sensitivity analyses	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2494	0.14964
frame	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4982	0.14945999999999998
drug class	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.249	0.1494
osteoclasts	BEYOND_CUTOFF	SIMPLE	Good	1	0.1493	0.1493
manganese	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4965	0.14895
vascular access	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2473	0.14837999999999998
carts	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4936	0.14808
bolus	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4936	0.14808
rrt	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.148	0.148
aggregates	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2111	0.14776999999999998
relative risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2461	0.14766
rise	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2108	0.14755999999999997
newspaper	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4918	0.14754
recent studies	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2448	0.14687999999999998
deterioration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2096	0.14672
advocacy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2096	0.14672
feasibility	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4889	0.14667
balloon	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4889	0.14667
coronary heart	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2444	0.14664
jaw	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4866	0.14598
titer	BEYOND_CUTOFF	SIMPLE	Good	1	0.1458	0.1458
vwd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1455	0.1455
radiography	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4843	0.14529
prostate cancer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.242	0.1452
zinc	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4837	0.14511
note	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2073	0.14511
psychosis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4831	0.14492999999999998
septic shock	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2411	0.14466
cognitive	BEYOND_CUTOFF	SIMPLE	Good	1	0.1445	0.1445
growth retardation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2407	0.14442
well-being	BEYOND CUTOFF and FILTERED OUT	HYPHENATION	Bad	0.3	0.4791	0.14373
village	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4791	0.14373
spring	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4791	0.14373
recess	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4791	0.14373
electricity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4791	0.14373
colitis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4791	0.14373
abstinence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4791	0.14373
health status	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2395	0.1437
incisor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4785	0.14354999999999998
aspiration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4779	0.14337
antagonist	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2036	0.14251999999999998
retardation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2032	0.14223999999999998
web	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4739	0.14217
ace	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4739	0.14217
imide	BEYOND_CUTOFF	SIMPLE	Good	1	0.142	0.142
imid	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.142	0.142
corticosteroid	BEYOND_CUTOFF	SIMPLE	Good	1	0.1417	0.1417
horizon	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2024	0.14168
cox proportional hazards	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2359	0.14154
amputation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.2021	0.14146999999999998
nocturnal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.7057	0.14114000000000002
follow-up study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2335	0.1401
asd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1401	0.1401
therapeutic intervention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2327	0.13962
influenzae	BEYOND_CUTOFF	SIMPLE	Good	1	0.1395	0.1395
sequelae	BEYOND_CUTOFF	SIMPLE	Good	1	0.1392	0.1392
sequela	BEYOND_CUTOFF	SIMPLE	Good	1	0.1392	0.1392
quality improvement	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2315	0.1389
hawaiian	BEYOND_CUTOFF	SIMPLE	Good	1	0.1389	0.1389
double-blind	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.1383	0.1383
ventricle	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4608	0.13824
precipitate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4608	0.13824
attention deficit	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2303	0.13818
internalization	BEYOND_CUTOFF	SIMPLE	Good	1	0.138	0.138
c-reactive protein	BEYOND_CUTOFF	Normal_NP	Good	1	0.1376	0.1376
porcine	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.6877	0.13754
hepatic	BEYOND_CUTOFF	SIMPLE	Good	1	0.1373	0.1373
negative	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4569	0.13707
fviii	BEYOND_CUTOFF	SIMPLE	Good	1	0.137	0.137
federation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1954	0.13677999999999998
biotechnology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4552	0.13656
chronic hepatitis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2271	0.13626
assessment of cancer therapy for breast	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.9075	0.136125
sheet	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.453	0.1359
of the biologic behavior of tumor cells	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.9036	0.13554
immunocompromised host	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.9028	0.13542
wealth	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4513	0.13538999999999998
edwards	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4513	0.13538999999999998
amplification	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1928	0.13496
atherosclerosis	BEYOND_CUTOFF	SIMPLE	Good	1	0.1349	0.1349
vida	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4491	0.13473
ulna	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4491	0.13473
bmi	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1343	0.1343
of age-specific screening services	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8949	0.134235
for cstf included booster injections	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8949	0.134235
splenectomised patients	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8941	0.13411499999999998
clinical guideline	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2235	0.1341
diagnostic approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2231	0.13385999999999998
vi	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4457	0.13371
anaplastic large cell lymphoma	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.891	0.13365
discontinuity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4452	0.13355999999999998
hall	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4446	0.13338
reconstituted botulinum toxin	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8878	0.13317
sanitation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4435	0.13305
jupiter	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4435	0.13305
palliative care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2216	0.13296
vulnerability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4424	0.13272
tumour	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4424	0.13272
medication adherence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2212	0.13272
glutamate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4424	0.13272
gestation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4424	0.13272
adversity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4424	0.13272
of randomised controlled trials	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8847	0.132705
retention	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1888	0.13216
symposium	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4391	0.13172999999999999
arrest	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1881	0.13166999999999998
venue for dissemination of dental hygiene research	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8761	0.131415
secondary eruption failure of the mandibular right	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8761	0.131415
of the non-osmotic release of arginine vasopressin	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8761	0.131415
immunocytochemical staining of cyto slides for p16	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8761	0.131415
development planning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.5256	0.1314
skeletal effects of oral anticoagulants vitamin k	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8754	0.13130999999999998
patient assessment of constipation quality of life	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8754	0.13130999999999998
controversy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4375	0.13125
competency	BEYOND_CUTOFF	SIMPLE	Good	1	0.1312	0.1312
muscle cell	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2185	0.1311
disease management ensured	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8738	0.13107
paradoxical occurrence of anti-tnf therapy-induced	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8722	0.13083
glabellar frown lines use of botulinum toxin for	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8722	0.13083
upregulated expression of glial fibrillary acidic	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8715	0.130725
skeletal effects of oral anticoagulants vitamin	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8715	0.130725
mammalian target of rapamycin signaling pathway	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8715	0.130725
thermodynamic equilibrium model of isorropia i	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8691	0.13036499999999998
systematic review of randomised controlled trials	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8691	0.13036499999999998
services of the autonomous region of cantabria	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8691	0.13036499999999998
journalistic strategy for representing transplants	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8691	0.13036499999999998
immunocytochemical staining of cyto slides for	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8691	0.13036499999999998
consideration of the practical implications of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8691	0.13036499999999998
-atpase activity of the sarcoplasmic reticulum	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8691	0.13036499999999998
lactation	BEYOND_CUTOFF	SIMPLE	Good	1	0.1303	0.1303
lactate	BEYOND_CUTOFF	SIMPLE	Good	1	0.1303	0.1303
of the mandibular right	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8684	0.13026
cream	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4336	0.13008
array	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4336	0.13008
surgical services of the autonomous region of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8668	0.13002
risk factors for cstf included booster injections	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8668	0.13002
patient assessment of constipation quality of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8668	0.13002
millennium development goal of reducing child	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8668	0.13002
complete resolution of constitutional symptoms	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8668	0.13002
clinical usefulness of the classifications of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8668	0.13002
logistic regression	BEYOND_CUTOFF	Normal_NP	Good	1	0.1297	0.1297
facial contouring	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8645	0.129675
vitro evaluation of the abrasiveness of acidic	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8637	0.129555
glabellar frown lines use of botulinum toxin	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8637	0.129555
for dissemination of dental hygiene research	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8637	0.129555
evoked potentials for the executive dysfunction	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8637	0.129555
current strategies for treating hyponatremia	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8637	0.129555
era	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4314	0.12942
ards	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4314	0.12942
ldl	BEYOND_CUTOFF	SIMPLE	Good	1	0.1294	0.1294
tooth	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4309	0.12927
nature	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4309	0.12927
majority	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4309	0.12927
major	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4309	0.12927
kappa	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4309	0.12927
manifestation of the non-osmotic release of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8614	0.12921
living friendly summary of the body of evidence	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8614	0.12921
continuous infusion modality of factor viii	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8614	0.12921
homeostasis	BEYOND_CUTOFF	SIMPLE	Good	1	0.1291	0.1291
upregulated expression of glial fibrillary	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8606	0.12909
therapy association combined sections meetings	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8606	0.12909
meta-analysis of randomised controlled trials	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8606	0.12909
infusion modality of factor viii administration	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8606	0.12909
-atpase activity of sarcoplasmic reticulum	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8606	0.12909
of the screening guide	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8591	0.12886499999999998
reflectivity	BEYOND_CUTOFF	SIMPLE	Good	1	0.1288	0.1288
reflectance	BEYOND_CUTOFF	SIMPLE	Good	1	0.1288	0.1288
caregivers	BEYOND_CUTOFF	SIMPLE	Good	1	0.1288	0.1288
year of advanced pharmacy practice experience	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8583	0.128745
strain-gauge contraction properties of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8583	0.128745
prescribing observatory for mental health	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8583	0.128745
pathognomonic features of nocturnal frontal	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8583	0.128745
nonprewhitening matched filter with an eye	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8583	0.128745
assessment of constipation quality of life	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8583	0.128745
utilization rates of age-specific screening	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8568	0.12852
oral medication	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2142	0.12852
immunocytochemical staining of cyto slides	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8568	0.12852
evidence-based practice for improving quality	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8568	0.12852
eruption failure of the mandibular right	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8568	0.12852
vitro evaluation of the abrasiveness of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.856	0.1284
southern californian native hawaiians native	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.856	0.1284
overview of the sickkids strategy management	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.856	0.1284
of the abrasiveness of acidic dentifrices	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.856	0.1284
of manifestations of increasing complexity	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.856	0.1284
match service for prospective orthopaedic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.856	0.1284
final year of advanced pharmacy practice	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.856	0.1284
development goal of reducing child mortality	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.856	0.1284
complementarity of interventions targeting	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.856	0.1284
aggravating factors for chronic migraine	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.856	0.1284
-amp-activated kinase	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8545	0.128175
disadvantage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1828	0.12796
province	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4265	0.12794999999999998
pigments	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4265	0.12794999999999998
bladder	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4265	0.12794999999999998
insulin	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.426	0.1278
taxane for the first-line treatment of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8514	0.12771
prophylactic replacement therapy of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8514	0.12771
predictive value of the screening guide	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8514	0.12771
nonprewhitening matched filter with an	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8514	0.12771
introduction of haemophilia home treatment	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8514	0.12771
heart failure disease management ensured	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8514	0.12771
clotting times of platelet-rich plasma	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8514	0.12771
agency for sanitary security of health	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8514	0.12771
's empirico-transcendentalism reconsidered	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8514	0.12771
target of rapamycin signaling pathway	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8507	0.127605
primary hyperparathyroidism vitamin d	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8507	0.127605
of the autonomous region of cantabria	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8507	0.127605
of the body of evidence	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8499	0.127485
intramedullary nailing	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8499	0.127485
cardiovascular event	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2123	0.12738
of demographic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8484	0.12726
criminolog a	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8484	0.12726
work group comprised of thought leaders	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
strategies for treating hyponatremia	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
stakeholders regarding rems challenges	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
secondary data analysis of demographic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8476	0.12714
recommendations for stakeholders rems	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
proposed goals of specialty pharmacy	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
practice standards for treating patients	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
of the practical implications of rems	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
manifestations of increasing complexity	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
key indicators of complementary feeding	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
friendly summary of the body of evidence	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
disinhibition of contralateral frontal	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8476	0.12714
diabetes intervention program targeting	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8476	0.12714
cochrane library for existing reviews	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8476	0.12714
centro brasileiro de estudos da sa de	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8476	0.12714
electrochemically	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.635	0.127
success for percutaneous closure of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8461	0.126915
review of randomised controlled trials	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8461	0.126915
of interventions targeting individuals	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8461	0.126915
nonprewhitening matched filter with	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8461	0.126915
conventional plain film radiography	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8461	0.126915
lives	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1813	0.12691
disease progression	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2115	0.12689999999999999
m ller cell gliosis	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8445	0.126675
stabilization of the luxated tooth	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8438	0.12657
primary venue for dissemination of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8438	0.12657
cognitive evoked potentials for the	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8438	0.12657
association combined sections meetings	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8438	0.12657
workforce	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4217	0.12651
uk cf trust for existing guidelines	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8422	0.12633
subclinical atherosclerosis of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8422	0.12633
strategy for representing transplants	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8422	0.12633
service for prospective orthopaedic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8422	0.12633
risk models for predicting morbidity	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8422	0.12633
rearrangements of the factor viii	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8422	0.12633
physiotherapeutic treatment of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8422	0.12633
physiologic characteristics of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8422	0.12633
pathognomonic features of nocturnal	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8422	0.12633
overview of the sickkids strategy	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8422	0.12633
of the biologic behavior of tumor	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8422	0.12633
modality of factor viii administration	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8422	0.12633
foot	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4211	0.12633
european quality of life-5 dimensions	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8422	0.12633
thresholding	BEYOND_CUTOFF	SIMPLE	Good	1	0.1262	0.1262
study population	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.21	0.126
-sensitive fluo-4	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.84	0.126
secondary eruption failure of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8392	0.12588
prescribing observatory for mental	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8392	0.12588
indicators of complementary feeding	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8392	0.12588
equilibrium model of isorropia i	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8392	0.12588
assessment of cancer therapy for	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8392	0.12588
's murine encephalomyelitis virus	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8392	0.12588
leadership	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1796	0.12572
psychology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.419	0.12569999999999998
carbohydrate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.419	0.12569999999999998
work group comprised of thought	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8377	0.125655
public hospitals of the autonomous	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8377	0.125655
pathological alternations of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8377	0.125655
pacific trust territories of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8377	0.125655
introduction of haemophilia home	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8377	0.125655
final year of advanced pharmacy	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8377	0.125655
cognitive evoked potentials for	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8377	0.125655
chemical loss of volatile organic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8377	0.125655
antibiotic susceptibility of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8377	0.125655
agency for sanitary security of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8377	0.125655
seasons	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4184	0.12552
season	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4184	0.12552
cosmetic	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4184	0.12552
liver	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4179	0.12536999999999998
mn	BEYOND_CUTOFF	SIMPLE	Good	1	0.1253	0.1253
tendency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1789	0.12523
standardised treatment concept	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8346	0.12519
preparations for treating crow	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8346	0.12519
predictive value of the screening	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8346	0.12519
of rapamycin signaling pathway	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8346	0.12519
of constipation quality of life	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8346	0.12519
motorised low-profile delivery	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8346	0.12519
hypoplastic left heart syndrome	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8346	0.12519
genotype of enteroviruses differed	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8346	0.12519
federated states of micronesia	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8346	0.12519
conical crown morphology of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8346	0.12519
cf trust for existing guidelines	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8346	0.12519
anatomic characteristics of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8346	0.12519
affecting arteries	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8339	0.125085
hemophilia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4163	0.12489
upregulated expression of glial	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8324	0.12486
undercarboxylated osteocalcin	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8324	0.12486
systematic significance of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8324	0.12486
spectrum of manifestations of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8324	0.12486
proportional hazards	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2081	0.12486
hyperparathyroidism vitamin d	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8324	0.12486
haemophilic arthropathy of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8324	0.12486
evidence base for health planning	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8324	0.12486
cardiovascular mortality	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2081	0.12486
brasileiro de estudos da sa de	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8324	0.12486
trauma	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1782	0.12473999999999999
m ller cell	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8316	0.12473999999999999
risk factors for cstf included	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8308	0.12462
of cancer therapy for breast	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8308	0.12462
non-native hawaiian homeless	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8308	0.12462
models for predicting morbidity	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8308	0.12462
institutional review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2077	0.12462
dental hygiene research dental	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8308	0.12462
research project	BEYOND_CUTOFF	Normal_NP	Good	1	0.1244	0.1244
estudos da sa de	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8286	0.12429
sediment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4141	0.12423000000000001
bicarbonate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4141	0.12423000000000001
trust for existing guidelines	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8278	0.12416999999999999
standards for treating patients	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8278	0.12416999999999999
spectrum of pathology of mr	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8278	0.12416999999999999
proposed goals of specialty	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8278	0.12416999999999999
madrid health system for the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8278	0.12416999999999999
library for existing reviews	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8278	0.12416999999999999
goal of reducing child mortality	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8278	0.12416999999999999
femoral intramedullary nailing	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8278	0.12416999999999999
evidence-based decision-making	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8278	0.12416999999999999
's focal cortical dysplasia	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8278	0.12416999999999999
discriminability	BEYOND_CUTOFF	SIMPLE	Good	1	0.1241	0.1241
definition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1771	0.12397
temporal consistency of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8263	0.123945
statistic difference of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8263	0.123945
haemophilia registry of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8263	0.123945
full-genome sequence of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8263	0.123945
european quality of life-5	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8263	0.123945
biologics technology of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8263	0.123945
's province-wide implementation	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8263	0.123945
ma	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4131	0.12393
treatment planning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.4953	0.123825
viii administration	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8248	0.12372
lipid	BEYOND_CUTOFF	SIMPLE	Good	1	0.1235	0.1235
clinical management	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2058	0.12348
occupation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1764	0.12347999999999999
occupancy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1764	0.12347999999999999
scientific evidence of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8218	0.12326999999999999
practice for improving quality	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8218	0.12326999999999999
of haemophilia home treatment	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8218	0.12326999999999999
novel botulinum toxin topical	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8218	0.12326999999999999
matched filter with an eye	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8218	0.12326999999999999
literature review infectious	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8218	0.12326999999999999
for prospective orthopaedic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8218	0.12326999999999999
detrimental factor affecting	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8218	0.12326999999999999
clinical usefulness of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8218	0.12326999999999999
clinical long term evolution	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8218	0.12326999999999999
bilateral swellings of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8218	0.12326999999999999
analytical review concerning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8218	0.12326999999999999
's disease activity index	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8218	0.12326999999999999
femur	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4104	0.12312
digit	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4104	0.12312
child	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4104	0.12312
surgical resection of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8195	0.12292499999999999
spectrum of pathology of	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8195	0.12292499999999999
of factor viii administration	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8195	0.12292499999999999
infection of respiratory	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8195	0.12292499999999999
immunocytochemical staining	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8195	0.12292499999999999
identification of adverse	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8195	0.12292499999999999
hypertension status of native	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8195	0.12292499999999999
follow-up problems of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8195	0.12292499999999999
digital renderings of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8195	0.12292499999999999
chemical loss of volatile	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8195	0.12292499999999999
retrospective cohort study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2047	0.12281999999999998
magnetic resonance	BEYOND_CUTOFF	Normal_NP	Good	1	0.1227	0.1227
brasil m dico	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.818	0.12269999999999999
surgical services of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8173	0.122595
revista de criminolog a	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8173	0.122595
reversibly self-assemble	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8173	0.122595
organisation for economic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8173	0.122595
ongoing outcome monitoring	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8173	0.122595
individual self-monitoring	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8173	0.122595
impacting diabetes awareness	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8173	0.122595
dynamic contrast-enhanced	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8173	0.122595
conventional plain film	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8173	0.122595
coagulation factor viii	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8173	0.122595
clinical features of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8173	0.122595
clinical evidence of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8173	0.122595
coronary artery disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.2043	0.12258
hg	BEYOND_CUTOFF	SIMPLE	Good	1	0.1224	0.1224
cancer screening	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.4895	0.122375
vitro evaluation of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
textbook example of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
temporal right occipital	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
taxonomic status of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
surgical anatomy of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
southern californian native	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
recommendations regarding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8158	0.12236999999999999
recommendation grade c	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
public hospitals of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
predictive value of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
pacific islanders physical	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
of contralateral frontal	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
hypoplastic left heart	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
haemophilia home treatment	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
encapsulated haematomas	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
discrimination index d	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
critical members of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
concerning antipsychotic	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8158	0.12236999999999999
concentrations of acidic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
anesthetic power of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
-dihexyloxacarbocyanine	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8158	0.12236999999999999
lifetime	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4078	0.12233999999999999
pharmacists	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4072	0.12215999999999999
medicina legal	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8143	0.122145
chi	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4067	0.12201
nobel	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4062	0.12186
quality control of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.812	0.1218
prospective orthopaedic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.812	0.1218
pacific islander physical	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.812	0.1218
model observer for the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.812	0.1218
medical relevance new	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.812	0.1218
genome sequence of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.812	0.1218
contrast module of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.812	0.1218
consultations concerning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.812	0.1218
chronic disease of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.812	0.1218
potassium	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4056	0.12168
ligand	BEYOND_CUTOFF	SIMPLE	Good	1	0.1215	0.1215
rearrangements of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
overexpression of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
organised network of	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
of the luxated tooth	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8083	0.12124499999999999
model of isorropia i	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8083	0.12124499999999999
m lanosome transport	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
m lanosome biogenesis	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
interventions targeting	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8083	0.12124499999999999
interpretation of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
european union population	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
distal portion of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
complet genome of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
clinical onset of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
carboxylated proteins	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
anaplastic large cell	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
abovementioned substances	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8083	0.12124499999999999
schizophrenia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4035	0.12105
guidance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1729	0.12102999999999998
psiquiatr a	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8053	0.120795
e2100 trial	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8053	0.120795
chromosome	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.4025	0.12075
elisa	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1203	0.1203
validated interventions	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8016	0.12023999999999999
stakeholders regarding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8016	0.12023999999999999
stabilization of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
scientific advisory	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
participation of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
novartis pharmaceutical	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
manifestation of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
inversion of integral	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
heterogeneity of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
glycated hemoglobin	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
gas-particle partitioning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8016	0.12023999999999999
european quality of	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
epidermal m lanosome	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
deterioration of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
contralateral frontal	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
consolidation of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
clinically significant	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
chronic hepatitis c	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
arterial spin-labeling	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8016	0.12023999999999999
work group comprised	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8001	0.120015
targeting individuals	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8001	0.120015
standardised treatment	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
segmentation of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
risk factor for the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
resting muscle tone	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8001	0.120015
rejuvenation of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
reaffirming health	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8001	0.120015
pakistan demographic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
of the factor viii	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
of pathology of mr	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.8001	0.120015
of nocturnal frontal	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
mobilization of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
millilitres for the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
key elements of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
guidelines concerning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.8001	0.120015
epigenetic infectious	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
cf foundation clinical	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
age-specific gastric	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
abrasiveness of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
-aminobutyric acid	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.8001	0.120015
fracture risk	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1995	0.1197
particle	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3988	0.11964
acceptability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3983	0.11948999999999999
stenting	BEYOND_CUTOFF	SIMPLE	Good	1	0.1192	0.1192
situ	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3972	0.11915999999999999
sinus	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3972	0.11915999999999999
playing	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3972	0.11915999999999999
implementation of nccn guidelines	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.4762	0.11905
underutilised option	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7927	0.11890499999999998
significant severe	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7927	0.11890499999999998
residual confounding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7927	0.11890499999999998
organised network	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7927	0.11890499999999998
investigator global	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7927	0.11890499999999998
ino brasil m dico	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7927	0.11890499999999998
hawaiian homeless	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7927	0.11890499999999998
hardening correction	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7927	0.11890499999999998
focus groups of native	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7927	0.11890499999999998
floodplains of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7927	0.11890499999999998
examination of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7927	0.11890499999999998
culturally sensitive	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7927	0.11890499999999998
anemia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3962	0.11886
clinical presentation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.198	0.1188
ligament	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3956	0.11868
certification	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1695	0.11865
certificate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1695	0.11865
attenuation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1695	0.11865
ca	BEYOND_CUTOFF	SIMPLE	Good	1	0.1186	0.1186
t-test	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.1183	0.1183
transparency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3941	0.11823
targeting hispanics	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7875	0.118125
mandibular right	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7875	0.118125
management ensured	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7875	0.118125
impacting diabetes	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7875	0.118125
exploiting sparsity	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7875	0.118125
concerning influence	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7875	0.118125
autosomal recessive	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7875	0.118125
-dependent regulation	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7875	0.118125
http	BEYOND_CUTOFF	SIMPLE	Good	1	0.1175	0.1175
targeting populations	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7823	0.11734499999999999
secondary organic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7823	0.11734499999999999
paginated index	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7823	0.11734499999999999
paediatric surgical	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7823	0.11734499999999999
ontology for the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7823	0.11734499999999999
o brasil m dico	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7823	0.11734499999999999
norwegian women	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7823	0.11734499999999999
nocturnal frontal	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7823	0.11734499999999999
journal of dental	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7823	0.11734499999999999
hawaii homeless	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7823	0.11734499999999999
evolution of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7823	0.11734499999999999
m ller	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7816	0.11723999999999998
australia	BEYOND_CUTOFF	SIMPLE	Good	1	0.1172	0.1172
recent advances	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.195	0.11699999999999999
advent	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1671	0.11696999999999999
temporal right	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
symptoms of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
rvwf only rvwf	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
regarding issues	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7779	0.116685
pediatric septic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
pediatric critical	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
of respiratory	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
of isorropia i	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
federal supreme	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
excess absolute	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
embryonic neural	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
efficacy of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
decreased vco2	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7779	0.116685
abstract available	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7779	0.116685
milk	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3889	0.11667
item	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3889	0.11667
screening tool	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.4665	0.116625
european healthy cities network	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7772	0.11657999999999999
chronic migraine	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1943	0.11657999999999999
minority	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3884	0.11652
handle	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3884	0.11652
steroid	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3873	0.11618999999999999
society	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3873	0.11618999999999999
newborn	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3873	0.11618999999999999
consistency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3873	0.11618999999999999
battery	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3873	0.11618999999999999
adenoma	BEYOND_CUTOFF	SIMPLE	Good	1	0.1161	0.1161
spgi low	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7728	0.11592
kg	BEYOND_CUTOFF	SIMPLE	Good	1	0.1158	0.1158
genetic characterization of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7706	0.11558999999999998
bias	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1648	0.11535999999999999
taxane for the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7684	0.11525999999999999
segment of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7684	0.11525999999999999
resting muscle	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7684	0.11525999999999999
profile of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7684	0.11525999999999999
luxated tooth	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7684	0.11525999999999999
isotype of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7684	0.11525999999999999
indirect visual	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7684	0.11525999999999999
bullae ruptured	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7684	0.11525999999999999
amassing clinical	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7684	0.11525999999999999
pulmonary	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.5761	0.11521999999999999
cam	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3837	0.11510999999999999
revision	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1644	0.11507999999999999
catheter	BEYOND_CUTOFF	SIMPLE	Good	1	0.1149	0.1149
mass index	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1914	0.11483999999999998
marketing	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3827	0.11481
exclusivity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3827	0.11481
cervix	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3827	0.11481
capsule	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3827	0.11481
priorities	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3817	0.11450999999999999
neurology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3817	0.11450999999999999
diagnostic criteria	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1907	0.11442
vwf	BEYOND_CUTOFF	SIMPLE	Good	1	0.1144	0.1144
establishment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1634	0.11437999999999998
contraception	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3801	0.11402999999999999
cavity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3796	0.11388
career	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3796	0.11388
sa de em debate	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.759	0.11384999999999999
rhythmic tapping	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.759	0.11384999999999999
mbar decreased	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.759	0.11384999999999999
cancer of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.759	0.11384999999999999
advent of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.759	0.11384999999999999
crp	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1138	0.1138
ring	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3791	0.11373
pool	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3791	0.11373
idea	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1624	0.11367999999999999
smid	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3786	0.11357999999999999
fistula	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3776	0.11327999999999999
faculty	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3776	0.11327999999999999
collection	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1617	0.11319
mglur i	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7539	0.11308499999999999
sf	BEYOND_CUTOFF	SIMPLE	Good	1	0.113	0.113
contaminants	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1614	0.11297999999999998
substitution	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1611	0.11276999999999998
pre-stage i	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7503	0.11254499999999999
isorropia i	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7503	0.11254499999999999
hepatitis c	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7503	0.11254499999999999
hawaii cervical	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7503	0.11254499999999999
european quality	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7503	0.11254499999999999
beam hardening	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7503	0.11254499999999999
-atpase activity	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7503	0.11254499999999999
tobacco	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.375	0.11249999999999999
cochrane	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.375	0.11249999999999999
anomaly	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.375	0.11249999999999999
sense	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1607	0.11248999999999999
clinical implication	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1874	0.11244
video	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3745	0.11234999999999999
stone	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3745	0.11234999999999999
human	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3745	0.11234999999999999
equipment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1604	0.11227999999999998
birth	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1604	0.11227999999999998
quality-adjusted life-year	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.187	0.1122
healthcare	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.374	0.1122
urban planning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7446	0.11169
of nocturnal	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7446	0.11169
mild bleeding	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7446	0.11169
fourth national	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7446	0.11169
doublet cx	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7446	0.11169
9th annual	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7446	0.11169
sd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.1116	0.1116
economic evaluation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1853	0.11117999999999999
methyl	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3704	0.11112
entity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3704	0.11112
counseling	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1587	0.11109
counsel	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1587	0.11109
anatomic	BEYOND_CUTOFF	SIMPLE	Good	1	0.111	0.111
landscape	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3699	0.11097
m dico	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7389	0.110835
hypertensive	BEYOND_CUTOFF	SIMPLE	Good	1	0.1107	0.1107
therapeutic option	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1845	0.11069999999999999
negative impact	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1845	0.11069999999999999
matrix	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3684	0.11052
biopsy	BEYOND_CUTOFF	SIMPLE	Good	1	0.1105	0.1105
surgical intervention	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1838	0.11027999999999999
radiograph	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3674	0.11022
preservation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1574	0.11018
tmj clicking	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.7339	0.110085
of integral	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7339	0.110085
of adverse	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7339	0.110085
m lanosome	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7339	0.110085
emg of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7339	0.110085
ederer ii	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7339	0.110085
cv diseases	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7339	0.110085
-criteria	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7339	0.110085
auditory	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.5475	0.1095
snp	BEYOND_CUTOFF	SIMPLE	Good	1	0.1094	0.1094
correction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1561	0.10926999999999999
offer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1558	0.10905999999999999
thyroid	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3634	0.10901999999999999
shortage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3634	0.10901999999999999
radiation therapy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1817	0.10901999999999999
library	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3634	0.10901999999999999
insufficiency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3614	0.10842
dermatologic	BEYOND_CUTOFF	SIMPLE	Good	1	0.108	0.108
couple	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3599	0.10797
costa	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3599	0.10797
recommendations for the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7197	0.107955
oxidation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1541	0.10786999999999998
prognostic	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3594	0.10782
vegetation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1538	0.10765999999999999
advice	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1538	0.10765999999999999
zone	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1532	0.10724
clinical experience	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1785	0.10709999999999999
assistant	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1528	0.10695999999999999
modular	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.5347	0.10694
management strategy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1778	0.10668000000000001
restorative	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3544	0.10632
phenomenon	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3539	0.10617
clinical examination	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1768	0.10608000000000001
sleep	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1515	0.10604999999999999
statistical manual of mental	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7064	0.10596
collaborative nature of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7064	0.10596
fitting	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.353	0.1059
fat	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.353	0.1059
grade c	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7057	0.10585499999999999
da sa de	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7057	0.10585499999999999
avoli m	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7057	0.10585499999999999
-sensitive	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7057	0.10585499999999999
-granules	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7057	0.10585499999999999
osteoblast	BEYOND_CUTOFF	SIMPLE	Good	1	0.1058	0.1058
childhood	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3525	0.10575
predictive	BEYOND_CUTOFF	SIMPLE	Good	1	0.1056	0.1056
university	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.352	0.10559999999999999
upregulated expression of	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.7036	0.10554
genotyping	BEYOND_CUTOFF	SIMPLE	Good	1	0.105	0.105
genotypic	BEYOND_CUTOFF	SIMPLE	Good	1	0.105	0.105
genotype	BEYOND_CUTOFF	SIMPLE	Good	1	0.105	0.105
mt	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.349	0.10469999999999999
em	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.349	0.10469999999999999
smoking	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3485	0.10454999999999999
carcinoma	BEYOND_CUTOFF	SIMPLE	Good	1	0.1045	0.1045
artery disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1736	0.10416
expectancy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1486	0.10402
individualization	BEYOND_CUTOFF	SIMPLE	Good	1	0.1039	0.1039
polarization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1483	0.10380999999999999
prognostic value of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6918	0.10376999999999999
characterization of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6918	0.10376999999999999
sa de	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6904	0.10356
doctor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3451	0.10353
nccn guidelines	BEYOND_CUTOFF	Normal_NP	Good	1	0.1034	0.1034
incorporation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1477	0.10339
percentage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3441	0.10323
hypothesis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3441	0.10323
ii low	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6877	0.103155
multiplicative	BEYOND_CUTOFF	SIMPLE	Good	1	0.1031	0.1031
probability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3436	0.10308
event-related potentials	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.687	0.10305
cost-effective alternative	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.687	0.10305
version	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3432	0.10296
gain	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.147	0.10289999999999999
dental care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1712	0.10271999999999999
pediatric	BEYOND_CUTOFF	SIMPLE	Good	1	0.1026	0.1026
jerks	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3417	0.10251
approval	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1464	0.10248
mood	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3412	0.10235999999999999
translations	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1461	0.10227
translation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1461	0.10227
european healthy cities	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6815	0.102225
upregulated expression	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6801	0.10201500000000001
national comprehensive	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6801	0.10201500000000001
dysregulation of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6801	0.10201500000000001
consideration of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6801	0.10201500000000001
teaching	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3398	0.10193999999999999
plaque	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3398	0.10193999999999999
engineering	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3398	0.10193999999999999
basin	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3398	0.10193999999999999
pregnancy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3388	0.10164
potential diagnostic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6767	0.101505
implications of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6767	0.101505
consequences of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6767	0.101505
oncologist	BEYOND_CUTOFF	SIMPLE	Good	1	0.1015	0.1015
specialist	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1448	0.10136
fungi	BEYOND_CUTOFF	SIMPLE	Good	1	0.1013	0.1013
ta	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3373	0.10118999999999999
pa	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3373	0.10118999999999999
termination	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1445	0.10114999999999999
resident	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1442	0.10093999999999999
residence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1442	0.10093999999999999
river	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3354	0.10061999999999999
therapeutic approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1675	0.1005
haemorrhage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3344	0.10031999999999999
noise	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1432	0.10024
strategic planning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.4009	0.100225
norm	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3335	0.10005
flux	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3335	0.10005
recognition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1429	0.10003
chronicity	BEYOND_CUTOFF	SIMPLE	Good	1	0.1	0.1
rupture	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.333	0.0999
modulation of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6651	0.099765
family history	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1661	0.09966
opinion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1423	0.09961
km	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3311	0.09933
european healthy	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6617	0.099255
-synucleinopathies	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6617	0.099255
conductivity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3306	0.09918
underlying cause	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.661	0.09915
pulp	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3301	0.09902999999999999
methodology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3292	0.09876
ethnicity	BEYOND_CUTOFF	SIMPLE	Good	1	0.0986	0.0986
vector	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3282	0.09845999999999999
expanse	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3282	0.09845999999999999
release	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1398	0.09786
risk assessment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1631	0.09785999999999999
infectious	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.4889	0.09778
anatomy of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6503	0.09754499999999999
plane	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3249	0.09747
mobility	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3249	0.09747
chain	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3249	0.09747
protection	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1392	0.09743999999999998
therapeutic target	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1621	0.09726
respirator	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3235	0.09705
session	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1386	0.09702
quantification	BEYOND_CUTOFF	SIMPLE	Good	1	0.0968	0.0968
origin	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.138	0.0966
officer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3216	0.09648
office	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3216	0.09648
aggressive	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.4814	0.09628
2nd	BEYOND_CUTOFF	SIMPLE	Good	1	0.0961	0.0961
nitric	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.4791	0.09582000000000002
rr	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0958	0.0958
adequacy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3192	0.09576
physical activity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1594	0.09563999999999999
acquisition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1364	0.09548
treatment outcome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1591	0.09545999999999999
female	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3178	0.09534000000000001
european union	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6356	0.09534000000000001
colon	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3178	0.09534000000000001
ae	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0953	0.0953
episode	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1361	0.09527
health-related quality of life	BEYOND CUTOFF and FILTERED OUT	too_many_chunks	Bad	0.15	0.6336	0.09504
treatment strategy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1581	0.09485999999999999
dosage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1355	0.09485
randomized prospective study	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6323	0.094845
hygiene guidelines	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.9467	0.09467
embryo	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.315	0.0945
bone resorption	BEYOND_CUTOFF	Normal_NP	Good	1	0.0945	0.0945
crisis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3146	0.09437999999999999
perception	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1346	0.09422
mouse	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3132	0.09395999999999999
health-related quality of	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6257	0.09385500000000001
surveillance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.134	0.0938
medical visits	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.9362	0.09362000000000001
separation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1337	0.09359
reliability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3113	0.09339
fluoride	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3113	0.09339
wastes	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1331	0.09316999999999999
waste	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1331	0.09316999999999999
district	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3099	0.09297
execution	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1328	0.09296
rank	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1325	0.09275
immunocompromised patient	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.6179	0.092685
feed	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3085	0.09255
qaly for liraglutide	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.9234	0.09234
nutrition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1318	0.09226
kidney	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3072	0.09215999999999999
rehabilitation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1315	0.09204999999999999
polymer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3062	0.09186000000000001
facility	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3062	0.09186000000000001
conceptions of nature influence media coverage	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.9178	0.09178
mm	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3058	0.09174
mmhg	BEYOND_CUTOFF	SIMPLE	Good	1	0.0917	0.0917
integration of gene expression analysis tools	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.9162	0.09162000000000001
nhs	BEYOND_CUTOFF	SIMPLE	Good	1	0.0915	0.0915
fish	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3049	0.09147
country	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3044	0.09132
science	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3035	0.09104999999999999
head	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.13	0.091
ontology for the gene expression domain	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.9075	0.09075
north africa	BEYOND_CUTOFF	Normal_NP	Good	1	0.0907	0.0907
symptoms of the schizophrenic spectrum	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.9067	0.09067
localities	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.3017	0.09051000000000001
epidemiological	BEYOND_CUTOFF	SIMPLE	Good	1	0.0905	0.0905
epidemiologic	BEYOND_CUTOFF	SIMPLE	Good	1	0.0905	0.0905
reflection	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1288	0.09015999999999999
introduction of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.601	0.09015
government	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1283	0.08980999999999999
governance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1283	0.08980999999999999
excess	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1283	0.08980999999999999
coronary artery	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1496	0.08976
profile of golimumab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8973	0.08973
ultrasound	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2989	0.08967
competition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.128	0.0896
prenosologic evaluation of health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8957	0.08957000000000001
cost-effectiveness of eltrombopag	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8957	0.08957000000000001
infant	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2985	0.08954999999999999
index d	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.5965	0.089475
statistics	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1277	0.08939
health-related quality	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.5959	0.08938499999999999
hygiene research	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8933	0.08933
treatment alternative	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.5939	0.089085
randomized study	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.5939	0.089085
maximum	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1268	0.08875999999999999
channel	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2958	0.08874
meta-analysis	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.0887	0.0887
count	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1265	0.08854999999999999
calcification	BEYOND_CUTOFF	SIMPLE	Good	1	0.0885	0.0885
adverse	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.4424	0.08848
consent for aortic pathology	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8824	0.08824
toxicant	BEYOND_CUTOFF	SIMPLE	Good	1	0.0882	0.0882
republic	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2939	0.08817
consensus	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1259	0.08813
randomised trial	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.5869	0.08803499999999999
evoked potentials	BEYOND CUTOFF and FILTERED OUT	verb+NP	Medium	0.15	0.5869	0.08803499999999999
replicates	BEYOND_CUTOFF	SIMPLE	Good	1	0.088	0.088
business	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1256	0.08791999999999998
proteomic researches of legume-rhizobium symbiosis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8754	0.08754
ovarian cancer tissue indices of oxidative stress	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8754	0.08754
optimizing use of tumor necrosis factor inhibitors	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8754	0.08754
novel compound heterozygous mutation of hibch gene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8754	0.08754
simulator	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.125	0.0875
simulation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.125	0.0875
southern	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.873	0.0873
hyperplasia	BEYOND_CUTOFF	SIMPLE	Good	1	0.0873	0.0873
percutaneous closure of paravalvular aortic leaks	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8722	0.08722
atherosclerosis of the coronary arteries--effect	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8722	0.08722
transcatheter aortic valve replacement for aortic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8715	0.08715
strain-gauge contraction properties of the frog	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8715	0.08715
biochimical feature of symptomatic hypocalcemia	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8715	0.08715
health promotion	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1451	0.08706
political will	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.5799	0.08698499999999999
social determinant of health--air quality--and	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8691	0.08691
pericranial infiltrations of onabotulinumtoxin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8691	0.08691
pathophysiology of non-cancerous breast diseases	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8691	0.08691
implantation of a subtalar joint endoprosthesis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8691	0.08691
asymptomatic deficiency of serum free-carnitine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8691	0.08691
discrimination	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1241	0.08687
markers of neurodegeneration	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8684	0.08684
pci	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0868	0.0868
syndrome of inappropriate antidiuretic hormone	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8668	0.08668000000000001
stereotactic radiotherapy for liver metastasis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8668	0.08668000000000001
novel compound heterozygous mutation of hibch	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8668	0.08668000000000001
expression of glial fibrillary acidic protein	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8668	0.08668000000000001
biologics technology of the palladin institute	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8668	0.08668000000000001
carpal bone	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8661	0.08661
muscular	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.4325	0.08650000000000001
facial contour	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8645	0.08645000000000001
bands	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2881	0.08643
band	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2881	0.08643
visits for pediatric asthma pediatric asthma	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8637	0.08637
thermodynamic equilibrium model of isorropia	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8637	0.08637
pathogenesis of sporadic parathyroid adenomas	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8637	0.08637
neurodegenerative disease for idiopathic rbd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8637	0.08637
enzymatic activity of methylenetetrahydrofolate	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8637	0.08637
dynamic properties of skeletal muscle preparation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8637	0.08637
rt-pcr	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0863	0.0863
coverage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1232	0.08624
hospital stay	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1436	0.08616
surgical resection of the epileptogenic zone	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8614	0.08614000000000001
occurrence of anti-tnf therapy-induced imid	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8614	0.08614000000000001
non-osmotic release of arginine vasopressin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8614	0.08614000000000001
long-acting injections of antipsychotic medication	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8614	0.08614000000000001
full-genome sequence of the wad medani virus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8614	0.08614000000000001
compound heterozygous mutation of hibch gene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8614	0.08614000000000001
chemoprevention of colorectal carcinogenesis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8614	0.08614000000000001
symptoms of gastroesophageal reflux disease	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8606	0.08606000000000001
patient assessment of constipation symptoms	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8606	0.08606000000000001
pathophysiologic characteristics of asthma	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8606	0.08606000000000001
pathogenesis of secondary hyperparathyroidism	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8606	0.08606000000000001
nonosmotic release of arginine vasopressin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8606	0.08606000000000001
electrochemical potential of uterus myocytes	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8606	0.08606000000000001
efficacy of the onabotulinumtoxina molecule	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8606	0.08606000000000001
drugs for osteoporosis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8591	0.08591
preparation for cultural competency training	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8583	0.08583
crown morphology of the maxillary incisors	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8583	0.08583
dermatitis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2859	0.08577
relative cost-effectiveness of denosumab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8568	0.08568
parenteral administration of bisphosphonates	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8568	0.08568
mitral valve therapy for mitral regurgitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8568	0.08568
incidental aggravation of venous malformation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8568	0.08568
holland bloorview for off-site rehabilitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8568	0.08568
cost-effectiveness studies of omalizumab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8568	0.08568
activation of matrix metalloproteinase-9	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8568	0.08568
ad	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1224	0.08567999999999999
vivo	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2854	0.08561999999999999
iron	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2854	0.08561999999999999
researches of legume-rhizobium symbiosis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.856	0.08560000000000001
receptor activator of nuclear factor-kb	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.856	0.08560000000000001
pathophysiology of non-cancerous breast	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.856	0.08560000000000001
longer-term safety profile of golimumab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.856	0.08560000000000001
depolarization of mitochondrial membrane	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.856	0.08560000000000001
antiretroviral drug development for hiv	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.856	0.08560000000000001
commercial dentifrices	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8545	0.08545000000000001
agency for healthcare	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8545	0.08545000000000001
eye	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1218	0.08526
allergy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2841	0.08523
stressful characteristics of demandingness	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8514	0.08514000000000001
paracrine regulator of vascular calcification	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8514	0.08514000000000001
non-pharmacological management of agitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8514	0.08514000000000001
national library of medicine bookshelf	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8514	0.08514000000000001
full-genome sequence of the wad medani	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8514	0.08514000000000001
activity of the sarcoplasmic reticulum	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8514	0.08514000000000001
fiber	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2837	0.08511
the microbiological aerosol distribution	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8507	0.08507
the immunotherapeutic agent rituximab	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8507	0.08507
protein mammalian target of rapamycin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8507	0.08507
potentials for the executive dysfunction	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8507	0.08507
onset of the neurodegenerative disease	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8507	0.08507
noninferiority of incobotulinumtoxina	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8507	0.08507
mammalian target of rapamycin pathway	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8507	0.08507
congress angio access for hemodialysis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8507	0.08507
the wad medani virus	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8499	0.08499000000000001
southern californian native hawaiians	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8476	0.08476
resolution of constitutional symptoms	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8476	0.08476
millilitres for the paediatric population	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8476	0.08476
mediators of pathologic bone metabolism	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8476	0.08476
immunoregulatory role of nitric oxide	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8476	0.08476
dynamic properties of skeletal muscle	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8476	0.08476
biologics technology of the palladin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8476	0.08476
bacterial genomics of medical importance	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8476	0.08476
abundance of angiostatin infibrocystic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8476	0.08476
efficiency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2824	0.08471999999999999
cancer treatment	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1411	0.08466
chronic daily headache	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.5642	0.08463
traditional evidence-based approaches	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8461	0.08461
taxonomic status of the burana virus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
regulation of phosphorus homeostasis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
proliferatious form of fibroadenoma	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
overexpression of the cyclin d1 gene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
morphology of the maxillary incisors	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
medical visits for diabetes mellitus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
ixodidae ticks of pasture biocenosis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
haemostaseologic centers of saxonia	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
epidemiology of infectious endocarditis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
closure of paravalvular aortic leaks	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
antigenic determinants of orbiviruses	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8461	0.08461
stem cell research	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8445	0.08445000000000001
patient safety indicators	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8445	0.08445000000000001
immunity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2815	0.08444999999999998
treatment of haematological malignancies	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
tissue indices of oxidative stress	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
the otorhinosinusal system account	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8438	0.08438000000000001
resection of the epileptogenic zone	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
intracellular formation of mevalonate	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
heterozygous mutation of hibch gene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
half-life time assessment of fviii	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
haemophilic arthropathy of the hip	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
genome sequence of the burana virus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
development for hematologic disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
consistency of the primary symptoms	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
biallelic combination of cebpa mutations	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
assessment of constipation symptoms	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
approach of intracellular bacteria	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
activity of sarcoplasmic reticulum	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
activity of methylenetetrahydrofolate	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8438	0.08438000000000001
adverse events	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1404	0.08424
treatment of hematological malignancies	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
quantification of aortic regurgitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
phenotypic diversity of macrophages	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
organisation for economic co-operation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
medical knowledge of nitrous oxide	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
discontinuation rates for fga-lais	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
deficiency of serum free-carnitine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
cost-effectiveness of trabectedin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
cost-effectiveness of prucalopride	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
co-registration of mr-mammography	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
bluecross blueshield of minnesota	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
aortic valve replacement for aortic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8422	0.08422
fixation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1203	0.08421
loss of vocs	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8407	0.08407
normal muscle tone	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.84	0.084
radiotherapy for liver metastasis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8392	0.08392
madrid health system for the psi	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8392	0.08392
genomic endophenotypes of attention	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8392	0.08392
floodplains of the syr-darya river	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8392	0.08392
evidence for public health decision	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8392	0.08392
cost-effectiveness of omalizumab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8392	0.08392
cost-effectiveness of ofatumumab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8392	0.08392
cost-effectiveness of liraglutide	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8392	0.08392
bloorview for off-site rehabilitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8392	0.08392
culturing	BEYOND_CUTOFF	SIMPLE	Good	1	0.0839	0.0839
visualisation of pulpal anatomy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
the syr-darya valley fever virus	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8377	0.08377000000000001
the haemophilia treatment centres	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8377	0.08377000000000001
taxane for the first-line treatment	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
success for percutaneous closure	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
subtype of non-hodgkin lymphoma	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
spectrum of aortic valve annulus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
philosophy of nicolaus taurellus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
patient identification strategy	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8377	0.08377000000000001
pathophysiology of hyponatremia	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
paradigms for optimizing survival	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
overexpression of the cyclin d1	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
optimizing use of tumor necrosis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
medical bacteriology laboratories	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8377	0.08377000000000001
liver inflammation recent studies	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8377	0.08377000000000001
injections of antipsychotic medication	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
influence of chrysotile asbestos	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
full-genome sequence of the wad	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
cost-effectiveness of denosumab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
cause of end-stage renal disease	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
anti-atherogenic activity of bp	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
advent of video-polysomnography	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8377	0.08377000000000001
segmentation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1195	0.08364999999999999
segment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1195	0.08364999999999999
disturbance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1195	0.08364999999999999
the onabotulinumtoxina molecule	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8346	0.08346
targets for hematologic malignancies	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8346	0.08346
swellings of the parotid glands	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8346	0.08346
pre-tetanus period of contraction	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8346	0.08346
neutral experimental dentifrices	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8346	0.08346
hygiene research dental hygiene	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8346	0.08346
doctrine of creation ex nihilo	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8346	0.08346
culturally competent curricula	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8346	0.08346
contrast module of the catphan	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8346	0.08346
colitis disease activity index	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8346	0.08346
biallelic combination of cebpa	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8346	0.08346
activator of nuclear factor-kb	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8346	0.08346
abrasiveness of acidic fluoride	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8346	0.08346
glucose	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.278	0.0834
hodgkin	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2775	0.08325
vitro evaluation of the abrasiveness	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
trials for hematologic disorders	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
the coronary arteries--effect	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8324	0.08324000000000001
supplementation of l-carnitine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
s-esters of thiosulfonic acids	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
prophylaxis of epileptogenesis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
optimizing treatment of heart	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
neurocognitive models of adhd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
library of medicine bookshelf	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
hotspot mutation of prrt2 gene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
goals of osteoporosis therapy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
evolution of the hup programme	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
distal portion of the nephron	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
centrality of public participation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
aggravation of venous malformation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
activation of skeletal growth	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
absence of subjective symptoms	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8324	0.08324000000000001
joint instability	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8316	0.08316000000000001
san	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2771	0.08313
bin	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2771	0.08313
the neurodegenerative disease	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8308	0.08308
the inter-hospital transport	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8308	0.08308
regulator of vascular calcification	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8308	0.08308
infection of endothelial cells	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8308	0.08308
downregulation of membrane k	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8308	0.08308
angio access for hemodialysis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8308	0.08308
account of epistemic subjectivity	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8308	0.08308
2nd world congress of thoracic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8308	0.08308
randomised controlled trial	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.5537	0.08305499999999999
the burana virus	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8286	0.08286
visits for diabetes mellitus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
therapy for mitral regurgitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
target of rapamycin pathway	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
sequelae of cerebral abnormality	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
safety profile of golimumab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
risk factor for the chronification	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
risk factor for osteoporosis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
percutaneous therapy for mr	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
outcome of a platelet count	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
options for alopecia areata	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
national library of medicine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
indices of oxidative stress	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
hyperactivation of platelets	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
cytoplasm of myometrium cells	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
complet genome of the sdvfv	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
co-existence of osteoporosis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
blood samples for dna study	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
account of linguistic cohesiveness	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
absence of positive symptoms	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8278	0.08278
spine	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2758	0.08274
ticks of pasture biocenosis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
the schizophrenic spectrum	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8263	0.08263000000000001
the sarcoplasmic reticulum	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8263	0.08263000000000001
the gene expression domain	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8263	0.08263000000000001
the focal infection theory	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8263	0.08263000000000001
symptoms of preterm labour	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
suboptimal quality of cancer	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
studies of botulinum toxin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
strain of burv leiv-krg760	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
samoa department of health	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
potential of uterus myocytes	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
pathogenesis of rhinosinusitis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
nasal mucosa of eosinophils	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
management of diuretic doses	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
incubation of mitochondria	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
genomics of medical importance	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
disease for idiopathic rbd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
daughter cells of neoplastic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
cohort of uk resident patients	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
advent of the focal infection	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8263	0.08263000000000001
public opinion	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8248	0.08248
joint committee	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8248	0.08248
epileptic patients	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8248	0.08248
paper	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1178	0.08245999999999999
the polyprotein-precursor	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8218	0.08218
symptoms of irlen syndrome	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
status of the burana virus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
status of native hawaiians	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
severest variants of phpt	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
science communication activity	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8218	0.08218
risks of clinical vertebral	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
patient navigator program	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8218	0.08218
normal male control population	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8218	0.08218
medical school curriculum	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8218	0.08218
knowledge of nitrous oxide	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
impact of aortic regurgitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
hotspot mutation of prrt2	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
focus of functional genomics	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
byproducts of pth metabolism	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
activation of pka account	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
activation of angiogenesis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8218	0.08218
joint motion	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.821	0.0821
laser	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2736	0.08208
digital	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.4104	0.08208
curve	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2732	0.08195999999999999
world congress of thoracic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
the maternal endothelium	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8195	0.08195000000000001
synthetic agonist of pth	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
study of social artifacts	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
study of regional asthma	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
risk of microalbuminuria	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
quality of life-5 dimensions	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
primary symptoms of adhd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
medical emergency departments	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8195	0.08195000000000001
long-term care-funded initiative	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8195	0.08195000000000001
genotypes of enteroviruses	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
candidates for lai treatment	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
age of dyskinesias onset	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
activation of osteoblast	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8195	0.08195000000000001
academic setting surgeons	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8195	0.08195000000000001
protocol	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1169	0.08183
facial injections	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.818	0.0818
defect closure	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.818	0.0818
tolerability of ar-gg27	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
spectrum of aortic valve	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
social pediatrics model	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8173	0.08173000000000001
sensitivity of ct scanners	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
public policy interventions	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8173	0.08173000000000001
optimizing use of tumor	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
hypercalcemia of malignancy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
genotypes of enterovirus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
external facial contour	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8173	0.08173000000000001
downregulation of kir k	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
cytoplasm of myometrium	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
causative agent of hfmd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
blueshield of minnesota	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
bacteriology laboratories	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8173	0.08173000000000001
anabolic actions of pth	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
aggregation of platelets	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8173	0.08173000000000001
frequency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2723	0.08169
achievement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1166	0.08162
the executive dysfunction	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8158	0.08158
success of lai therapy	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8158	0.08158
social aspects of cancer	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8158	0.08158
s-esters of thiosulfonic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8158	0.08158
measles vaccine vaccination	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8158	0.08158
guidelines for oncology	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8158	0.08158
diversity of macrophages	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8158	0.08158
arthropathy of the hip	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8158	0.08158
activation of leukocytes	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8158	0.08158
relative motion	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8143	0.08143
normal muscle	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8143	0.08143
mouth disease	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8143	0.08143
low contrast	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8143	0.08143
hygiene education	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8143	0.08143
phantom	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.271	0.0813
molecular genetic	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.5414	0.08120999999999999
threshold of n-reflex	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
the palladin institute	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.812	0.08120000000000001
the objective benefits	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.812	0.08120000000000001
the maxillary incisors	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.812	0.08120000000000001
the haemophilia population	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.812	0.08120000000000001
the epileptogenic zone	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.812	0.08120000000000001
subset of fihp families	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
studies of omalizumab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
samples for dna study	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
safety climate survey	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.812	0.08120000000000001
resources for program	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
public sector networks	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.812	0.08120000000000001
public health preservation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.812	0.08120000000000001
philosophy of nicolaus	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
mutation of prrt2 gene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
mutation of hibch gene	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
module of the catphan	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
introductory pharmacy	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.812	0.08120000000000001
inactivation of tumor	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
downregulation of kir	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
comorbidities of imid	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.812	0.08120000000000001
abundance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2701	0.08103
enzyme	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2697	0.08091
transference	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1155	0.08085
transfer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1155	0.08085
the medical committee	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8083	0.08083000000000001
the acidic dentifrices	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8083	0.08083000000000001
spectrum of pathology	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
social pediatrics initiative	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8083	0.08083000000000001
replication of study	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
replacement for aortic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
public health report	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8083	0.08083000000000001
pharmacist preceptors	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8083	0.08083000000000001
pathogenesis of imid	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
mucosa of eosinophils	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
management of anemia	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
links of pathogenesis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
fourth national meeting	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8083	0.08083000000000001
evolution of the hup	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
essential fatty acids	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8083	0.08083000000000001
dosage of l-carnitine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
defect heart surgery	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8083	0.08083000000000001
criteria for project	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
conceptions of nature	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
classic form of phpt	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
cancer of the cervix	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
c-13 studies of cancer	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
affinity for calcium	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
activation of matrix	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8083	0.08083000000000001
mr	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0808	0.0808
loads	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2693	0.08078999999999999
loadings	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2693	0.08078999999999999
load	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2693	0.08078999999999999
list	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1152	0.08063999999999999
pool defect	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8053	0.08053
motor delay	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8053	0.08053
cost-effectiveness	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.0803	0.0803
the primary symptoms	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8016	0.08016000000000001
the medial diastema	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8016	0.08016000000000001
the clinical experiences	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8016	0.08016000000000001
strategies for aortic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8016	0.08016000000000001
role of nitric oxide	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8016	0.08016000000000001
quarterly pac visits	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8016	0.08016000000000001
qaly of trabectedin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8016	0.08016000000000001
prognostic criteria	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8016	0.08016000000000001
plastic reconstruction	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8016	0.08016000000000001
pathogenesis of ibd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8016	0.08016000000000001
mtc analysis of rct	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8016	0.08016000000000001
individual bracelet	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8016	0.08016000000000001
genome of the sdvfv	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8016	0.08016000000000001
facial skin rejuvenation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8016	0.08016000000000001
external professionals	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8016	0.08016000000000001
epileptic phenomena	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8016	0.08016000000000001
development for hiv	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8016	0.08016000000000001
criteria of symptoms	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8016	0.08016000000000001
competent curricula	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8016	0.08016000000000001
certain durable medical	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8016	0.08016000000000001
bedside medical care	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8016	0.08016000000000001
account of objectification	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8016	0.08016000000000001
wildlife sanctuary	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8001	0.08001000000000001
validation of her2	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
therapy for breast	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
the physical dynamics	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.8001	0.08001000000000001
surgery for ischemic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
study of pentraxin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
reactivation of uveitis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
public policy documents	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8001	0.08001000000000001
professional women	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8001	0.08001000000000001
male control population	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8001	0.08001000000000001
healthy urban planning	BEYOND CUTOFF and FILTERED OUT	verb+NP	Bad	0.1	0.8001	0.08001000000000001
dynamic joint instabilities	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8001	0.08001000000000001
credibility for quality	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
congress of thoracic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
commercial consultancy	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8001	0.08001000000000001
cohort of uk resident	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
city health profiles	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8001	0.08001000000000001
basis for care-agreements	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
balance of calcium	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
assessment of cancer	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.8001	0.08001000000000001
academic scientists	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.8001	0.08001000000000001
duration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2667	0.08001
intake	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2663	0.07988999999999999
depression	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1141	0.07987
melanoma	BEYOND_CUTOFF	SIMPLE	Good	1	0.0798	0.0798
sensitivity training	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7971	0.07971
peptide	BEYOND_CUTOFF	SIMPLE	Good	1	0.0796	0.0796
safety indicators	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7941	0.07941000000000001
human skin	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7941	0.07941000000000001
upper ankle joint	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7927	0.07927000000000001
the syr-darya river	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7927	0.07927000000000001
the research team	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7927	0.07927000000000001
the parotid glands	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7927	0.07927000000000001
the cyclin d1 gene	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7927	0.07927000000000001
symptoms of irlen	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7927	0.07927000000000001
isotype of the ab	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7927	0.07927000000000001
islands of hawaii	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7927	0.07927000000000001
hygiene discipline	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7927	0.07927000000000001
dynamic joint motion	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7927	0.07927000000000001
double refractory	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7927	0.07927000000000001
cells of neoplastic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7927	0.07927000000000001
catabolism of pth	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7927	0.07927000000000001
byproducts of pth	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7927	0.07927000000000001
asbestos industry	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7927	0.07927000000000001
amplitude of p300	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7927	0.07927000000000001
aerosol distribution	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7927	0.07927000000000001
activation of pka	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7927	0.07927000000000001
absence of hg cin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7927	0.07927000000000001
chemotherapy regimen	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7912	0.07912000000000001
story	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2637	0.07911
resin	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2637	0.07911
x-ray	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.0791	0.0791
comparator	BEYOND_CUTOFF	SIMPLE	Good	1	0.0789	0.0789
worker	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1127	0.07888999999999999
nurses	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2628	0.07884
nurse	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2628	0.07884
transparent	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.3941	0.07882
visionary zealot	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7875	0.07875
variants of phpt	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7875	0.07875
the hup programme	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7875	0.07875
symptoms of agitation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7875	0.07875
symptoms of adhd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7875	0.07875
spectrum of aortic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7875	0.07875
public administrations	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7875	0.07875
models of service	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7875	0.07875
medical documentation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7875	0.07875
medical considerations	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7875	0.07875
medical committee	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7875	0.07875
fibrosis newborn	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7875	0.07875
evolution of rbd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7875	0.07875
efficacy of btxa	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7875	0.07875
consent for aortic	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7875	0.07875
cancer for adaptation	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7875	0.07875
anesthesia story	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7875	0.07875
aerosol concentration	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7875	0.07875
character	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2624	0.07872
health worker	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1309	0.07853999999999998
health work	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1309	0.07853999999999998
brain lesions	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7838	0.07838
sample	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2611	0.07833
regression	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1119	0.07833
the trauma patient	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7823	0.07823000000000001
the jupiter trial	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7823	0.07823000000000001
the exogenous cation	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7823	0.07823000000000001
studies of imid	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7823	0.07823000000000001
stem cell regulation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
social artifacts	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
role of fiocruz	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7823	0.07823000000000001
patient identification	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
pathology of mr	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7823	0.07823000000000001
national diabetes	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
motor behaviours	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
medical parameters	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
medical libraries	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
medical complexity	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
issues of tolerability	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7823	0.07823000000000001
initial dialysis	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
hygiene scholars	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
hygiene profession	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
hygiene practice	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
epileptic motor	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
dose constraints	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
contrast-enhanced	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7823	0.07823000000000001
civilian hospital	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
activity experts	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7823	0.07823000000000001
delirium	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2603	0.07808999999999999
contracts	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1113	0.07791
contract	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1113	0.07791
valley fever virus	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7787	0.07787
mice	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2594	0.07782
therapy for mr	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7779	0.07779000000000001
the valvular ring	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7779	0.07779000000000001
the breakpoints	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7779	0.07779000000000001
subset of fihp	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7779	0.07779000000000001
social attitudes	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
sector networks	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
safety attitude	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
residency clinic	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
regular surveys	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
personal happiness	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
motor behaviors	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
models of adhd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7779	0.07779000000000001
medical importance	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
medical executives	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
measles vaccine	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
emg of the hip	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7779	0.07779000000000001
divine concurrence	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
cohort of cancer	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7779	0.07779000000000001
climate survey	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
antibiotic era	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
affinity of bp	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7779	0.07779000000000001
activity of bp	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7779	0.07779000000000001
academic teaching	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7779	0.07779000000000001
release of arginine vasopressin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7772	0.07772000000000001
involvement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1099	0.07693
supreme court	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
stupor episodes	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
spring festival	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
social policies	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
royal society	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
quarterly pac	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
public sector	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
public hospitals	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
plaque rupture	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
plans for hup	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7684	0.07684
physician roles	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
nas of ukraine	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7684	0.07684
medical relevance	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
medical emergency	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
media coverage	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
inner membrane	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
diesel pollution	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
diabetes awareness	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
culture media	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
cell research	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
caries detection	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
breast diseases	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
alcoholic liver	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
aerosol sampler	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7684	0.07684
absence of hg	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7684	0.07684
instrumentation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2561	0.07683
instrument	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2561	0.07683
journals	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2552	0.07655999999999999
journal	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2552	0.07655999999999999
public participation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7655	0.07655
exclusive	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.3827	0.07654
potential benefit	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1274	0.07644000000000001
burden	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1091	0.07637
training modalities	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
the diaspora	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.759	0.07590000000000001
stage embryos	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
social status	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
skin pigmentation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
self-monitoring	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.759	0.07590000000000001
rapid replacement	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
public trust	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
public arena	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
proper brain	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
normal people	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
motor disorders	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
motion simulator	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
introductory	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.759	0.07590000000000001
gland disease	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
dynamic instability	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
divine substance	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
coupling bone	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
cohort of uk	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.759	0.07590000000000001
bone metabolism	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.759	0.07590000000000001
patient assessment	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7561	0.07561000000000001
organisation	BEYOND_CUTOFF	SIMPLE	Good	1	0.0754	0.0754
aid	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1077	0.07539
explanations	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1074	0.07518
the nephron	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7503	0.07503
the entanglement	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7503	0.07503
the chronification	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7503	0.07503
the catphan	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7503	0.07503
the biomarker	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7503	0.07503
social awareness	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
safety climate	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
rapid emergence	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
radio drama	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
radical role	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
pl of adult	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7503	0.07503
passive potencies	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
normal diet	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
milk policy	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
lobe seizures	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
ganglia lesions	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
facial rash	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
cord stimulation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
comic strips	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
certain durable	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
asthma clinic	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
ankle joint	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7503	0.07503
phenotypic	BEYOND_CUTOFF	SIMPLE	Good	1	0.0745	0.0745
phenotype	BEYOND_CUTOFF	SIMPLE	Good	1	0.0745	0.0745
excretion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1064	0.07447999999999999
the retina	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7446	0.07446000000000001
spin-labeling	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7446	0.07446000000000001
skin color	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7446	0.07446000000000001
risk of mp	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7446	0.07446000000000001
regular eye	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7446	0.07446000000000001
normal tone	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7446	0.07446000000000001
land irrigation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7446	0.07446000000000001
dose index	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7446	0.07446000000000001
divine act	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7446	0.07446000000000001
age of pkd	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.7446	0.07446000000000001
narrative	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2477	0.07431
ag	BEYOND_CUTOFF	SIMPLE	Good	1	0.0743	0.0743
prediction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1056	0.07392
garnered	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7389	0.07389
disease severity	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.123	0.07379999999999999
abortion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1053	0.07371
visuality	BEYOND_CUTOFF	SIMPLE	Good	1	0.0736	0.0736
roundtable monograph	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7353	0.07353
the sdvfv	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7339	0.07339
shaft fixation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7339	0.07339
pac visits	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7339	0.07339
high business	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7339	0.07339
early indicators	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7339	0.07339
bone density	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7339	0.07339
peroxide	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2436	0.07308
scientist	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2432	0.07296
import	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1042	0.07293999999999999
implementation of nccn	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.25	0.2913	0.072825
subtyping	BEYOND_CUTOFF	SIMPLE	Good	1	0.0723	0.0723
subtype	BEYOND_CUTOFF	SIMPLE	Good	1	0.0723	0.0723
multiplication	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1031	0.07217
multiple	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1031	0.07217
spectrum disorder	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1201	0.07206
valvular	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7204	0.07204
the hfmd	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7204	0.07204
reconsidered	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7204	0.07204
homeless	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7204	0.07204
bone balance	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7204	0.07204
clinical practice guideline	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1198	0.07188
abuse	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1021	0.07146999999999999
flora	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2379	0.07137
prescription	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1018	0.07125999999999999
bone loss	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7099	0.07099
stenosis	BEYOND_CUTOFF	SIMPLE	Good	1	0.0709	0.0709
the psi	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7057	0.07057000000000001
the icu	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.7057	0.07057000000000001
productive	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7057	0.07057000000000001
high t2	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7057	0.07057000000000001
frontal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7057	0.07057000000000001
embryonic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7057	0.07057000000000001
dignified	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7057	0.07057000000000001
certain	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7057	0.07057000000000001
biochemical	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7057	0.07057000000000001
life-year	BEYOND_CUTOFF	HYPHENATION	Good	1.0	0.0705	0.0705
link	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1007	0.07049
statement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1005	0.07035
cytokine	BEYOND_CUTOFF	SIMPLE	Good	1	0.0703	0.0703
cleavage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2343	0.07029
aberrant	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.7015	0.07015
public health policies	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.7008	0.07008
assumption	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.1	0.06999999999999999
dialysis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0997	0.06978999999999999
cancer cell	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1163	0.06978
calculators	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0994	0.06958
calculation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0994	0.06958
supply	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0992	0.06943999999999999
comorbidity	BEYOND_CUTOFF	SIMPLE	Good	1	0.0694	0.0694
low	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6925	0.06925
authority	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0989	0.06923
author	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0989	0.06923
tavi	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0692	0.0692
blood glucose concentration	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6918	0.06918
facial wrinkle scale	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6911	0.06911
city health development	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6911	0.06911
nailing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6904	0.06904
detectability	BEYOND_CUTOFF	SIMPLE	Good	1	0.0689	0.0689
month	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2295	0.06885
cancer preventive	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.4586	0.06879
the ab	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.6877	0.06877
temporal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6877	0.06877
richer	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6877	0.06877
partitioning	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6877	0.06877
fourth	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6877	0.06877
clenching	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6877	0.06877
annual	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6877	0.06877
nature of the project	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.687	0.06870000000000001
dioxide	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2287	0.06860999999999999
normal saline	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6856	0.06856
adherent	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0979	0.06853
adherence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0979	0.06853
bacteria	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2283	0.06849
piece	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2279	0.06837
proportion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0976	0.06832
profession	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0976	0.06832
bowel disease	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6828	0.06828
antibiotic susceptibility	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6815	0.06815
public health decision	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6801	0.06801
public health implications	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6767	0.06767
treatment approach	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1121	0.06726
smooth muscle cells	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6699	0.06699000000000001
in-patient hospital	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6699	0.06699000000000001
bone mineral density	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6699	0.06699000000000001
city health	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6692	0.06692000000000001
unequal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6685	0.06685
grinding	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6685	0.06685
genital	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6685	0.06685
focal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6685	0.06685
fatal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6685	0.06685
dedicated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6685	0.06685
cumulative	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6685	0.06685
clicking	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6685	0.06685
medical knowledge	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6651	0.06651
white matter	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6644	0.06644
discharge	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0948	0.06635999999999999
explored	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6624	0.06624000000000001
haemophilia patient	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6617	0.06616999999999999
care team	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1102	0.06612
workforce crisis	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.661	0.0661
treatment modality	BEYOND_CUTOFF	Normal_NP	Good	1	0.0661	0.0661
clinical evidence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1096	0.06576
agenda	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0938	0.06566
visual analogue	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.655	0.0655
tract obstruction	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.655	0.0655
reactivity	BEYOND_CUTOFF	SIMPLE	Good	1	0.0655	0.0655
reactive	BEYOND_CUTOFF	SIMPLE	Good	1	0.0655	0.0655
reactivation	BEYOND_CUTOFF	SIMPLE	Good	1	0.0655	0.0655
medical service	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.655	0.0655
media campaign	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.655	0.0655
further analyses	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.655	0.0655
meeting	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0935	0.06545
atrophy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2181	0.06542999999999999
enamel	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2177	0.06530999999999999
legal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6509	0.06509000000000001
the recommendation	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.6503	0.06503
complementary	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6503	0.06503
biology assays	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6503	0.06503
rheumatoid arthritis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1083	0.06498
slowing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6496	0.06496
locking	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6496	0.06496
immunology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2165	0.06495
mediator	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0927	0.06489
mediation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0927	0.06489
islander	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2161	0.06483
island	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2161	0.06483
pac	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2157	0.06471
tnf	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0646	0.0646
leak	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.215	0.0645
choice	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.092	0.0644
native hawaiian	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1072	0.06432
renal disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.1069	0.06413999999999999
skin rejuvenation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6403	0.06403
mineral density	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6403	0.06403
clinic visit	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6403	0.06403
calcium stone	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6403	0.06403
breast tissue	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6403	0.06403
gel	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2134	0.06402
validation	BEYOND_CUTOFF	SIMPLE	Good	1	0.064	0.064
vision	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0912	0.06384
icer	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0638	0.0638
department	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2119	0.06357
patient safety	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6356	0.06356
facial skin	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.635	0.0635
hormonal	BEYOND_CUTOFF	SIMPLE	Good	1	0.0634	0.0634
mixed treatment	BEYOND CUTOFF and FILTERED OUT	verb+NP	Good	0.25	0.2535	0.063375
root	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0902	0.06314
hawaii	BEYOND_CUTOFF	SIMPLE	Good	1	0.063	0.063
home treatment	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6277	0.06277
child mortality	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6277	0.06277
cell regulation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6277	0.06277
bone mineral	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6277	0.06277
pubmed	BEYOND_CUTOFF	SIMPLE	Good	1	0.0626	0.0626
therapeutic alternative	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.4168	0.06251999999999999
pathogenicity	BEYOND_CUTOFF	SIMPLE	Good	1	0.0623	0.0623
pathogenic	BEYOND_CUTOFF	SIMPLE	Good	1	0.0623	0.0623
tapping	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6224	0.06224
pct	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6224	0.06224
fed	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6224	0.06224
long-acting injection	BEYOND_CUTOFF	Normal_NP	Good	1	0.0621	0.0621
prevalence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.207	0.062099999999999995
rapid pace	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6192	0.06192
long-term	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6192	0.06192
topic	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2054	0.061619999999999994
current	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2051	0.06153
concern	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0875	0.06124999999999999
orthopaedic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.612	0.061200000000000004
northern	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.6088	0.060880000000000004
gradient	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2028	0.06084
randomized controlled trial	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.4046	0.06069
severe motor	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.6062	0.06062
economic modelling	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.101	0.0606
economic model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.101	0.0606
radiotherapy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.2013	0.06039
molar	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.201	0.0603
host	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.086	0.06019999999999999
public health issue	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.601	0.0601
medical practitioner	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.601	0.0601
pollution	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0858	0.060059999999999995
treated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5991	0.05991
deficit	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0855	0.05985
conventional	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5965	0.05965000000000001
medical intervention	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5959	0.059590000000000004
chemical compounds	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5959	0.059590000000000004
welfare	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1984	0.059519999999999997
radiology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1976	0.05928
public health interventions	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5927	0.05927
matter	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0846	0.059219999999999995
medical profession	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5907	0.059070000000000004
medical network	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5907	0.059070000000000004
ix	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5895	0.05895
cx	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5895	0.05895
botulinum toxin	BEYOND_CUTOFF	Normal_NP	Good	1	0.0589	0.0589
poisoning	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5882	0.05882
access for hemodialysis	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.5856	0.05856
philosophy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1947	0.058410000000000004
health professional	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0971	0.05826
motor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1939	0.05816999999999999
icu	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0581	0.0581
hour	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1936	0.05807999999999999
medical management	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5799	0.05799
ontology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1932	0.05796
consolidation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0827	0.05788999999999999
delay	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0824	0.057679999999999995
basis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0822	0.057539999999999994
today	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1917	0.05751
child health	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5742	0.057420000000000006
lobe	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.191	0.0573
refining	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5724	0.057240000000000006
mitigated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5724	0.057240000000000006
existing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5724	0.057240000000000006
ensured	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5724	0.057240000000000006
synthesis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0815	0.05705
infectious disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.095	0.056999999999999995
copper	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1888	0.056639999999999996
care provider	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0943	0.05657999999999999
gland	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1885	0.056549999999999996
cervical cancer	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.094	0.0564
enrolled	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5636	0.05636
epilepsy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1878	0.056339999999999994
africae	BEYOND_CUTOFF	SIMPLE	Good	1	0.0563	0.0563
the cervix	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.563	0.056299999999999996
social act	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.563	0.056299999999999996
normal cells	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.563	0.056299999999999996
mantle cell	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.563	0.056299999999999996
immune	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.2815	0.056299999999999996
matching	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5617	0.05617
matched	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5617	0.05617
ovarian cancer	BEYOND_CUTOFF	Normal_NP	Good	1	0.0561	0.0561
la	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.186	0.055799999999999995
withdrawal	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0793	0.05550999999999999
peeling	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5549	0.05549
caries	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1849	0.05547
regression model	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0922	0.05532
formula	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1842	0.05526
comparability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0789	0.055229999999999994
regurgitation	BEYOND_CUTOFF	SIMPLE	Good	1	0.0551	0.0551
guided	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5493	0.05493000000000001
stratified	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5475	0.05475
hazard	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0782	0.05474
deviation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0782	0.05474
primary care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.091	0.054599999999999996
habits	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.182	0.054599999999999996
availability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.182	0.054599999999999996
facial rejuvenation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5432	0.05432000000000001
cf	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0543	0.0543
fibrosis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.181	0.054299999999999994
coordination	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0773	0.05410999999999999
industry	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1803	0.05408999999999999
medical school	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5389	0.05389000000000001
microscopy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1796	0.053880000000000004
cardiovascular	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5353	0.05353
triggering	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5347	0.05347
rhythm	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1782	0.05346
characterization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0763	0.05341
ar	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0534	0.0534
peripheral blood	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.089	0.053399999999999996
rbd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0532	0.0532
demand	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0759	0.05313
nab	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.531	0.05310000000000001
mcl	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.531	0.05310000000000001
all	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.531	0.05310000000000001
medical facilities	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5304	0.053040000000000004
daily headache	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5304	0.053040000000000004
cohort study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0877	0.05262
oxidative stress	BEYOND_CUTOFF	Normal_NP	Good	1	0.0526	0.0526
antigenicity	BEYOND_CUTOFF	SIMPLE	Good	1	0.0524	0.0524
antigen	BEYOND_CUTOFF	SIMPLE	Good	1	0.0524	0.0524
visible	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5238	0.05238000000000001
cell lung cancer	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5232	0.052320000000000005
accumulation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0747	0.052289999999999996
activity questionnaire	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5226	0.05226
pilot study	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.5208	0.05208000000000001
oxygenation	BEYOND_CUTOFF	SIMPLE	Good	1	0.052	0.052
promotion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0738	0.05166
promoter	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0738	0.05166
contouring	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5166	0.05166
tolerability	BEYOND_CUTOFF	SIMPLE	Good	1	0.0516	0.0516
visualization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0736	0.051519999999999996
stroke	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0734	0.05138
replacement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0731	0.05116999999999999
pneumonia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1702	0.051059999999999994
act	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0729	0.05103
id	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1699	0.050969999999999994
royal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5094	0.05094
behavioural	BEYOND_CUTOFF	SIMPLE	Good	1	0.0509	0.0509
sector	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1695	0.05085
household	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1692	0.05075999999999999
isolated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5059	0.05059
inflammatory disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0843	0.05058
rio	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1685	0.050550000000000005
diabetes mellitus	BEYOND_CUTOFF	Normal_NP	Good	1	0.0505	0.0505
cross-sectional study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0841	0.05046
template	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1678	0.05034
susceptibility	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1678	0.05034
mellitus	BEYOND_CUTOFF	SIMPLE	Good	1	0.0503	0.0503
so	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.5	0.05
candidate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0714	0.049980000000000004
exam	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1664	0.04992
lateral	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4982	0.04982
mg	BEYOND_CUTOFF	SIMPLE	Good	1	0.0498	0.0498
tumor cell	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0829	0.04974
patient population	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.4971	0.049710000000000004
leukemia	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1654	0.04962
fragmentation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0707	0.04949
scanning	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4936	0.04936
none	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4936	0.04936
viruses	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1644	0.049319999999999996
building	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1644	0.049319999999999996
the hip	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.4918	0.04918
phenomena	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1634	0.049019999999999994
metric	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4901	0.04901
adjusted	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4901	0.04901
tasked	BEYOND_CUTOFF	SIMPLE	Good	1	0.049	0.049
spatial	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4889	0.04889
self-assemble	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4883	0.048830000000000005
median age	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0812	0.04871999999999999
detection	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0689	0.04823
effusion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1604	0.048119999999999996
cancer patient	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.08	0.048
damage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0685	0.04795
global	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4791	0.04791000000000001
affecting	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4791	0.04791000000000001
architecture	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1597	0.04791
partner	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1584	0.04752
led	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4739	0.04739
adhesive	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0676	0.047319999999999994
adhesion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0676	0.047319999999999994
preservative	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1574	0.047220000000000005
social interaction	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.4716	0.04716000000000001
medical therapy	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.4716	0.04716000000000001
medical practice	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.4716	0.04716000000000001
difficulty	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1571	0.04713
amplitude	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1568	0.04704
inhibition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0672	0.04703999999999999
platform	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1564	0.04692
artery	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.067	0.0469
cell death	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.4682	0.04682
transition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0668	0.046759999999999996
therapeutic strategy	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0779	0.04674
offering	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1558	0.04674
medical record	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.4665	0.046650000000000004
scientific evidence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0777	0.04662
joint	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1554	0.04662
ontario 's province-wide implementation	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.9322	0.046610000000000006
gene expression	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0775	0.0465
exchangeability	BEYOND_CUTOFF	SIMPLE	Good	1	0.0465	0.0465
of nitrous oxide	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.929	0.046450000000000005
reformation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0663	0.04640999999999999
reform	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0663	0.04640999999999999
deleted	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4637	0.04637
basic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4637	0.04637
oxides	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1541	0.04622999999999999
oxide	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1541	0.04622999999999999
vegetable	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1538	0.046139999999999994
board	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1538	0.046139999999999994
vascular	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4608	0.04608
clinical manifestation	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0768	0.046079999999999996
evidence-based	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4603	0.04603
for end-stage renal disease	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9194	0.045970000000000004
john	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1532	0.04596
of oral second-generation antipsychotic drugs	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9162	0.045810000000000003
genomic	BEYOND_CUTOFF	SIMPLE	Good	1	0.0458	0.0458
genome	BEYOND_CUTOFF	SIMPLE	Good	1	0.0458	0.0458
of oral anticoagulants vitamin k antagonists	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9147	0.045735
of the haemophilia population	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9123	0.045615
of emergency care--single	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9123	0.045615
mammalian target of rapamycin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.4558	0.04558
representative	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0651	0.04557
cat	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1519	0.04557
chemical loss of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9107	0.045535
of the microbiological aerosol distribution	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9099	0.04549500000000001
of the immunotherapeutic agent rituximab	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9099	0.04549500000000001
domain	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0649	0.04543
of statins	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9083	0.045415000000000004
of gestational antiblastic chemotherapy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9075	0.045375
of the wad medani virus	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9051	0.045255000000000004
virtual	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4524	0.04524
sustainable	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4524	0.04524
cv	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4519	0.04519000000000001
of the otorhinosinusal system account	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9036	0.04518
of the jetpeel -3-carbocaine protocol	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.9036	0.04518
of oral second-generation antipsychotic	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9036	0.04518
implantation	BEYOND_CUTOFF	SIMPLE	Good	1	0.0451	0.0451
of complementary food	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.9004	0.045020000000000004
for liraglutide	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8988	0.04494000000000001
will	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4491	0.044910000000000005
pacing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4491	0.044910000000000005
gaming	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4491	0.044910000000000005
editing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4491	0.044910000000000005
resorption	BEYOND_CUTOFF	SIMPLE	Good	1	0.0449	0.0449
of tumor necrosis factor inhibitors	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.898	0.0449
of the haemophilia treatment centres	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.898	0.0449
of nccn colorectal cancer guidelines	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.898	0.0449
confocal laser scanning microscopy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.898	0.0449
of ev	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8965	0.044825000000000004
of extracorporeal membrane oxygenation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8957	0.044785000000000005
of peroxisome proliferator activator	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8949	0.04474500000000001
of gene expression analysis tools	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8949	0.04474500000000001
ion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.149	0.0447
reconstruction algorithms evaluation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8918	0.044590000000000005
of environmental computer simulation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8918	0.044590000000000005
lv	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4457	0.04457
of static pressure-volume loop	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.891	0.044550000000000006
of native hawaiian stake- holders	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.891	0.044550000000000006
corresponding	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4452	0.044520000000000004
of the burana virus	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8902	0.04451
complementary feeding practices	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8878	0.044390000000000006
hormone	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0634	0.044379999999999996
of golimumab	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8871	0.044355000000000006
of cantabria	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8871	0.044355000000000006
cause	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0632	0.04424
of the polyprotein-precursor	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8847	0.044235000000000003
of rem sleep behavior disorder	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8847	0.044235000000000003
genus	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1474	0.04422
of temporomandibular disorders	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8824	0.04412
of symptomatic hypocalcemia	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8824	0.04412
of health--air quality--and	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8824	0.04412
follow-up reducing readmissions	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8824	0.04412
overall survival	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.4402	0.044020000000000004
prenosologic evaluation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.88	0.044000000000000004
informa  o e biotecnologia	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.88	0.044000000000000004
for multistudy data exploration	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.88	0.044000000000000004
for dental hygiene practice	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.88	0.044000000000000004
consultation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0628	0.04395999999999999
concept	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0628	0.04395999999999999
of skeletal muscle preparation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8785	0.043925
of second-look ultrasound	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8785	0.043925
laser scanning microscopy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8785	0.043925
comprised of thought leaders	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8785	0.043925
physics	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1464	0.04392
the project	BEYOND_CUTOFF	Normal_NP	Medium	0.1	0.4375	0.043750000000000004
mouse model	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.4375	0.043750000000000004
of bullous rash	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8746	0.043730000000000005
outcomes included perioral	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8738	0.04369000000000001
of the palladin institute	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8738	0.04369000000000001
of bilophila wadsworthia	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8738	0.04369000000000001
cognitive evoked potentials	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8738	0.04369000000000001
of ddavp	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.873	0.04365
thiazide- sensitive sodium-chloride cotransporter	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8715	0.043575
hyperactivity disorder cognitive evoked potentials	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8715	0.043575
target of rapamycin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.4353	0.043530000000000006
talk story discussion groups expressed concern	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8691	0.043455
myogenic potential--and modulators thereof--are	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8691	0.043455
living frisbee : living friendly summary of the	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8691	0.043455
diabetes intervention program targeting hispanics	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8691	0.043455
semantic integration of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8684	0.04342
prescribing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4342	0.04342
of occupational medicine	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8684	0.04342
of high-sensitivity crp	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8684	0.04342
of essential fatty acids	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8684	0.04342
of cancer health disparities	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8684	0.04342
for healthcare research	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8684	0.04342
terminal	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1445	0.04334999999999999
cognition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1445	0.04334999999999999
intrinsic myocardial growth signaling pathways	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8668	0.043340000000000004
: living friendly summary of the body of evidence	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8668	0.043340000000000004
rct	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0433	0.0433
residency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1442	0.04326
media	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1442	0.04326
randomised	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4325	0.043250000000000004
three-dimensional coaxial positioning catheter	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8637	0.043185
recessive inherited hermansky-pudlak syndrome	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8637	0.043185
rcts comparing epirubicin-containing triplets	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8637	0.043185
presentation of lacrimo-auriculodento- digital	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8637	0.043185
mr angiography demonstrated vessel irregularity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8637	0.043185
holland bloorview kids rehabilitation hospital	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8637	0.043185
hepatobiliary cancers address hepatocellular	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8637	0.043185
californian native hawaiians native hawaiians	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8637	0.043185
chloride	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1439	0.04317
of the medial diastema	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.863	0.04315
soc	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4314	0.043140000000000005
right	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4309	0.04309
multidisciplinary approach involving restorative	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8614	0.043070000000000004
living frisbee : living friendly summary of	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8614	0.043070000000000004
focus groups of native hawaiian stake- holders	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8614	0.043070000000000004
automatic gestures mimicking daily-life activities	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8614	0.043070000000000004
transcatheter aortic valve replacement for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8606	0.043030000000000006
neurodevelopmental disorders including autism	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8606	0.043030000000000006
investigator 's global assessment of lateral	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8606	0.043030000000000006
anti-tumor necrosis factor therapies tumor	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8606	0.043030000000000006
work conditions class	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8591	0.042955
patient assessment of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8591	0.042955
of executive dysfunction	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8591	0.042955
for continuous improvement	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8591	0.042955
story discussion groups expressed concern	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8583	0.042915
pediatric crohn 's disease activity index	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8583	0.042915
long-acting injections long-acting injections	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8583	0.042915
heart failure follow-up reducing readmissions	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8583	0.042915
durable medical equipment , prosthetics ,	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8583	0.042915
angiography demonstrated vessel irregularity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8583	0.042915
theiler 's murine encephalomyelitis virus	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8568	0.04284
studies antipsychotic long-acting injections	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8568	0.04284
serum pepsinogen levels serologic screening	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8568	0.04284
oral anticoagulants vitamin k antagonists	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8568	0.04284
low-income countries confronting shortage	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8568	0.04284
cerebrovascular events complicating tavi	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8568	0.04284
of her2-negative metastatic breast cancer	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.856	0.042800000000000005
of a low-cost science communication activity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.856	0.042800000000000005
novel compound heterozygous mutation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.856	0.042800000000000005
for hematologic disorders antibody-drug	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.856	0.042800000000000005
apoptosis	BEYOND_CUTOFF	SIMPLE	Good	1	0.0428	0.0428
phosphate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1426	0.04278
potential markers of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8545	0.042725000000000006
of the research team	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8545	0.042725000000000006
for elective surgery	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8545	0.042725000000000006
clinical outcome	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0711	0.04266
persistent	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4265	0.04265
persisted	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4265	0.04265
transcatheter mitral valve therapy for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8514	0.042570000000000004
strain-gauge contraction properties of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8514	0.042570000000000004
placental functions including endocrine	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8514	0.042570000000000004
long-acting injections clinical experience	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8514	0.042570000000000004
defective architectural structuring of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8514	0.042570000000000004
conselho de informa  o e biotecnologia	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8514	0.042570000000000004
clinical guideline recommendations for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8514	0.042570000000000004
advocacy efforts regional asthma management	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8514	0.042570000000000004
potential--and modulators thereof--are	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8507	0.042535
of legume-rhizobium symbiosis proteomics	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8507	0.042535
of functional musculoskeletal parameters	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8507	0.042535
lateral canthal lines botulinum toxin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8507	0.042535
intervention program targeting hispanics	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8507	0.042535
hcx or trastuzumab , cisplatin , 5-fu	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8507	0.042535
for pediatric asthma pediatric asthma	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8507	0.042535
pathophysiology	BEYOND_CUTOFF	SIMPLE	Good	1	0.0425	0.0425
pathophysiological	BEYOND_CUTOFF	SIMPLE	Good	1	0.0425	0.0425
pathophysiologic	BEYOND_CUTOFF	SIMPLE	Good	1	0.0425	0.0425
prostate cancer for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8499	0.042495000000000005
of parvimonas micra	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8499	0.042495000000000005
of oxidative stress	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8499	0.042495000000000005
of anti-tnf therapies	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8499	0.042495000000000005
for chronic migraine	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8499	0.042495000000000005
estimate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0607	0.04248999999999999
tomography	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1414	0.04242
potential pharmacological effects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8476	0.04238
of inappropriate antidiuretic hormone	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8476	0.04238
of advanced pharmacy practice experience	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8476	0.04238
millennium development goal of reducing	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8476	0.04238
investigator 's global assessment of	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8476	0.04238
hormonal contraceptives severe stroke	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8476	0.04238
for cultural competency training modalities	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8476	0.04238
environmental factors including diet	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8476	0.04238
durable medical equipment , prosthetics	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8476	0.04238
cosmetic indications botulinum toxin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8476	0.04238
bloorview kids rehabilitation hospital	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8476	0.04238
prophylactic replacement therapy of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8461	0.042305
pathophysiologic characteristics of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8461	0.042305
myocardial growth signaling pathways	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8461	0.042305
hematologic disorders antibody-drug	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8461	0.042305
haemophilic arthropathy reducing quality	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8461	0.042305
discussion groups expressed concern	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8461	0.042305
detrimental factor affecting arteries	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8461	0.042305
cancers address hepatocellular cancer	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8461	0.042305
antiretroviral drug development for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8461	0.042305
anticoagulants vitamin k antagonists	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8461	0.042305
, intersectoral-interdisciplinary ,	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8461	0.042305
reconstructive	BEYOND_CUTOFF	SIMPLE	Good	1	0.0423	0.0423
of the exogenous cation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8445	0.042225000000000006
for seizure recurrence	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8445	0.042225000000000006
, cisplatin , 5-fu	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8445	0.042225000000000006
thermodynamic equilibrium model of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
taylor 's focal cortical dysplasia	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8438	0.042190000000000005
pepsinogen levels serologic screening	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
participants completed pipaq-short	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
of the syr-darya valley fever virus	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
of occupational therapeutic service	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
of glial fibrillary acidic protein	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
mr angiography demonstrated vessel	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
health care services included lack	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
familial isolated hyperparathyroidism	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
evidence-based practice for improving	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
continuous surveillance system for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
analytical review concerning influence	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8438	0.042190000000000005
or trastuzumab , cisplatin , 5-fu	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8422	0.04211
of the onabotulinumtoxina molecule	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8422	0.04211
of nature influence media coverage	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8422	0.04211
of gastroesophageal reflux disease	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8422	0.04211
of a subtalar joint endoprosthesis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8422	0.04211
non-pharmacological management of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8422	0.04211
guidelines concerning antipsychotic	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8422	0.04211
gestures mimicking daily-life activities	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8422	0.04211
disorder cognitive evoked potentials	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8422	0.04211
decision antiblastic treatment of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8422	0.04211
, intersectoral-interdisciplinary	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8422	0.04211
qaly for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8415	0.042075
of the valvular ring	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.84	0.042
isolation rate of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.84	0.042
for public health	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.84	0.042
for dental hygiene	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.84	0.042
for a rvwf-rfviii	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.84	0.042
ovarian cancer tissue indices of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
of the coronary arteries--effect	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
of second-generation antipsychotics	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
of developmental language disorders	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
of anti-tnf therapy-induced imid	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
native hawaiians native hawaiians	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
living frisbee : living friendly	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8392	0.04196
journalistic strategy for representing	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
interventions targeting individuals	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
hcx or trastuzumab , cisplatin ,	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8392	0.04196
for the inter-hospital transport	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
clinical practice guidelines for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
advocacy efforts regional asthma	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8392	0.04196
registry	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0599	0.04193
psychological	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.419	0.0419
valvular diseases informed consent	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8377	0.041885000000000006
serum pepsinogen levels serologic	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8377	0.041885000000000006
of the neurodegenerative disease	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8377	0.041885000000000006
of sporadic parathyroid adenomas	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8377	0.041885000000000006
of lacrimo-auriculodento- digital	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8377	0.041885000000000006
nutritional recommendations for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8377	0.041885000000000006
model observer correlated templates	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8377	0.041885000000000006
emergency department visits for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8377	0.041885000000000006
crohn 's disease activity index	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8377	0.041885000000000006
continuous infusion modality of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8377	0.041885000000000006
clinicians-scientists need passion	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8377	0.041885000000000006
influenza	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1395	0.041850000000000005
calibrated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4184	0.04184
language	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0597	0.04179
work group identified challenges	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
von willebrand-j rgens syndrome	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
trastuzumab , cisplatin , 5-fu	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8346	0.04173
subclinical atherosclerosis of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
relative cost-effectiveness of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
recommendations regarding issues	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
physiotherapeutic treatment of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
physiologic characteristics of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
pediatric crohn 's disease activity	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8346	0.04173
pacific islanders physical activity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
out-patients haemophilia treatment	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
of non-cancerous breast diseases	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
millennium development goal of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
jetpeel -3-carbocaine protocol	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8346	0.04173
infectious diseases specialists	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
immunocytochemical staining of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
hcx or trastuzumab , cisplatin	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8346	0.04173
for the gene expression domain	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
epistemological privileging of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
cervical cancer screening cancer	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8346	0.04173
proteins vp1-vp4	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8339	0.041695
of hbsag quantification	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8339	0.041695
of eb virus replication	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8339	0.041695
cisplatin , 5-fu	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8339	0.041695
caf  scientifique	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8339	0.041695
of nocturnal frontal lobe epilepsy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8331	0.041655
question	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0595	0.04164999999999999
stereotactic radiotherapy for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
secondary eruption failure of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
particle size distribution of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
of the schizophrenic spectrum	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
of the sarcoplasmic reticulum	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
of the focal infection theory	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
of secondary hyperparathyroidism	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
of matrix metalloproteinase-9	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
neurodegenerative disease for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
longer-term safety profile of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
investigator 's global assessment	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8324	0.041620000000000004
intravenous administration of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
interventions targeting populations	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
injections long-acting injections	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
hepatobiliary cancers address	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
gap long-acting injections of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
epirubicin , cisplatin , 5-fu	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8324	0.041620000000000004
efforts regional asthma management	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
countries confronting shortage	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
cost-effectiveness studies of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
bacteroides thetaiotaomnicron	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
amplitude accompanied decrease	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
age-specific screening services	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8324	0.041620000000000004
two-alternative forced choice	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
stressful characteristics of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
relevant clinical issues for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
primary treatment method for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
peripheral blood samples for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
pericranial infiltrations of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
perceptual processing disorder	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
pathological alternations of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
participants reported improvements	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
parenteral administration of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
pacific trust territories of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
of uterine smooth muscle cells	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
of medication abuse criteria	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
of legume-rhizobium symbiosis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
nonprewhitening matched filter	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
lacrimo-auriculodento- digital	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8308	0.04154
ionophor stimulated platelets	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
half-life time assessment of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
glabellar frown lines use of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
epidemiological studies kvik	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
electrochemical potential of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
derivative daughter cells of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
cstf included booster injections	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
consultations concerning cam	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
antibiotic susceptibility of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
anti-atherogenic activity of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8308	0.04154
of neurodegeneration	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8286	0.04143
of her2 expression	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8286	0.04143
of fibroadenoma	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8286	0.04143
for the chronification	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8286	0.04143
for health planning	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8286	0.04143
abrasiveness of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8286	0.04143
rapamycin signaling pathway	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
protein mammalian target of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
productive operating theatre	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
principal match service for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
prescribing observatory for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
of the maternal endothelium	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
of the biologic behavior of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
of secondary organic carbon	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
of paravalvular aortic leaks	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
of colorectal carcinogenesis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
of antibiotic dicloxacillin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
new treatment paradigms for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
native hawaiian stake- holders	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8278	0.04139
long-acting formulations of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
laboratory surveillance for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
kinetic characterization of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
indications botulinum toxin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
haemostaseologic centers of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
for structural heart disease	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
evidence-based practice for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
durable medical equipment ,	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8278	0.04139
daptmomycin received approval	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
contraceptives severe stroke	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
conical crown morphology of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
care services included lack	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
anatomic characteristics of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8278	0.04139
trend	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0591	0.04137
willebrand-j rgens syndrome	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
topical problems of improving	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
therapeutic strategies for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
systematic significance of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
stakeholders regarding rems	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
spontaneous complete bowel	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
secondary data analysis of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
preoperative informed consent	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
partnership structures for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
of pathologic bone metabolism	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
of microbiological aerosol	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
of dental hygiene research	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
of angiostatin infibrocystic	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
kids rehabilitation hospital	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
intracellular free calcium	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
intracellular formation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
insensitive measurement of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
injections clinical experience	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
hereditary bleeding disorder	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
haemophilic arthropathy of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
for the executive dysfunction	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
fluence field modulated ct	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
epirubicin , oxaliplatin ,	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8263	0.041315000000000004
eneas study screening guide	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
conceptual perspectives of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
cochrane library for existing	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
coaxial positioning catheter	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
asymptomatic deficiency of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8263	0.041315000000000004
of trabectedin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8248	0.04124
of the nephron	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8248	0.04124
of the biomarker	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8248	0.04124
of food poisoning	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8248	0.04124
of eltrombopag	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8248	0.04124
of bevacizumab	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8248	0.04124
for cardiac events	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8248	0.04124
rural neighbor islands of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
preliminary incubation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
practice standards for treating	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
pediatric crohn 's disease	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8218	0.04109
pathognomonic features of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
paradoxical occurrence of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
orthodontic treatment for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
of sarcoplasmic reticulum	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
of methylenetetrahydrofolate	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
of intracellular bacteria	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
of extracorporeal membrane	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
of end-stage renal disease	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
of constitutional symptoms	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
observer correlated templates	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
negative repercussions of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
munich started data enrollment	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
molecular pathogenesis of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
journalistic strategy for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
incidental aggravation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
hawaiians native hawaiians	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
genomic endophenotypes of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
for treating hyponatremia	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
for healthcare practitioners	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
discussion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0587	0.04109
discontinuation rates for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
current strategies for treating	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
congress angio access for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
complementary feeding indicators	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
clinical effectiveness of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
cancer research center of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
biotypes revealed concerns	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
approach involving restorative	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
antigenic determinants of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8218	0.04109
density	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1367	0.04101
trastuzumab treatment of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
scale intensity level of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
radiographic imaging capabilities	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
psychological account of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
program targeting hispanics	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
predictive power of working	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
potential candidates for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
percutaneous therapy for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
of video-polysomnography	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
of the objective benefits	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
of the maxillary incisors	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
of the epileptogenic zone	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
of the biologic behavior	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
of regional asthma management	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
of phosphorus homeostasis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
of nocturnal frontal lobe	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
of mitochondrial membrane	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
of haematological malignancies	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
neurocognitive models of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
madrid health system for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
inappropriate control of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
immunoregulatory role of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
health services delivery	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
health professions organizations	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
for substance use disorders	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
for representing transplants	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
final approved recommendations	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
events complicating tavi	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
ethical-social issues of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
epirubicin , oxaliplatin	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8195	0.040975000000000004
epirubicin , cisplatin ,	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8195	0.040975000000000004
epidemiologic picture of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
eeep level increased pao	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
cumulative index to nursing	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
correio da manh  newspaper	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8195	0.040975000000000004
contrast sensitivity for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
chemical compositions of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
cancer screening resources	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
calcium sensing receptor	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
biallelic combination of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
antiblastic treatment of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8195	0.040975000000000004
derivative	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0585	0.04095
of omalizumab	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.818	0.0409
of micronesia	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.818	0.0409
of l-carnitine	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.818	0.0409
of acidic gases	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.818	0.0409
lymphoma	BEYOND_CUTOFF	SIMPLE	Good	1	0.0409	0.0409
final year of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.818	0.0409
work group comprised of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
univariate analyses for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
uk nhs clinical practice	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
therapeutic targets for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
therapeutic features of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
theological doctrine of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
temporal consistency of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
statistic difference of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
serious underlying cause	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
risk models for predicting	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
review concerning influence	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
regarding rems challenges	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
proteomic researches of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
potential prevention of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
pooled hpv-based screening	BEYOND CUTOFF and FILTERED OUT	too_many_verbs	Bad	0.05	0.8173	0.040865000000000005
phenotypic diversity of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
optimizing treatment of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
of tumor suppressor genes	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
of the medical committee	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
of the acidic dentifrices	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
of osteoporosis therapy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
of non-hodgkin lymphoma	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
of nccn colorectal cancer	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
of hematological malignancies	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
of health impact assessment	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
of constipation symptoms	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
of air particulate matter	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
mitochondria binding dyes	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
hermann von helmholtz 's	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8173	0.040865000000000005
healthy cities approach	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
haemophilia registry of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
full-genome sequence of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
for public health decision	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
explorative analysis of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
disorders including autism	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
disorders antibody-drug	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
descriptors acute intoxication	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
contrast sensitivity of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
conselho de informa  o e	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8173	0.040865000000000005
classification tree for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
cancer screening services	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
bluecross blueshield of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
biologics technology of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
autonomous community of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
arthropathy reducing quality	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
antitumor antibiotic of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8173	0.040865000000000005
treatment approach for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
study effectiveness of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
services included lack	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
proliferatious form of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
of the primary symptoms	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
of the clinical experiences	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
of serum free-carnitine	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
of replacement therapy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
of reducing child mortality	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
of infectious endocarditis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
of incobotulinumtoxina	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
of ecological contamination	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
nutrition evidence for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
modulators thereof--are	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
mixed-methods approach	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
islanders physical activity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
interaction effect for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
important mediators of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
ides analogues therapy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
hypertension status of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
guillain-barr  syndrome	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8158	0.04079
for statistical analyses	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
for off-site rehabilitation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
for non-inhibitor patients	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
for hematologic malignancies	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
for hematologic disorders	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
ex vivo measurement of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
ethical guidelines for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
epirubicin , cisplatin	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8158	0.04079
diseases informed consent	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
diagnostic criteria of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
diagnostic approach of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
current strategies for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
count concentration of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
conselho de informa  o	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8158	0.04079
concentrations of no3-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8158	0.04079
concentration peaks of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
complete resolution of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
clinical usefulness of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
cancellation rates for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
bone remodeling statins	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
biochimical feature of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
biochemical effects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
bilateral swellings of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
beam hardening correction	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
anabolic properties of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8158	0.04079
central	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4078	0.040780000000000004
diversity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1358	0.04074
of orbiviruses	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8143	0.040715
of demandingness	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8143	0.040715
of cebpa mutations	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8143	0.040715
genotypes of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8143	0.040715
epirubicin ,	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8143	0.040715
wnt-  catenin pathway	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.812	0.040600000000000004
uk cf trust for existing	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
treatment methods for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
treatment efficacy of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
systematic studies of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
surgical resection of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
social determinant of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
scientific account of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
prevalence studies of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
pre-tetanus period of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of the physical dynamics	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of subjective symptoms	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of subjective perception	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of specialty pharmacy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of medicine bookshelf	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of increasing complexity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of enteroviruses differed	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of creation ex nihilo	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of complementary feeding	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of chrysotile asbestos	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
of bacterial pathogens	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
nonosmotic release of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
nccn guidelines adaptation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
molecular assembly of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
mass concentration of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
management system for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
intra-abdominal pres-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.812	0.040600000000000004
integral parameter of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
holland bloorview for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
for predicting morbidity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
for optimizing survival	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
for existing guidelines	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
follow-up problems of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
enzymatic activity of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
ecological aspects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
dynamic properties of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
digital renderings of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
cancer screening cancer	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
bacterial genomics of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
2nd world congress of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.812	0.040600000000000004
headache	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1352	0.04055999999999999
clinical excellence	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0674	0.04044
utilization rates of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
tumor cells apoptosis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
treatment effects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
transitory nature of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
synthetic agonist of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
surgical services of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
study screening guide	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
static compliance of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
severity criteria of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
severest variants of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
proteomic studies of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
prognostic impact of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
potential success of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
postnatal effects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
poc testing accreditation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
oncology managed care	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of thiosulfonic acids	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of the syr-darya river	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of the parotid glands	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of the cyclin d1 gene	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of research collaborators	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of rapamycin pathway	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of prophylaxis treatment	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of pasture biocenosis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of onabotulinumtoxin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of nuclear factor-kb	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of nicolaus taurellus	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of filamentous fungi	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of epistemic subjectivity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of dyskinesias onset	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of cardiovascular event	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
of antipsychotic medication	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
normative account of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
nhs clinical practice	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
mutation analysis of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
mild bleeding disorders	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
medical knowledge of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
living frisbee : living	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8083	0.040415000000000006
investigator 's global	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8083	0.040415000000000006
hcx or trastuzumab ,	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8083	0.040415000000000006
hawaiian stake- holders	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8083	0.040415000000000006
for stakeholders rems	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
for pregnancy termination	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
for economic co-operation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
for diabetes mellitus	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
final year of advanced	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
doctoral degrees for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
cochrane library for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
clinical evidence of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
bloorview kids rehab	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
baseline severity of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
anemia management of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8083	0.040415000000000006
food	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0577	0.040389999999999995
adaptive	BEYOND_CUTOFF	SIMPLE	Good	1	0.0403	0.0403
adaption	BEYOND_CUTOFF	SIMPLE	Good	1	0.0403	0.0403
of the hfmd	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8053	0.040265
of platelets	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8053	0.040265
of cpr carts	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8053	0.040265
of contraction	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8053	0.040265
nhs therapy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8053	0.040265
mbds records	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8053	0.040265
for the psi	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8053	0.040265
for fga-lais	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8053	0.040265
secondary	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4025	0.04025000000000001
molecular	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.4025	0.04025000000000001
follow-up	BEYOND CUTOFF and FILTERED OUT	HYPHENATION	Medium	0.7	0.0575	0.04025
of platelet-rich plasma	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8046	0.04023
rule	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0573	0.04010999999999999
topical problems of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
textbook example of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
taxonomic status of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
surgical anatomy of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
skeletal effects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
scientific study of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
samoa department of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
public hospitals of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
prototype strain of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
primary symptoms of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
preparations for treating	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
predictive value of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
practical tools for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of uk resident patients	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of the hup programme	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of service delivery	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of psychotic episodes	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of positive symptoms	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of nocturnal seizures	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of microalbuminuria	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of linguistic cohesiveness	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of functional genomics	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of clinical vertebral	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of calcium precipitation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of burv leiv-krg760	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of acidic dentifrices	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
of a platelet count	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
national library of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
model estimation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
mecaanically ventilated	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
mbar decreased vco2	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
laboratory tests of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
inflection point of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
hotspot mutation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
for recurrence risk	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
for mitral regurgitation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
for liver metastasis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
for existing reviews	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
for aortic pathology	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
for alopecia areata	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
federated states of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
diseases specialists	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
cumulative index to	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
critical members of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
comparative risk of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
color conversion of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
clinical effects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
catalytic effect of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
cardiac surgery for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
bowtie filtered fluence	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
bacteroides fragilis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
anesthetic power of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
anabolic actions of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
aetiologically mediated	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8016	0.040080000000000005
utility effects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
two-thirds decrease	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
topical aspects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
sickkids scorecard	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
search terms hibch	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
quality control of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
potential links of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of vascular disease	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of the trauma patient	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of the jupiter trial	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of social artifacts	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of public participation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of native hawaiians	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of language disorders	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of economic outcomes	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of chronic constipation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of cerebral abnormality	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of botulinum toxin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
of a disease incident	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
model observer for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
medical visits for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
isolation rates of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
hyperactivation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
hcx or trastuzumab	BEYOND CUTOFF and FILTERED OUT	contains_conjunction	Bad	0.05	0.8001	0.040005000000000006
genome sequence of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
for quality improvement	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
for policy developments	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
for optimal health	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
for idiopathic rbd	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
drug component for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
dental hygienist 's	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.8001	0.040005000000000006
contrast module of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
complementarity of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
co-registration of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
classifications of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
chronic disease of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
chemoprevention of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
causative agent of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
airway including rs	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
adolescents experience	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.8001	0.040005000000000006
stay	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0571	0.03997
of ca16	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7986	0.03993
algorithm	BEYOND_CUTOFF	SIMPLE	Good	1	0.0399	0.0399
executive	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1328	0.03984
admission	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0569	0.03983
ranking	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1325	0.03975
respiratory	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.1987	0.03974
of saxonia	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7941	0.039705000000000004
of mevalonate	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7941	0.039705000000000004
secretion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0567	0.039689999999999996
strategic role of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
strains transmission	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
social aspects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
scholars progress	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
review process of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
relative risks of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
rearrangements of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
proposed goals of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
professions organizations	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
primary venue for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
platelet  -granules	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7927	0.039635000000000004
pediatric crohn 's	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7927	0.039635000000000004
optimizing use of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of venous malformation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of the breakpoints	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of pulpal anatomy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of preterm labour	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of organic carbon	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of myometrium cells	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of medical importance	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of inactive carriers	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of cancer metabolism	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of brain metastases	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of acidic fluoride	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
of a uk scientist	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
key parameters of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
ixodidae ticks of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
for treating crow	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
for program evaluation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
for mental health	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
for health services	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
evidence base for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
estimate model of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
distal portion of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
depolarization of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
complet genome of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
clotting times of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
clinical value of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
clinical study of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
clinical signs of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
clinical onset of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
biomarkers candidates	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
bacteroides ovatus	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
analogues therapy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
ae screening guide	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7927	0.039635000000000004
candida	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1321	0.03963
shock	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0565	0.03955
clinician	BEYOND_CUTOFF	SIMPLE	Good	1	0.0394	0.0394
von willebrand 's	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7875	0.039375
visualisation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
stakeholders rems	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
savvy manager of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
primary focus of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
primary cause of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
preparations for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
plasma ratios of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
organisation for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of viral genotype	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of uterus myocytes	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of public health	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of nccn colorectal	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of life-5 dimensions	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of irlen syndrome	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of health disparities	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of health breast	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of formal defects	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of dental hygiene	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
of antitumor activity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
nccn launched initiatives	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
living frisbee :	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7875	0.039375
inhibitors treatment	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
hypercalcemia of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
guidelines adaptation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
for improving quality	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
evs included ca2	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
eox replaced ecx	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
end-expirato- my	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7875	0.039375
diverse group of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
dissemination of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
disinhibition of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
da manh  newspaper	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7875	0.039375
comorbidities of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
calibrated automated	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
algorithms evaluation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
adolescents with	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
absolute risk of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7875	0.039375
competence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1312	0.03936
of synapses	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7838	0.03919
of bont-a	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7838	0.03919
sodium	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1306	0.03918
uk cf trust for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
substitution of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
serum marker of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
segmentation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
risk models for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
remembrances of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
rejuvenation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
reactivation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
rational use of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
preparation for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
of thought leaders	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
of the diaspora	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
of second-generation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
of non-mass lesions	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
of mitochondria	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
of ladd syndrome	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
of hyponatremia	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
of diuretic doses	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
of chloride ion	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
nasal mucosa of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
mtc analysis of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
millilitres for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
legal basis for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
key mediator of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
key elements of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
inactivation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
focus groups of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
epidemiology of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
displacement of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
development for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
credibility for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
coordination of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
co-existence of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
classic form of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
cities approach	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
c-13 studies of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7823	0.039115000000000004
, oxaliplatin ,	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7823	0.039115000000000004
colon cancer	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.3899	0.038990000000000004
talipes equinus	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
risk impact of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
replication of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of work intensity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of trauma lists	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of the entanglement	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of the catphan	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of pth metabolism	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of prucalopride	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of pka account	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of pathogenesis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of orbital fat	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of nitric oxide	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of lai therapy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of high-sensitivity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of fihp families	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of extracorporeal	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of enteroviruses	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of bisphosphonates	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
of angiogenesis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
investigator 's	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7779	0.038895000000000006
for mp definition	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
for differentiation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
focuses attention	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
floodplains of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
examination of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
conceptions of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
cells apoptosis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
authors report	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
aggregation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
adherens junctions	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7779	0.038895000000000006
handling	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3884	0.038840000000000006
of asthma	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7765	0.038825
immobilized	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3873	0.03873
of prrt2	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7728	0.03864000000000001
for ethnicity	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7728	0.03864000000000001
adolescent	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1285	0.03855
adolescence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1285	0.03855
transmission	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0549	0.03843
resources for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
rems spectrum	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
rems challenges	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
regulation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
philosophy of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
oxaliplatin ,	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7684	0.03842
of the retina	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
of rhinosinusitis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
of ofatumumab	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
of liraglutide	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
of eosinophils	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
of enterovirus	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
of calmodulin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
nhs list prices	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
meninges play	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
median age of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
manh  newspaper	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7684	0.03842
for project cities	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
for lai treatment	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
for influenza	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
for dna study	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
event data of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
dental use of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
centrality of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
catabolism of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
assessment of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
antigens evidences	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7684	0.03842
subgrouping	BEYOND_CUTOFF	SIMPLE	Good	1	0.0383	0.0383
surgical	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3827	0.03827
focus	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0545	0.038149999999999996
capability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1271	0.03813
lung cancer	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.3806	0.038060000000000004
hiv-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7612	0.038060000000000004
willebrand 's	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.759	0.037950000000000005
threshold of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
studies kvik	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
ontology for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
of the sdvfv	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
of prrt2 gene	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
of presynaptic	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
of pentraxin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
of minnesota	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
of hibch gene	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
of denosumab	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
l-pbs injections	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
influence of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
for care-agreements	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
criteria for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
back-end for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.759	0.037950000000000005
pooled	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3791	0.03791
threshold	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1262	0.03786
of hfmd	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7539	0.037695000000000006
for chf	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7539	0.037695000000000006
genetic characterization of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7525	0.037625
biomarker	BEYOND_CUTOFF	SIMPLE	Good	1	0.0376	0.0376
of mr-mammography	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7518	0.037590000000000005
surgery for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
success for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
stake- holders	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7503	0.037515
s-esters of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
prolapse of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
of the risk	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
of objectification	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
of neoplastic	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
of n-reflex	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
of ibandronate	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
of ct scanners	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
hygienist 's	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7503	0.037515
for oncology	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
for calcium	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
consent for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7503	0.037515
reproductive	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.374	0.0374
with an eye	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
taxane for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
subtype of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
serum tnf-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7446	0.037230000000000006
segment of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
of the icu	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
of fiocruz	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
of ar-gg27	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
noebels jl	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
kids rehab	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
journal of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
isotype of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
for ischemic	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
for breast	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
balance of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7446	0.037230000000000006
men	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1238	0.03714
preferable	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3704	0.037040000000000003
aromatic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3704	0.037040000000000003
of vka	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7389	0.036945
of rrt	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7389	0.036945
of rems	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7389	0.036945
of lais	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7389	0.036945
, 5-fu	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7389	0.036945
growth signaling pathways	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7367	0.036835
of estrogens	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7346	0.036730000000000006
genotype of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7346	0.036730000000000006
theiler 's	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7339	0.036695
ontario 's	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7339	0.036695
of ukraine	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
of thoracic	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
of the ab	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
of malignancy	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
of hg cin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
issues of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
genes mutations	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
fws score	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
for adaptation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
drugs for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
dpb1*0401	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7339	0.036695
dosage of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
cancer of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7339	0.036695
cell proliferation	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.3669	0.03669
people	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1221	0.036629999999999996
for osteoporosis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7325	0.036625000000000005
health outcomes	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0609	0.03654
preventive treatment of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7275	0.036375000000000005
of arginine vasopressin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7275	0.036375000000000005
prognosis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1212	0.036359999999999996
of vocs	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7268	0.036340000000000004
tolerance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0516	0.03612
taylor 's	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7204	0.03602
of tolerability	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7204	0.03602
of emergency	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7204	0.03602
of adult	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7204	0.03602
nhs list	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7204	0.03602
hla-a*03	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7204	0.03602
scientific evidence of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7197	0.035985
healthy cities network	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7197	0.035985
perspectives	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0513	0.03591
for aes	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7169	0.035845
conversational	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3584	0.035840000000000004
downregulation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7155	0.035775
reaction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0511	0.035769999999999996
stent	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1192	0.03576
chemical	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1189	0.03567
cervical	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.1782	0.03564
of volatile organic compounds	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.712	0.0356
observational	BEYOND_CUTOFF	SIMPLE	Good	1	0.0356	0.0356
progress	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0507	0.03549
of mental disorders	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7092	0.035460000000000005
qaly of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7057	0.035285000000000004
plasma-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7057	0.035285000000000004
of no3-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.7057	0.035285000000000004
of nccn	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7057	0.035285000000000004
of hno3	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7057	0.035285000000000004
of btxa	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7057	0.035285000000000004
of agitation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7057	0.035285000000000004
ipc for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7057	0.035285000000000004
for hup	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7057	0.035285000000000004
qualitative evaluation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7036	0.03518
of cancer care	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.7022	0.03511
qaly	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0351	0.0351
ventilator	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0501	0.03507
ventilation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0501	0.03507
collaborative nature of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6946	0.034730000000000004
affinity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0496	0.034719999999999994
practice standards for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6918	0.03459
mass concentrations of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6918	0.03459
class	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0494	0.03458
of episodic migraine	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6911	0.034555
medical education	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.3446	0.034460000000000005
gap	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0492	0.03444
rater-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.6877	0.034385
of tlr	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6877	0.034385
of pkd	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6877	0.034385
of ibd	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6877	0.034385
of avp	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6877	0.034385
nas of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6877	0.034385
hcx or	BEYOND CUTOFF and FILTERED OUT	contains_conjunction	Bad	0.05	0.6877	0.034385
for mr	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6877	0.034385
emg of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6877	0.034385
, foot	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.6877	0.034385
coefficient	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1146	0.034379999999999994
suboptimal quality of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.687	0.034350000000000006
statistical manual of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.687	0.034350000000000006
remodelling	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3432	0.03432
remodeling	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3432	0.03432
autism spectrum disorder	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.3427	0.03427
formulation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0489	0.03423
depressive	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1141	0.03423
prognostic marker of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6842	0.034210000000000004
of evidence	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6835	0.034175000000000004
overview of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.2275	0.034125
of aortic regurgitation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6815	0.034075
expertise	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1135	0.03405
vitro evaluation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6801	0.034005
vascular access for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6801	0.034005
to community health	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6801	0.034005
clinical trials for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6801	0.034005
ulcer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1132	0.03396
secondary forms of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6767	0.033835
recommendation for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6767	0.033835
primary outcome of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6767	0.033835
differed	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3378	0.03378
consuming	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3364	0.033639999999999996
classifer	BEYOND_CUTOFF	SIMPLE	Good	1	0.0336	0.0336
clinical study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0559	0.03354
services delivery	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6699	0.033495000000000004
noninferiority of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6699	0.033495000000000004
key indicators of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6699	0.033495000000000004
incidence rate of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6699	0.033495000000000004
for treating patients	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6699	0.033495000000000004
marker	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0478	0.03346
pres-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.6685	0.033425
pl of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6685	0.033425
of oral	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6685	0.033425
of mr	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6685	0.033425
of mp	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6685	0.033425
of care	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6665	0.033325
interview	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0476	0.03332
ruptured	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.333	0.0333
stabilization of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6651	0.033255
primary goals of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6651	0.033255
of the recommendation	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6651	0.033255
meta-analysis of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6651	0.033255
complications of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6651	0.033255
comparability of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6651	0.033255
hypertension	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1107	0.03321
disparity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0474	0.033179999999999994
manifestation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6617	0.033084999999999996
deterioration of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6617	0.033084999999999996
years follow-up	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.661	0.03305
tolerability of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.661	0.03305
prescription of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.661	0.03305
optimisation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.661	0.03305
implications of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.661	0.03305
implantation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.661	0.03305
cox proportional	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.2196	0.03294
understanding	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3292	0.03292
methodological	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3292	0.03292
recovery	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.047	0.0329
differential diagnosis	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0547	0.032819999999999995
root causes of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.655	0.03275
facial wrinkle	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.3273	0.03273
peak	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0467	0.03269
of phpt	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6536	0.03268
agency for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.653	0.032650000000000005
tone	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1088	0.032639999999999995
liver disease	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.3259	0.03259
exchanger	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0465	0.032549999999999996
exchange	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0465	0.032549999999999996
of hg	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6509	0.032545000000000004
of bp	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6509	0.032545000000000004
byproducts of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6503	0.032515
induced	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3249	0.032490000000000005
pro-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.6496	0.03248
evidence review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0541	0.03246
documentation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0463	0.03241
dermatology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.108	0.0324
coalition	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1074	0.03222
infused	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3216	0.03216
vitamin d	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.2138	0.032069999999999994
of satisfaction	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6403	0.032015
of macrophages	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6403	0.032015
of intervention	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6403	0.032015
of potassium	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6376	0.03188
cytoplasm of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6376	0.03188
serum	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1061	0.03183
diet	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0454	0.03178
cities network	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6356	0.03178
syndrome of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.635	0.03175
sequelae of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.635	0.03175
of leukocytes	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.635	0.03175
efficacy of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.635	0.03175
utility	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0452	0.031639999999999995
utilities	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0452	0.031639999999999995
for cvd	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6317	0.031585
of hawaii	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.631	0.03155
tracking	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3146	0.03146
clinical manifestations of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6284	0.03142
min	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1047	0.03141
visit	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0447	0.03129
importance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1042	0.031259999999999996
of the project	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6251	0.031255
ci	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3122	0.031219999999999998
initiator	BEYOND_CUTOFF	SIMPLE	Good	1	0.0312	0.0312
individual	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1039	0.03117
oh*	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.6224	0.03112
malformation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1037	0.03111
clinical presentation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6218	0.031090000000000003
strain	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0444	0.03108
systematic review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0518	0.031079999999999997
retrospective review of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6205	0.031025000000000004
diagnostic criteria for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6205	0.031025000000000004
of phosphate	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6192	0.03096
prostate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1029	0.03087
feeding	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3085	0.030850000000000002
transformational	BEYOND_CUTOFF	SIMPLE	Good	1	0.0307	0.0307
hip	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.1023	0.03069
variable	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0438	0.030659999999999996
receptor activator of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6126	0.030630000000000004
invasive	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.3062	0.030620000000000005
systematic review of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6094	0.030470000000000004
integration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0435	0.030449999999999994
trend of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6088	0.030440000000000002
sharing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.303	0.0303
prognostic value of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6042	0.03021
predictive power of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6042	0.03021
negative effects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6042	0.03021
economic aspects of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.6042	0.03021
decrease	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.043	0.030099999999999995
supplementation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.601	0.03005
considerations for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.601	0.03005
of cancer	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5965	0.029825000000000004
stabilizer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0426	0.029819999999999996
stabilization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0426	0.029819999999999996
of epileptogenesis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5959	0.029795000000000002
visualization of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5939	0.029695
expectations for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5939	0.029695
consolidation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5939	0.029695
reconstruction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0423	0.029609999999999997
oncology	BEYOND_CUTOFF	SIMPLE	Good	1	0.0296	0.0296
oncological	BEYOND_CUTOFF	SIMPLE	Good	1	0.0296	0.0296
organization of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5907	0.029535000000000002
mobilization of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5907	0.029535000000000002
complication of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5907	0.029535000000000002
cortex	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0984	0.029519999999999998
of chronic migraine	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5901	0.029505
kidney disease	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.2944	0.02944
membrane	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0981	0.02943
serum-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.5882	0.02941
prophylaxis of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5869	0.029345
recording	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0418	0.029259999999999994
record	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0418	0.029259999999999994
repeated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2921	0.029210000000000003
safety	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0973	0.029189999999999997
institution	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0416	0.029119999999999997
of imid	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5812	0.029060000000000002
of adhd	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5812	0.029060000000000002
no3-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.5806	0.02903
osteoporosis	BEYOND_CUTOFF	SIMPLE	Good	1	0.029	0.029
of the cervix	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5799	0.028995
onset	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0413	0.02891
awareness	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0963	0.02889
interaction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0411	0.028769999999999997
onset age of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5742	0.028710000000000003
of transmission	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5742	0.028710000000000003
amplitude of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5742	0.028710000000000003
affinity for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5742	0.028710000000000003
pathologic	BEYOND_CUTOFF	SIMPLE	Good	1	0.0287	0.0287
differential diagnosis of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5736	0.02868
profile of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.573	0.02865
of the hip	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.573	0.02865
lung	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0955	0.02865
appraisal	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0408	0.02856
clinical application of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5686	0.02843
barrier	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0406	0.028419999999999997
death	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0404	0.028279999999999996
treatment options for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5642	0.028210000000000002
adaptation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0403	0.02821
quality of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.563	0.028149999999999998
anatomy of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.563	0.028149999999999998
healthy cities	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.281	0.028100000000000003
scenario	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0932	0.027960000000000002
clinical features of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5592	0.027960000000000002
biologic	BEYOND_CUTOFF	SIMPLE	Good	1	0.0279	0.0279
impaired	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.278	0.027800000000000005
learning	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0925	0.02775
accounts	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0396	0.02772
account	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0396	0.02772
who	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2771	0.027710000000000002
models of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5524	0.027620000000000002
seizure	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0393	0.02751
for prostate cancer	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5487	0.027435
of rbd	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5481	0.027405000000000002
correlation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0391	0.02737
dysregulation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5463	0.027315000000000002
usa	BEYOND_CUTOFF	SIMPLE	Good	1	0.0272	0.0272
advancement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0388	0.02716
advance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0388	0.02716
epidemiology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0905	0.027149999999999997
preservation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5414	0.02707
leader	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0386	0.02702
infrastructure	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.09	0.027
presentation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5383	0.026915
morbidity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0897	0.02691
dimension	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0897	0.02691
panel	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0895	0.02685
of osteoporosis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5353	0.026765
of cancer patient	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5353	0.026765
physiology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0892	0.02676
similar	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2675	0.026750000000000003
of food	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5347	0.026735
student	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.038	0.0266
of osteoblast	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5304	0.026520000000000002
toxicity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0882	0.02646
consumption	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0378	0.026459999999999997
home	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2641	0.026410000000000003
intensive care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.044	0.026399999999999996
inversion of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5274	0.02637
for aortic	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.525	0.026250000000000002
sampling	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2611	0.02611
attention	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0373	0.026109999999999998
pacific	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2607	0.02607
affinity of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5208	0.026040000000000004
rem	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.026	0.026
inequities	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0865	0.025949999999999997
median	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0863	0.02589
airway	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0863	0.02589
influence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0368	0.025759999999999998
behavioral	BEYOND_CUTOFF	SIMPLE	Good	1	0.0256	0.0256
of symptoms	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5118	0.02559
cox	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0853	0.025589999999999998
of vascular calcification	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5112	0.02556
of endothelial cells	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5112	0.02556
for hemodialysis	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5106	0.025530000000000004
committee	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0851	0.025529999999999997
public	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0848	0.02544
disability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0848	0.02544
excellence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0362	0.02534
interpretation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5065	0.025325
plans for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5041	0.025205
of anemia	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5041	0.025205
prospective study	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.042	0.0252
heterogeneity of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.5035	0.025175
culture	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0839	0.02517
supplement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0359	0.02513
impaction	BEYOND_CUTOFF	SIMPLE	Good	1	0.0251	0.0251
optimization of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4994	0.024970000000000003
theory	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0831	0.024929999999999997
observer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0356	0.024919999999999998
observation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0356	0.024919999999999998
proliferation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0354	0.02478
history	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0353	0.024709999999999996
arm	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0819	0.024569999999999998
validation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4912	0.024560000000000002
tubing	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0817	0.024509999999999997
tube	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0817	0.024509999999999997
search	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.035	0.0245
sensitization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0348	0.024359999999999996
characterization of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4854	0.02427
goal	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0346	0.02422
consequence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0342	0.02394
accredited	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2391	0.02391
reimbursement for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4773	0.023865
dental	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2383	0.023830000000000004
patient care	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.2367	0.02367
comparative	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0789	0.02367
emergency department	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.2363	0.02363
pcr	BEYOND_CUTOFF	SIMPLE	Good	1	0.0236	0.0236
calcium	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0786	0.02358
grade	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0784	0.02352
classification	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0336	0.023519999999999996
subset of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4693	0.023465
consent	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0334	0.023379999999999998
transports	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0333	0.02331
transporter	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0333	0.02331
transport	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0333	0.02331
health service	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0385	0.0231
color	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.077	0.0231
management of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4614	0.02307
study of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4608	0.02304
middle	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0766	0.02298
standardization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0328	0.02296
standard	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0328	0.02296
dna	BEYOND_CUTOFF	SIMPLE	Good	1	0.0229	0.0229
physician	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0763	0.02289
success	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0327	0.022889999999999997
intensity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0761	0.02283
of tumor cells	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4552	0.022760000000000002
balance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0325	0.02275
for chronic disease	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4541	0.022705000000000003
job	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0756	0.02268
filtered	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2263	0.02263
for hiv	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4524	0.02262
context	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0752	0.02256
pain	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0322	0.022539999999999998
overexpression of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4502	0.022510000000000002
heart disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0375	0.0225
alcohol	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.075	0.0225
situation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0318	0.02226
novel	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0741	0.02223
significance of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4441	0.022205000000000003
hiv	BEYOND_CUTOFF	SIMPLE	Good	1	0.0222	0.0222
anatomical	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.111	0.0222
mutational	BEYOND_CUTOFF	SIMPLE	Good	1	0.0221	0.0221
literature review	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0367	0.02202
targets	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0313	0.02191
target	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0313	0.02191
depended	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2188	0.02188
practice guideline	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0364	0.021840000000000002
initiation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0312	0.02184
modulation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4358	0.021790000000000004
arthritis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0725	0.02175
confidence interval	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.036	0.021599999999999998
chemotherapy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.072	0.021599999999999998
oral	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0718	0.02154
transformation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0307	0.02149
opportunity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0716	0.02148
classification of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4293	0.021465
scientific	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2142	0.02142
practitioner	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0306	0.021419999999999998
fragment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0707	0.02121
nccn clinical	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.1407	0.021105
middle east	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.1407	0.021105
ms	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0211	0.0211
manifestations of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4206	0.02103
ct	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.021	0.021
overview	BEYOND_CUTOFF	SIMPLE	Good	1	0.0209	0.0209
baseline	BEYOND_CUTOFF	SIMPLE	Good	1	0.0208	0.0208
incident	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0297	0.02079
of rapamycin	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4147	0.020735000000000003
cholesterol	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0687	0.02061
contribution	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0294	0.020579999999999998
of pth	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4115	0.020575
cycle	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0683	0.020489999999999998
prevention	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0292	0.02044
carbons	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0681	0.020429999999999997
carbon	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0681	0.020429999999999997
healing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.2039	0.020390000000000002
energy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0679	0.02037
treatment option	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0339	0.02034
quantification of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.4014	0.02007
radiation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0286	0.02002
's	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.1334	0.020009999999999997
programme	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0666	0.01998
abundance of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.3993	0.019965
modified	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1984	0.01984
anatomy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0659	0.01977
appropriate	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1976	0.01976
software	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0657	0.01971
contribution of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.393	0.01965
medical student	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.1961	0.019610000000000002
resource	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.028	0.0196
agency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0653	0.01959
incorporation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.3915	0.019575000000000002
consideration of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.3915	0.019575000000000002
federated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1954	0.019540000000000002
federal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1954	0.019540000000000002
cohort of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.3904	0.019520000000000003
exposure	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0278	0.019459999999999998
staging	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0642	0.019259999999999996
stage	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0642	0.019259999999999996
regulator	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0275	0.01925
validity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.064	0.0192
delivery	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0273	0.01911
consultancy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0628	0.01884
differentiation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0269	0.01883
differential	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0269	0.01883
monitor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0268	0.01876
dysfunctions	BEYOND_CUTOFF	SIMPLE	Good	1	0.0187	0.0187
dysfunction	BEYOND_CUTOFF	SIMPLE	Good	1	0.0187	0.0187
pathogen	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0623	0.01869
confidence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0267	0.01869
responding	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1863	0.01863
viii	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1856	0.01856
cardiovascular disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0309	0.01854
fracture	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0613	0.01839
fluid	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0611	0.01833
advent of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.3664	0.01832
optimal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1831	0.018310000000000003
available	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.182	0.0182
toxin	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0605	0.01815
prophylaxis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0603	0.01809
industrial	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1803	0.01803
framework	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0601	0.01803
valve	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0257	0.01799
chronic disease	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0299	0.017939999999999998
public policy	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.1792	0.017920000000000002
behavior	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0256	0.01792
regimen	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0597	0.01791
accessions	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0255	0.017849999999999998
access	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0255	0.017849999999999998
room	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0593	0.01779
toxic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.0882	0.01764
occupational	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1764	0.01764
impact	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0251	0.01757
mri	BEYOND_CUTOFF	SIMPLE	Good	1	0.0175	0.0175
breast	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0583	0.01749
funding	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1743	0.01743
tract	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0579	0.01737
association	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0247	0.01729
associate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0247	0.01729
pathogenesis	BEYOND_CUTOFF	SIMPLE	Good	1	0.0172	0.0172
significance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0245	0.01715
interpreters	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0243	0.017009999999999997
interpretations	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0243	0.017009999999999997
attenuated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1695	0.016950000000000003
adhd	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0169	0.0169
africa	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0563	0.01689
satisfaction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0241	0.01687
medicine	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.024	0.0168
preparation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0239	0.01673
life	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0235	0.01645
revised	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1644	0.01644
evolut	BEYOND_CUTOFF	SIMPLE	Good	1	0.0164	0.0164
transplant	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0234	0.01638
infection of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.3259	0.016295
metabolism	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0539	0.01617
article	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0537	0.01611
sensing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1607	0.01607
centre	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.053	0.015899999999999997
effort	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0227	0.01589
anxiety	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0528	0.01584
preserved	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1574	0.01574
implication	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0224	0.01568
species	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0522	0.01566
mental health	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0261	0.01566
correct	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1561	0.015609999999999999
oxygen	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.052	0.0156
mutation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0221	0.01547
defect	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0515	0.015449999999999998
tumoral	BEYOND_CUTOFF	SIMPLE	Good	1	0.0154	0.0154
examiners	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.022	0.015399999999999999
behaviour	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0509	0.015269999999999999
skin	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.05	0.015
quality of life	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.1	0.1499	0.014990000000000002
benefit	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0214	0.014979999999999999
task	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.049	0.0147
surgeon	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0487	0.01461
workshop	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0485	0.01455
presentation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0207	0.01449
city	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0483	0.01449
migraine	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0481	0.014429999999999998
residing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1442	0.01442
hygiene	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0479	0.014369999999999999
decision	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0205	0.01435
challenge	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0204	0.01428
profiles	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0203	0.014209999999999999
profile	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0203	0.014209999999999999
school	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0472	0.014159999999999999
malignancy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0469	0.01407
knowledge	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0201	0.01407
inhibitor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.02	0.013999999999999999
lai	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0139	0.0139
document	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0463	0.01389
expression	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0198	0.01386
environment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0461	0.01383
originating	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.138	0.013800000000000002
international	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.138	0.013800000000000002
internal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.138	0.013800000000000002
deficiency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.046	0.0138
provider	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0197	0.013789999999999998
survey	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0196	0.013719999999999998
von	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0456	0.01368
survival	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0195	0.013649999999999999
carbonic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.0681	0.01362
episodic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1361	0.01361
diverse	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1358	0.013580000000000002
option	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0194	0.01358
emergence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0193	0.01351
familial	BEYOND_CUTOFF	SIMPLE	Good	1	0.0135	0.0135
specialized	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1346	0.01346
special	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1346	0.01346
separated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1337	0.013370000000000002
introduction	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0191	0.013369999999999998
illness	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0442	0.013260000000000001
collaboration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0189	0.013229999999999999
participation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.2645	0.013225
receptor	BEYOND_CUTOFF	SIMPLE	Good	1	0.0132	0.0132
nutritional	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1318	0.01318
nccn	BEYOND_CUTOFF	ABBREVIATION	Good	1	0.0131	0.0131
integrity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0435	0.013049999999999999
stress	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0186	0.013019999999999999
demographics	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0432	0.012960000000000001
growth	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0185	0.012949999999999998
reflective	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1288	0.01288
reflecting	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1288	0.01288
governed	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1283	0.012830000000000001
loss	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0183	0.01281
stability	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0426	0.01278
recommendations for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.2556	0.01278
capable	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1271	0.012709999999999999
improvable	BEYOND_CUTOFF	SIMPLE	Good	1	0.0127	0.0127
work	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0181	0.01267
counting	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1265	0.012650000000000002
efficacy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0421	0.012629999999999999
institute	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0416	0.01248
mortality	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0178	0.012459999999999999
of calcium	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.249	0.012450000000000001
dynamic	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0414	0.012419999999999999
consequences of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.2473	0.012365000000000001
index	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0173	0.01211
healthy	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1209	0.01209
ii	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1206	0.012060000000000001
potentials	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0401	0.012029999999999999
potential	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0401	0.012029999999999999
compound	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0398	0.011940000000000001
inflammation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.017	0.0119
distribution	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0167	0.011689999999999999
mena	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0389	0.011669999999999998
of nccn guidelines	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.2299	0.011495
subgroup	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0383	0.01149
evolution	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0164	0.01148
virus	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0381	0.011430000000000001
indices	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0162	0.01134
reviewe	BEYOND_CUTOFF	SIMPLE	Good	1	0.0113	0.0113
pathway	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.016	0.0112
gender	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0372	0.011159999999999998
youth	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.037	0.011099999999999999
score	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0158	0.01106
identification	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0156	0.01092
individual patient	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.1085	0.01085
clinical trial	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0179	0.01074
questionnaire	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0357	0.01071
injury	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0153	0.010709999999999999
heart	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0152	0.01064
syndromic	BEYOND_CUTOFF	SIMPLE	Good	1	0.0105	0.0105
medication	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.015	0.010499999999999999
sensitivity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0348	0.01044
assessment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0149	0.01043
important	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1042	0.01042
analyses	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0148	0.01036
expert	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0345	0.01035
molecule	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0343	0.010289999999999999
consideration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0147	0.010289999999999999
issue	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0146	0.01022
accuracy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.034	0.0102
experiment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0145	0.01015
experience	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0145	0.01015
screen	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0337	0.01011
clinical excellent	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.0674	0.01011
event	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0144	0.010079999999999999
chronic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.1	0.010000000000000002
risk factor for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.1998	0.00999
diagnosis	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0142	0.00994
cohort	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0331	0.00993
women	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.033	0.0099
infective	BEYOND_CUTOFF	SIMPLE	Good	1	0.0099	0.0099
lesion	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0141	0.009869999999999999
ethnic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0986	0.00986
evaluation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.014	0.0098
skill	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0324	0.00972
activator	BEYOND_CUTOFF	SIMPLE	Good	1	0.0097	0.0097
medical treatment	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.0966	0.009660000000000002
investigator	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0138	0.009659999999999998
investigation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0138	0.009659999999999998
staff	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0321	0.009629999999999998
modelings	BEYOND_CUTOFF	SIMPLE	Good	1	0.0096	0.0096
professional	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0319	0.009569999999999999
administration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0136	0.009519999999999999
plasma	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0316	0.00948
surgery	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0134	0.00938
malignant	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.0469	0.00938
initiative	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0312	0.009359999999999999
educator	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0133	0.009309999999999999
education	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0133	0.009309999999999999
abnormality	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.031	0.0093
mediated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0927	0.00927
interventional	BEYOND_CUTOFF	SIMPLE	Good	1	0.0092	0.0092
diabetes	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0304	0.00912
plan	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.013	0.009099999999999999
vitro	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0303	0.009089999999999999
modules	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0302	0.00906
module	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0302	0.00906
implant	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.0451	0.00902
bone	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.03	0.009
physiological	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0892	0.00892
diagnostic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.0445	0.0089
improvement	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0127	0.008889999999999999
substance	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0293	0.00879
recommendation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0125	0.008749999999999999
concerning	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0875	0.008749999999999999
pre-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.1743	0.008715
integral	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.0435	0.0087
implementation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0124	0.008679999999999998
mass	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0289	0.008669999999999999
investigation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.1733	0.008665
demographic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.0432	0.00864
pathology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0287	0.00861
subject	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0122	0.00854
week	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0283	0.00849
service	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0121	0.008469999999999998
uk	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0282	0.008459999999999999
spectrum of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.1681	0.008405000000000001
hospitalization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.012	0.0084
cultured	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0839	0.00839
cultural	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0839	0.00839
biology	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0279	0.00837
european	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0836	0.00836
american	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0834	0.00834
manager	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0119	0.00833
day	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0276	0.00828
consolidated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0827	0.00827
reporter	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0118	0.00826
report	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0118	0.00826
organization	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0118	0.00826
pathophysiology of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.1651	0.008255
delayed	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0824	0.00824
clinical practice	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0137	0.00822
gene	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0117	0.00819
database	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0271	0.00813
evidence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0116	0.008119999999999999
breast cancer	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.081	0.008100000000000001
drug	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0115	0.00805
developers	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0114	0.00798
year	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0265	0.007949999999999999
complexes	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0264	0.00792
complex	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0264	0.00792
review	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0113	0.007909999999999999
comparable	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0789	0.00789
brain	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0263	0.00789
grading	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0784	0.00784
dose	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0259	0.007769999999999999
health care	BEYOND_CUTOFF	Normal_NP	Medium	0.6	0.0129	0.0077399999999999995
population	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.011	0.007699999999999999
outcome	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0109	0.00763
intensive	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0761	0.0076100000000000004
tissue	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0253	0.0075899999999999995
complication	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0108	0.00756
antibody	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0252	0.00756
participant	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0107	0.007489999999999999
accumulated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0747	0.007470000000000001
obesity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0249	0.007469999999999999
severity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0248	0.0074399999999999996
injection	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0106	0.0074199999999999995
visual	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0736	0.00736
activation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.1467	0.007335
training	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0244	0.00732
guideline	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0103	0.007209999999999999
assay	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0238	0.0071400000000000005
concentration	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0102	0.00714
concentrate	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0102	0.00714
trial	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0101	0.007069999999999999
bleeding	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.07	0.007000000000000001
research	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.01	0.006999999999999999
for	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0696	0.00696
site	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0232	0.006959999999999999
infection	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0099	0.00693
approach	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0099	0.00693
absence	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0231	0.0069299999999999995
asthma	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.023	0.0069
practice	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0098	0.006859999999999999
nations	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0227	0.00681
activation	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0097	0.00679
capacity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0226	0.00678
role	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0225	0.00675
modelling	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0096	0.006719999999999999
arterial	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.067	0.006700000000000001
tnf-	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.05	0.1331	0.006655
therapy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0095	0.00665
risk	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0095	0.00665
adult	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0219	0.0065699999999999995
blood	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0218	0.00654
care	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0093	0.006509999999999999
finding	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0216	0.0064800000000000005
tool	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0215	0.006449999999999999
further study	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.0644	0.00644
intervention	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0092	0.0064399999999999995
validated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.064	0.0064
valid	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.064	0.0064
policy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0213	0.00639
disorder	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0091	0.00637
treatment	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.009	0.006299999999999999
consulting	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0628	0.00628
concentrations of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.1247	0.006235000000000001
ml	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0619	0.00619
stem cell	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.0615	0.00615
study	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Medium	0.7	0.0087	0.006089999999999999
estimating	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0607	0.00607
estimated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0607	0.00607
laboratory	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0202	0.006059999999999999
questioned	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0595	0.00595
of life	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.1183	0.005915
concentration of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.118	0.0059
deriving	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0585	0.005850000000000001
derived	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0585	0.005850000000000001
emergency	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0193	0.00579
genetic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.0285	0.0057
modality	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.019	0.005699999999999999
secreted	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0567	0.0056700000000000006
collaborative	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0189	0.00567
spectrum	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0188	0.00564
risk factors for	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.1124	0.00562
medical care	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.0555	0.00555
new	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0553	0.00553
team	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0182	0.0054600000000000004
interval	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.018	0.005399999999999999
metabolic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0539	0.005390000000000001
alternative	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0535	0.005350000000000001
alternating	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0535	0.005350000000000001
administration of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.1066	0.0053300000000000005
acidity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0177	0.00531
acid	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0177	0.00531
literature	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0176	0.00528
networking	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0171	0.00513
network	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0171	0.00513
criteria	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0168	0.005039999999999999
ventilated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0501	0.0050100000000000006
evolution of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.1002	0.0050100000000000006
muscle	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0166	0.00498
children	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0163	0.004889999999999999
parameter	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0161	0.00483
of the	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.15	0.0315	0.004725
scale	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0157	0.00471
identification of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.093	0.0046500000000000005
manifests	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0155	0.00465
tumor	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0154	0.00462
clinic	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0151	0.00453
medical	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.015	0.0045
visiting	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0447	0.00447
overview of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.0873	0.004365
symptoms of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.087	0.00435
integrated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0435	0.00435
decreased	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.043	0.0043
status	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0143	0.0042899999999999995
institutional	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0416	0.00416
interacting	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0411	0.00411
family	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0135	0.00405
project	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0131	0.00393
correlated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0391	0.00391
advanced	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0388	0.00388
aging	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0128	0.00384
ages	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0128	0.00384
age	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0128	0.00384
program	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0126	0.00378
protein	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0123	0.0036899999999999997
influencing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0368	0.00368
subjectivity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0122	0.00366
native	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0365	0.00365
distribution of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.0727	0.003635
excellent	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0362	0.0036200000000000004
hospital	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.012	0.0036
supplemented	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0359	0.0035900000000000003
organism	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0118	0.0035399999999999997
organ	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0118	0.0035399999999999997
introduction of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.0698	0.00349
sensitive	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0348	0.00348
quality	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0111	0.00333
strategy	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.011	0.0032999999999999995
standardized	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0328	0.0032800000000000004
balancing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0325	0.0032500000000000003
balanced	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0325	0.0032500000000000003
cost-effectiveness of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.0636	0.0031800000000000005
syndrome	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0105	0.00315
symptom	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0104	0.00312
cell	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0104	0.00312
absence of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.0617	0.003085
transforming	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0307	0.0030700000000000002
transformed	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0307	0.0030700000000000002
transform	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0307	0.0030700000000000002
prevented	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0292	0.0029200000000000003
activity	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0097	0.00291
model	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0096	0.0028799999999999997
pathological	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0287	0.00287
cancer	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0094	0.00282
biological	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0279	0.0027900000000000004
implementation of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.0557	0.002785
patient	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0091	0.0027300000000000002
monitoring	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0268	0.00268
disease	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0089	0.00267
health	BEYOND CUTOFF and FILTERED OUT	SIMPLE	Bad	0.3	0.0088	0.00264
dosing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0259	0.0025900000000000003
impacting	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0251	0.00251
impacted	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0251	0.00251
severe	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0248	0.00248
significant	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0245	0.0024500000000000004
subjective	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.0122	0.0024400000000000003
medicinal	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.024	0.0024000000000000002
organic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Medium	0.2	0.0118	0.00236
pathogenesis of	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.05	0.0437	0.0021850000000000003
presenting	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0207	0.0020700000000000002
presented	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0207	0.0020700000000000002
challenged	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0204	0.00204
expressing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0198	0.0019800000000000004
providing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0197	0.00197
surviving	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0195	0.0019500000000000001
emerging	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0193	0.0019300000000000003
working	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0181	0.0018100000000000002
acidic	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0177	0.00177
public health	BEYOND CUTOFF and FILTERED OUT	Normal_NP	Bad	0.1	0.0165	0.0016500000000000002
scoring	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0158	0.0015800000000000002
scaling	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0157	0.00157
assessing	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0149	0.00149
considerable	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0147	0.00147
evaluated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.014	0.0014000000000000002
planning	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.013	0.0013
improving	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0127	0.00127
improved	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0127	0.00127
programming	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0126	0.00126
reporting	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0118	0.00118
of	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0112	0.0011200000000000001
complicated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0108	0.00108
infected	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0099	0.0009900000000000002
practical	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0098	0.00098
activating	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0097	0.00097
activated	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0097	0.00097
modeling	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0096	0.0009599999999999999
caring	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0093	0.0009299999999999999
studying	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0087	0.00087
studied	BEYOND CUTOFF and FILTERED OUT	In_or_Out_of_Dictionary	Bad	0.1	0.0087	0.00087
the screening guide	BEYOND CUTOFF and FILTERED OUT	unexpected_POS_sequence	Bad	0.0	0.8001	0.0
the practical implications of rems	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.0	0.8422	0.0
the non-osmotic release of arginine vasopressin	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.0	0.8715	0.0
the mandibular right	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.0	0.8083	0.0
the luxated tooth	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.0	0.7927	0.0
the jetpeel -3-carbocaine protocol	BEYOND CUTOFF and FILTERED OUT	bad_character	Bad	0.0	0.8438	0.0
the factor viii	BEYOND CUTOFF and FILTERED OUT	sequence_with_XP_chunk	Bad	0.0	0.7823	0.0
the body of evidence	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Bad	0.0	0.7875	0.0
the biologic behavior of tumor cells	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.0	0.8438	0.0
the autonomous region of cantabria	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.0	0.8438	0.0
the abrasiveness of acidic dentifrices	BEYOND CUTOFF and FILTERED OUT	2_Part_NP	Medium	0.0	0.8476	0.0
m	BEYOND CUTOFF and FILTERED OUT	1-character-term	None	0	0.0805	0.0
d	BEYOND CUTOFF and FILTERED OUT	1-character-term	None	0	0.5401	0.0
,	BEYOND CUTOFF and FILTERED OUT	1-character-term	None	0	0.1958	0.0
